The typical lockup is 180 days after IPO allowing private shareholders, executives the opportunity to monetize. Everyone knows the date, and it sits in the prospectus months ahead. The lead up to these events serve as a well-known opportunity for long and short investors to position ahead of the feared supply that will swamp demand on the days that follow lockup expiry.

So, I went to check whether that actually happens. My last piece, Nine in Ten IPOs Break, found that most of an IPO’s damage lands in the first few months. That is well before the lockup opens. This is the follow-up, and it puts the lockup itself under a microscope.

I pulled 19 of the most recognizable IPOs of the past fifteen years, and ran a study of the period around each one’s 180-day unlock. Every figure here is market-adjusted, meaning the stock’s return minus the S&P 500 over the same days. A falling market

never gets counted as a lockup effect. Day 0 is the first trading day at or after 180 calendar days from listing. Direct listings sit out, since going public without underwriters means there is no lockup at all. Coinbase, Palantir, and Roblox are therefore excluded.

Here is the short version. The dip everyone waits for has already happened by the time the lockup arrives. The unlock day itself is a volume event with a small price notch. The two largest insider floods in the sample did not crater their stocks. They rallied them.

Subscribe now

The fade shows up before the unlock

The dip is mostly over by the time insiders can sell. Stack all 19 names on the same clock and the shape is plain. The average IPO walks into its unlock already down about 15% against the market over the prior 30 trading days. The median is worse, at down 21%. By the time insiders can legally sell, the selling is nearly done.

Some of that slide is ordinary post-IPO drift. These are expensive stocks. The quiet period ends, when the company and its bankers stop promoting the stock, and the first earnings misses land. Some of the slide is the market front-running a date it can see coming. I will not claim the lockup causes the whole 15%. But the direction is clear, and it runs opposite to the folk model. The weakness comes before the event.

Volume is the only thing you can count on

The one dependable feature of an unlock is a jump in volume. On the day itself, volume explodes. The mean is 4.5× normal, and the median is 3×. Every marquee name in the sample lit up. Twitter traded 11×. Uber traded 15×. The float, meaning the shares actually available to trade, multiplies overnight, and the tape shows it at once.

The price move is a different animal. The unlock day is usually a small down-notch. 15 of the 19 names fell against the market. But the average was only −2.7%, and it does not stick. Volume tells you the event happened. It tells you almost nothing about direction.

The reaction is an average, not a rule

The base rate dissolves the moment you look at the names. The 20-day reaction runs from Beyond Meat at −28% to Facebook at +33%. Just over half the sample was negative. The rest rose, some of them sharply. This is not something you can trade blind on any single name. It is a faint tilt buried inside huge dispersion.

The worst-behaved cohort is the one you would guess. The 2019 profitless-unicorn class averaged −5% on the day, on roughly 7× volume. Uber, Lyft, Pinterest, and Peloton led it. The three names that barely flinched arrived at their IPO already profitable, namely Alibaba, Zoom, and Facebook. That is the same fault line my last piece found across the whole asset class.

The biggest single unlocks rallied

The largest single unlocks in the data went up, not down. The cleanest test sits inside two stocks that released their shares in stages.

Facebook spread its release across five dates. The reactions ran the full range. Down 7% on the 90-day tranche. Almost nothing on the 150-day. Then up 14% on the 180-day unlock, which freed 777 million shares. That was the single largest block of the whole schedule. The biggest flood of insider stock in the sample produced a rally.

The +19% pop a few days earlier was Facebook’s Q3 earnings, not a lockup. The two get conflated constantly, and they are not the same thing.

Snap tells it in miniature. Its first unlock freed 400 million shares to early investors. The stock had already bled 22% into the date, and it slipped about 1%. Then came the big one. 782 million employee shares, freed four days after a poor earnings report. That is the exact setup the fear model says should be catastrophic. The stock rose 5.5%.

The mechanism is not mysterious. By the time the flood everyone circled finally arrives, it is the most anticipated seller in the market. The overhang that pressed on the stock for weeks clears. The last buyer of downside protection is done. It is sell the rumor and buy the news, expressed in share count.

The size of the flood is irrelevant

The size of an unlock does not predict the reaction. If the fear model were right, the deals that free the most stock should fall hardest, and they do not. Initial float across the 19 names clustered in a thin band. The median was around 10% of shares outstanding, with none above 20%. So the lockup takes each stock from a sliver of tradeable float to nearly all of it. That is a float expansion of roughly 6× to 16× overnight.

The expansion has no reliable link to the reaction. The rank correlation is near zero over the 20 days after the unlock. On the day itself the faint tilt runs backwards, with bigger expansions posting slightly better days. The two largest single-session releases settle it without a regression. Facebook freed 36% of its shares in one day, and Snap freed 67%. Both rose. What sets the reaction is not how much stock unlocks. It is whether the market saw it coming, and with the date in the prospectus for months, it always does.

Robinhood shows where the cliff went

The clean 180-day cliff is disappearing, and Robinhood is the tell. Its lockup was a patchwork of early releases. A slug of shares became sellable under Rule 144 from the 91st day. Rule 144 is the SEC rule that lets holders sell restricted stock after a set holding period. Price-based triggers freed more, and the nominal 180-day date sat underneath it all.

By the time that date arrived in late January 2022, it was a non-event. Volume ran 1.1× normal. The float had already been let out in pieces, and the stock had already fallen by roughly two-thirds on its own merits. Robinhood’s worst day in the window was not a lockup at all. It was the −10% reaction to Q3 earnings.

More deals now write in these staggered, performance-based releases. The single date you could once circle is turning into a smear. If you still trade the lockup, use the date where the shares actually move. The volume spike will tell you, and often it is nowhere near the 180-day mark.

The folk trade runs backwards

The intuitive lockup trade is backwards. The obvious version is to wait for the lockup and short the flood, and it points the wrong way. The fade is a pre-event, not a post-event. By the day the shares unlock, the crowd has already shorted it, and the overhang is already in the price.

The evidence says the stock is closer to a local bottom than to a fresh leg down. Across the sample, the average name is at its worst the day after the unlock. Then it grinds back to roughly flat against the market within 60 trading days.

If there is an edge near the event, it is the mirror of the folk trade. It is the weakness into the print, not out of it. But the same wall from my last piece applies here, and harder. Borrow on a fresh IPO is scarce and expensive. It gets cheap only once the lockup floods the float, and by then the move is over.

Options are the cleaner vehicle, but implied volatility around these dates is brutal. The pattern is real, but the tradeable version is small. It lives in careful timing and instrument selection. That gap is probably why it survives.

Caveats

This is 19 hand-picked marquee names, not the full universe. They are the famous, heavily analyzed deals with the loudest lockup coverage. That is deliberate. It also bakes in survivorship and selection, and the small-cap tail behaves worse. Returns are market-adjusted with a beta of one, not a fitted factor model.

The 180-day mark is a convention. I use each stock’s first trading day at or after IPO plus 180 calendar days. For the two names with staggered or early-release structures, Snap and Robinhood, that date misses the real unlock. That is why their day-0 volume is flat. The “down 15% into the event” figure blends real pre-positioning with ordinary post-IPO drift, so it should not be read as pure lockup anticipation. LinkedIn belonged in the sample but was dropped, since clean split-adjusted history for it no longer exists after its acquisition.

What I take from this

The lockup is a supply event the market prices in advance. The damage lands in the weeks before, not the day of. If you wait for the unlock to tell you something, you are quite possibly reading yesterday’s news.

Volume is the signal, and price is noise. Every unlock spikes volume. The direction of the day is a small, mostly-down flicker that fades within weeks.

The size of the flood is not the risk. The two largest insider unlocks in the sample both rallied. Across all 19 names, the float-expansion multiple has no bearing on the move. A fully anticipated seller clearing the overhang is a bottoming mechanism, not a crash.

Check the date, not the calendar. Early-release and staggered structures have moved the real unlock off the 180-day mark. Follow the volume, not the six-month rule of thumb.

The lockup is not where IPOs break. It is where the market finishes pricing a break it saw coming months earlier. And often enough, it is where the selling finally ends.

19 marquee US IPOs from 2012 to 2021, with daily prices from Financial Modeling Prep. Event study around each name’s 180-day lockup expiration, defined as the first trading day at or after IPO plus 180 calendar days. Returns are market-adjusted against the S&P 500. Staggered-tranche dates for Facebook and Snap, and the Robinhood early-release timeline, come from contemporaneous reporting and SEC filings. Per-tranche volume uses a trailing 20-day median. Unlock magnitude compares each deal’s base offering size, excluding the greenshoe, to shares outstanding from the quarterly filing nearest each unlock. The greenshoe is the underwriters’ option to sell up to about 15% more shares. Direct listings are excluded. None of this is investment advice. It is a base-rate study. See here for Disclosures & Disclaimers.

So I had Fable build it. Roughly 3,000 US operating company IPOs from 2010 through mid 2026, assembled from Ritter’s IPO database, IPOScoop’s offer price records, and SEC prospectus filings. SPACs, closed end funds, and ETF listings are stripped out. After requiring a valid offer price of at least $4 and a clean daily price history from listing day forward, the core sample is about 1,700 IPOs. Of those, 1,638 also have financial statements from around the time of listing.

The typical IPO loses money

Index every IPO to its offer price, so offer equals 100, and stack all the price paths on top of each other. The median IPO closes day one around 106. It drifts up for a few weeks, tops out, and then bleeds. By the end of year one the median IPO trades below its offer price. By the end of year two it sits around 87 and is still falling.

The mean tells a completely different story. It stays above par and grinds higher the whole time. That gap between mean and median is the entire IPO asset class in one chart. The average gets rescued by a small right tail of enormous winners while the typical name in the group is a losing investment from the first print. Buy every IPO at the day one close and your results depend almost entirely on whether you caught the handful of Airbnbs (priced at $68, peaked at $220, then chopped between $80 and $160 for ~5 years).

A few base rates from the sample are worth having in your head. The median day one pop is 6.5%. The mean is 17%, dragged up by the tail. And about 29% of IPOs close their first day below the offer price. The pop is not a law of nature. It is a coin flip with a mild upward tilt.

The early peak comes fast. Looking at the first 60 trading days, the median IPO tops out around trading day 24, roughly a month after listing. About one in five IPOs peaks within the first three days, meaning the pop was the top.

Then comes the purge. Measured from that early peak, the median maximum drawdown over the following year is 50%. The 25th percentile is 70%. This is not a mega cap thing or a busted small cap thing. It is the base rate for the asset class, and it sits right in the range Truist found on their 30 famous names.

More than 90% trade below their offer price at some point, and the median first breach happens around trading day 31, about six weeks in, after the quiet period ends and well before the lockup opens.

Who comes back

Since breaching the offer price is nearly universal, the interesting question is how long stocks stay under. Most breaches are brief. A stock hovering near its offer dips below and pops back within days. But there is a thick, stubborn tail. I ran the recovery question through survival analysis, treating delistings both as censored observations and as permanent failures, and the two versions barely differ. About 15% of breachers are still below their offer price a full year after first going under. Roughly 10% are still under three years later. Once a name settles into that tail, delisting becomes a common exit. About 40% of the full sample no longer trades today.

Only about six in ten IPOs ever get back to their early peak, and the ones that do often take the better part of a year.

One accounting flag splits the whole market

At the time of listing, only 38% of these companies had positive net income and only 51% had positive EBITDA in their latest fiscal year before the offering. Split every path metric by that one flag and you get two different asset classes.

The EBITDA positive group pulls back a median of 38% from its early peak. Its median price path hovers around par, 103 at one year and 99 at two. Two thirds of these names eventually reclaim their early peak. These stocks mean revert.

The EBITDA negative group pulls back a median of 60%. The median path sits at 88 after one year and 68 after two, still declining. Nearly half are delisted today.

And the part that should bother you. The unprofitable names pop harder on day one, a median of 8.7% versus 5.5% for the profitable ones. The market pays its biggest opening premium to exactly the cohort with the worst subsequent outcomes. Story stocks pop on story. Then the quiet period ends, the lockup expires, the cash burn continues, and gravity does the rest. As far as I can tell, essentially the entire famous long run IPO underperformance result lives inside the unprofitable half of the market.

Two refinements on this.

First, pop size interacts with profitability until it stops mattering. Profitability protects you in every pop bucket except the biggest one. A modestly popping profitable IPO, up 0 to 10% on day one with positive EBITDA, behaves like a normal stock, with a median one year forward return from the day five close of about plus 3%. But IPOs that popped more than 75% were toxic no matter what the financials said. Median one year forward returns were minus 37% for the unprofitable ones and minus 47% for the profitable ones, though that last cell is small. A giant pop is not a quality signal. It is a supply and demand dislocation that gets corrected over the following year, usually violently.

Second, growth partially redeems cash burn. Among the EBITDA negative names, the top quartile of revenue growers, with growth above roughly 80% and a median near 170, showed much better forward returns, roughly minus 12% over the next year versus minus 30 for the slower growers, along with lower delisting rates. The true kill zone is the slow growing money loser. Burning cash while growing less than about 20% carried a median pullback of 64% and about half of those names are gone. Burning cash while hypergrowing is a gamble. Burning cash while growing slowly is a diagnosis. VC backing, for what it is worth, mostly proxies this same split, since 79% of VC backed IPOs came public without positive EBITDA.

The uncomfortable trade

Put the pieces together and a systematic pattern falls out that is almost embarrassing in its simplicity. Short the unprofitable IPOs after the early peak. Entering short at the day 20 close and covering six months later produced a median gain to the short of about 16% with a 63% hit rate across 800 EBITDA negative IPOs. Waiting until day 40 or 60 does slightly better still. Run the same trade on the profitable cohort and you get about 2%, which is no edge at all. The whole anomaly is concentrated in the cash burners.

Before anyone runs off to build this, those numbers are gross of borrow costs, and borrow is exactly where the market defends itself. There is no rule stopping you from shorting a new listing. You can short the moment your broker locates shares. The problem is that shares barely exist to borrow at first. IPO stock has not settled, lendable float is tiny, and fees on fresh deals routinely run to triple digits annualized. In practice, borrow becomes possible within the first week on larger deals, tolerable over the first month, and cheap only after the lockup expiration floods the float about six months in, by which point much of the fade has already happened. Options usually start listing about a week after the IPO and are often the cleaner early vehicle, though implied vol on fresh IPOs is brutal and eats a good share of the expected fade. The edge in the data is real. The implementable edge is smaller and lives in careful instrument selection. That gap, where everyone can see the pattern but few can cheaply trade it, is probably why the pattern survives.

Caveats on base rates

Prices are split adjusted, and I cross checked day one closes against contemporaneous records to catch adjustment mismatches. About a fifth of names needed correction, mostly reverse split casualties. Names with unrecoverable price history, which skew heavily toward fast failures, are missing entirely, so if anything these numbers flatter the asset class. Fundamentals use the fiscal year closest to listing, which for some names is the first post IPO year. Companies that changed tickers along the way, which usually means they were acquired or rebranded, drop out of the sample, and since acquisitions skew toward good outcomes this cuts mildly against the recovery numbers. Offer price records also thin out after 2020, so a handful of famous recent listings like Reddit, Arm, and Cava sit outside the offer price sample even though their price paths check out fine. Direct listings were never in scope since they have no offer price at all. Recent IPOs have not had time to complete their arc. And the 2020 and 2021 vintage, where 60% of IPOs were unprofitable and median pullbacks hit 66%, weighs heavily on the worst cells. The pattern shows up in every era but the magnitudes move with the cycle.

What I take from this

If you like an IPO, plan around a better than 90% chance it trades below its offer price at some point, most likely one to three months after listing. The best time to buy something you believe in is rarely week one. The supply calendar and the data both argue for patience measured in months, not days.

One accounting flag, positive EBITDA at listing, separates stocks that mean revert from stocks that melt. It is the cheapest quality screen in the market and almost nobody applies it to new issues.

And if a deal doubles on day one, that is a reason for caution rather than celebration. The biggest pops had the worst year one outcomes even among profitable companies.

The IPO market is not mysterious. It sells stories at peak enthusiasm into constrained supply, then delivers the shares, and the truth, on a six to twelve month delay.

Data covers roughly 3,000 US operating company IPOs from 2010 to 2026, built from Ritter’s IPO database, IPOScoop, and SEC filings, with daily prices from FMP and Yahoo. The core sample with financials is 1,638 names. None of this is investment advice. It is a base rate study, and base rates are where the bodies are buried.

The verdict, up front

Supply is close to a known quantity. Every project is announced and mapped. The entire 2028 supply band, from announced-only to a fully induced wave, is about 3 to 4 points wide, and the single biggest swing inside it is one company’s tool orders. Undersupply persists through 2028 on the announced path, the base-case 2028 gap is roughly minus 1 point, and 2029 re-tightens because the buildout outruns everything under construction.

Demand is the debate. Morgan Stanley raised its 2027-28 hyperscaler capex forecasts by 9% and 10%, to $1.2 and $1.4 trillion, and now models hyperscaler compute capacity growing roughly 4x from 2025 to 2028 (SemiAnalysis is ahead of even these figures). On top of that curve sits a stack of innovation vectors, each individually worth 2 to 10 points of the 2028 balance, each with a dated gate inside the next 18 months, and each with real companies shipping real products against it today. That stack, not the fabs, decides whether 2028 digests or re-tightens early.

One conditional governs everything. If AI capex enters a bear market, all bets are off, and the point to watch is spot prices cracking while contract prices hold, alongside widening credit spreads on datacenter debt. On the branch where spend keeps pace with expectations, buyers planning in multi-year cycles rationally pay for uninterrupted supply rather than haggle over one year’s balance, and the deposits flooding producer balance sheets say that is exactly what they are doing.

Subscribe now

Price is doing all the work

Korea hosts roughly ~60% of world NAND capacity and publishes its exports monthly in both dollars and kilograms. Divide one by the other and the implied selling price is up three to four times year over year while physical volume sits flat. Volumes stay flat through the coming quarters by construction... no new fab delivers first bits inside 2026, and a wafer already started still needs about a quarter to finish. Every claim in this piece can be checked against that one free dataset, on the first of every month.

The tape behind that chart is worth spelling out, because the individual prints are hard to believe until you line them up. Korea’s NAND exports ran +366% year over year in January, +377% for the first quarter, and +207% in May... on falling kilograms. A one-terabit TLC chip that sold for $4.80 has printed $10.70. First-quarter contract prices settled up 33 to 100% depending on the product, and second-quarter settlements came in up another 70 to 75%. Counterpoint put first-quarter industry revenue at $46 billion, an annualized pace nearing $200 billion against roughly $74 billion for all of 2025. One honesty note belongs here because it applies to every forecast you will ever read on this market, including this one. The suppliers stopped disclosing absolute bit shipments years ago, so every exabyte model in existence, TrendForce’s, the sell side’s, and this one, is constructed by chaining disclosed growth rates off an anchor. The dollars and the kilograms are the only hard numbers in the whole debate, which is exactly why the Korea series is the referee.

Twelve years of deflation, inverted in one

NAND’s natural state is falling prices... cost per gigabyte drops 15 to 25 percent a year, bits compound, and buyers get rescued by physics on schedule. Twelve years of that pattern ended with the 2023 bust pricing bits at cash cost, roughly $0.055 per gigabyte, and producers answering with the deepest cuts in the industry’s history. AI demand arrived in late 2025 into a supply base that had been deliberately shrunk.

Walk the regimes and a base rate falls out. The 2016-18 supercycle was cloud demand landing on the 3D transition, and supply arrival cured it... prices fell roughly 60% in 2019, about two years after the price signal. The covid whipsaw pulled demand forward and then took it back. The 2022-23 collapse was the worst in the industry’s history, the first time bits ever traded at cash cost, and it did something no previous bust had done... it taught the survivors what the bottom actually looks like. Industry revenue went $57 billion in 2018, $39 billion in 2023, $74 billion in 2025, and the 2026 build now points to roughly $320 billion. Read that last jump carefully. Bits are up maybe 10% this year. The rest is price. Every prior shortage in this market was cured by supply within 18 to 30 months of the price signal, and that base rate is the strongest argument the bears have. The counterargument is physical. This time the cure is slower, because stacking toward 1,000-plus layers now requires bonding finished wafers together, every bonding step costs yield, and roughly a fifth of world capacity sits politically frozen at legacy nodes in China under export-control rules. The deflation that always rescued buyers is fading exactly as the biggest buyer the industry has ever seen walks in.

The buyers keep raising their own numbers

Plain and simple, buildout numbers keep going up... at least for now, though the revisions are smaller than early 2026 rounds. Morgan Stanley’s rebuilt bottom-up model puts hyperscaler compute capacity at about 30 gigawatts in 2025 growing to roughly 120 by 2028, four times in three years, and its 2027-28 capex forecasts moved up 9% and 10% in a single week, with Meta up 29% and 22% and Amazon up 15% and 29%. And look at what is driving the cost of a datacenter from $35 billion per gigawatt on GB200 racks to $39 billion on GB300 to $49 billion on Vera Rubin... partly memory inflation itself. Memory prices are now large enough to move the cost of the datacenter, which feeds the capex forecasts, which feed memory demand. Revisions this cycle have run one direction.

Those bars slot into the wider global picture. SemiAnalysis tracks global datacenter capacity outside China near 89 gigawatts in 2026, about 106 by 2027 on grid-connected supply, and as much as roughly 338 by 2030 once converted sites and behind-the-meter generation are counted. Inside that envelope, converting disclosed capex to capacity at $45-55 billion per gigawatt yields gross additions of 25-30 gigawatts in 2026 rising toward 70-77 by 2029, about 60-65 net of equipment refresh, and Morgan Stanley’s hyperscaler-only additions of 21, 29, and 36 gigawatts sit inside it as the floor. Each gross gigawatt carries 16 to 17 exabytes of NAND in the base case, and an independent rack-by-rack build lands within one percent of that arithmetic in every overlapping year.

AI is taking the market

AI is now the marginal buyer of every bit, and it is pushing phones and PCs down the queue. Handset makers are already cutting storage per device to absorb the price shock, resuming their traditional role as the market’s shock absorber, while enterprise and AI bits go from 22% of the market in 2024 to roughly 58% by 2030 in this build. Consumer becomes the residual claimant on wafers, which is why it absorbs the shocks in both directions.

The engine behind that green wedge... when a model works a task, it holds a running memory of the session, the KV cache. The physics of it can be derived on one page. A model writes somewhere between 35 kilobytes of cache per token, for the most aggressively compressed architectures like DeepSeek’s, and 300-plus kilobytes for frontier dense models, which means a single million-token session occupies 35 to 300 gigabytes per conversation. That state used to live in scarce GPU memory and die with the session. Agents broke the arrangement, because an assistant working a multi-day task cannot afford amnesia, and the operators did the arithmetic. Parking the state on flash costs about ten cents a day, while recomputing it burns about two dollars of GPU time every single time, and takes minutes the user will not wait. A 70-billion-parameter Llama model writes about 326 kilobytes of cache per token, which means a terabyte of expensive DRAM holds roughly eight minutes of context before eviction begins and hit rates collapse. Manus, the agent startup Meta bought for $2 billion, calls cache hit rate the single most important metric in agentic AI, and agents generate on the order of 100 times the tokens of a human chat. Moonshot’s Mooncake has pooled these caches across DRAM and SSDs at thousands-of-nodes scale since 2024, with peer-reviewed serving gains of 59% to 498%. Nvidia industrialized the pattern in January... ICMS, a dedicated flash tier for each Rubin pod, sized in Nvidia’s own words at petabytes per pod, shipping with the BlueField-4 processor in the second half of this year.

And the pull on wafers is bigger than the bits. A flash tier written like memory reserves 2 to 3 units of physical capacity per unit of usable capacity to spread the wear, and the AI tier is reviving one-bit-per-cell SLC media, which consumes three times the wafer area of a mainstream TLC bit. Samsung has exited MLC outright, and every low-bit-per-cell tier is reported extremely short. Stacked, the affected volume draws three to four times the wafers per usable exabyte, which is why wafer demand is rising faster than bit demand and why the shortage binds at the wafer, not the exabyte.

Supply... take it as given, inside a defined band

A handful of companies own effectively all the fabs, a greenfield takes 15 to 42 months from decision to first bits, and every project is announced and mapped below. That makes supply the knowable side of this market, and the honest way to treat it is as a given with a band. The band runs like this. 2026 is fully written, about 55,000 wafers per month of additions, 3.6 percent of the installed base, plus or minus a point. 2027 is plus or minus 2 points, set by K2’s ramp cadence and Dalian’s tool installs. 2028 is plus or minus 3 to 4 points, and Samsung is nearly the entire swing... V10 is slated for mass production in late 2026, yet as of May the tool orders had not been placed, and those purchase orders start a 15-to-21-month clock the whole market can read. 2029-30 widens to 8 to 10 points as M17, P5, Singapore, and YMTC’s next fab ramp or slip. Everything else is a 2029 story.

Why so much confidence in the band? Because the machinery only has so many levers, and the fast ones all point the wrong way. A wafer takes about three months and a thousand sequential steps to flow through a fab, so output physically cannot spike inside a quarter... that is the base clock under everything. Above it, the menu is short. Restoring idled utilization is the one fast lever that adds bits, and it is already spent... that is precisely what the flat Korea kilogram data means. Switching wafers into the AI-preferred one-bit mode is instant and subtracts two-thirds of their output. Node conversions are J-curves... output falls during the tool swap, then yield climbs from roughly 60% to 90% over a year. Greenfield is 30 to 42 months of concrete physics. And sitting on top of all of it is the most under-modeled friction in the industry... qualification. An enterprise drive must pass 6 to 12 months of hyperscaler validation per drive per platform, and a new node restarts much of it, so qualified supply structurally lags physical supply by two to four quarters. The net of all this is that supply arrives as datable lumps, the earliest observable event in the longest chain is a tool order, and that is why a single Samsung purchase-order headline carries more information than most quarters of earnings.

One paragraph of history explains why the band is credible rather than hopeful. This market earned its undisciplined reputation honestly... around 2003, roughly a dozen producers expanded into every uptick, and twenty years of losses did the consolidating, down to five groups plus one Chinese entrant, with the top two controlling about 58% of wafers. The 2023 bust finished the education. Now, against the strongest inducement any commodity has ever offered, a $15-20 billion fab paying back in under two years, the incumbents are still holding formation. The Kioxia/SanDisk joint venture funds growth entirely inside existing building shells, with either partner able to veto expansion and any new-fab decision pushed to fiscal 2027-28. Micron’s stated policy is no new NAND wafers beyond its Singapore project. SK hynix waited until this month to announce the cycle’s first true greenfield, and its first bits land in 2029, not 2028. The exception is state-funded YMTC, around 8 percent of wafers heading toward 17 by 2030, indifferent to price by design. Whether formation holds against a decade-long demand wave is a fair question. The tell is public, and it is Samsung’s order book.

The balance, and where the real debate lives

Cross the demand envelope against the two edges of the supply band...

In 2028, the difference between announced-only supply and a fully induced wave is worth about 2 points. The difference between the demand paths is worth up to 9. Supply sets the stage... demand writes the year. That is why the rest of this piece is about demand.

2028... the demand drivers, one at a time

The fair way to handle a feared year is not to argue it away. It is to quantify what would deepen it and what would fill it, each variable alone, with a probability and a date. Do not sum the green bars... several are correlated (the attach dial and the SLC shift overlap in the same racks), and stacking them would manufacture a bull case. Read them as independent answers to one question. How much does this single variable move the 2028 balance if it goes its way?

1. The intensity dial (+7 to +9 points, roughly a 30 percent chance). The base case holds storage per gigawatt flat, and every hardware precedent argues against that... HBM content grew roughly 50 percent per GPU generation, the newest racks carry four times the system memory of the prior ones, and cache-hit economics improve as storage is added, meaning flash converts directly into effective compute. The plumbing for this is shipping, not slideware. Nvidia’s Dynamo scheduler and its NIXL transfer library, riding GPUDirect Storage, let a GPU pull cache straight from flash with microsecond latency, and BlueField-4 fronts the whole tier. The storage industry has piled in behind it. WEKA’s Augmented Memory Grid, already generally available and validated with Supermicro, streams cache between GPU memory and what it calls a token warehouse at roughly 300 gigabytes a second per host, claiming a thousand times the cache capacity of DRAM and a twenty-fold cut in time-to-first-token on 128,000-token contexts. VAST Data open-sourced its equivalent, VUA, showing roughly threefold faster first tokens at 30,000-token contexts. Pliops sells a purpose-built accelerator card, an ASIC that turns a GPU server’s SSDs into a cache tier without touching the cluster architecture. Hammerspace, DDN, Lightbits, ScaleFlux, Peak:AIO, MinIO, Cloudian, and Graid all ship variants, and Quanta builds a server around the concept. If attach compounds the way memory content always has, 2028 swings from minus 1 to plus 8 on this dial alone. The range is measurable... the context tier spans 300 to 2,500 terabytes per rack depending on whose configuration wins, a spread worth roughly $200 billion of 2028 industry revenue, and it converts from assumption to measurement the day someone opens a shipping enclosure with a screwdriver, likely in the first quarter of 2027.

2. The memory transition (+3 to +5 points, roughly even odds). The deeper story practitioners keep telling is flash entering the memory hierarchy itself, and it is a wafer story, not a bit story. High Bandwidth Flash is SanDisk’s invention... sixteen flash dies stacked into a 512-gigabyte device delivering 1.6 terabytes a second, in a footprint that drops into an HBM4 socket, holding about four times the capacity of the HBM it sits beside at comparable cost. SanDisk seated David Patterson, the Berkeley architect behind RISC and RAID, and veteran chip designer Raja Koduri on its technical advisory board to shepherd it, then signed SK hynix last August to co-develop the standard, a competitor-turned-partner arrangement the industry has not seen since the early HBM days. Samsung and Micron are reported to be running their own designs behind it. One rung down, Kioxia’s XL-FLASH answers Nvidia’s explicit specification for a high-IOPS AI drive... single-bit cells read in about five microseconds, an order of magnitude faster than ordinary flash, with samples due this year. Both products run on the same production lines as mainstream flash, so every wafer they win comes out of the common pool, and because single-bit media takes triple the area, each exabyte of this tier effectively withdraws about two more exabytes of ordinary supply. The tier does not need to be huge to matter... it needs to exist.

3. The CPU-server line (+5 to +10 points, genuinely unresolved). Agentic AI turns out to be CPU-hungry... the scaffolding around every model call, the tool calls, retrieval, sandboxing, and scheduling, runs on ordinary cores, whether Intel and AMD sockets or the hyperscalers’ own Graviton, Axion, and Cobalt chips. A JPMorgan and Gartner forecast circulating this spring put server CPU units at 68 million by 2028 versus 26 million in 2025... stress-tested against wafer supply and the more conservative sell-side numbers, the mechanism survives with the magnitude cut by a third, to roughly 44 million. The strongest confirmation on record came from AMD itself, guiding that its server CPU shipments will decline in late 2026 because memory cannot be procured. Every one of those servers carries enterprise flash. The open question, and it deserves to be stated as open rather than assumed... is this buildout already inside the gigawatt envelope, or additive to it? If additive, it is the largest single tightener on the board, and Mercury Research’s late-August unit print will start answering it.

4. SOCAMM returns as flash (+2 to +3 points, roughly even odds). When Nvidia cut the Vera Rubin memory configuration from 192 to 96 gigabytes per module, the displaced context state did not vanish... it moved down the hierarchy toward flash, and the module sockets ship installed and empty either way. Dell, HPE, Supermicro, and Quanta are productizing the flash bays now, and the first wave of buyers is on the record... CoreWeave, Crusoe, Lambda, Nebius, and Oracle Cloud among them. If the deferred state lands in those bays through 2027-28, it is incremental NAND demand that no percentage forecast contains.

5. Samsung slips (+2 to +3 points, maybe one chance in three) is the one supply-side row worth carrying... every quarter of V10 slippage past mid-2027 removes supply from a 2028 that consensus already books.

The looseners get equal weight. A hyperscaler funding shock (minus 20 to 30 points, perhaps a one-in-eight chance) is the only force fast enough to break the balance before the fabs do, and it announces itself... spot cracks while contracts hold, and credit spreads on datacenter debt widen. Model routing (minus 3 to 5 points) is the honest demand-side risk... cheap small models handling more queries could shrink state per query even as queries grow. The compression version of this fear was just answered the other way. DeepSeek’s latest model cut cache size roughly tenfold, and total flash-resident context rose as cache-hit pricing collapsed and usage exploded, the oldest pattern in technology economics. Routing remains open. The full supply wave (minus 2 to 4 points) is smaller than intuition suggests, because even a maximal wave mostly lands in 2029 and later. Deeper consumer cuts (minus 2 to 3 points) are the shock absorber absorbing more.

What the fork does to price

Here is where the volume debate becomes a dollars debate, and where the structure of this cycle diverges hardest from every prior one. While shortages persist, price rises, capped only by what the contracts allow. A correction is not a schedule... it is an event, and the event requires two things to happen together, tool orders that have not yet been placed, and a demand undershoot that the buyers’ own raised forecasts argue against. In the base case, blended pricing grinds to roughly five times late-2025 levels by the end of 2027, gives back about 15% through the 2028 digestion, and firms again into 2029. The revenue arithmetic under that path runs from a peak near $314 billion in 2027 to a trough around $215 billion in 2028 and back to roughly $298 billion by 2030. The bull path, where content compounds and the correction never gets room to happen, grinds toward $936 billion by 2030... which, for calibration, is roughly the world the most evangelical price targets in this sector quietly require. The bear needs everything at once, soft demand and a full supply race and bending floors, and even then it produces $82 billion in 2028, a one-year drawdown harsher than the entire 2023 crash.

Two things on that chart deserve a hard stare. First, 2026 and 2027 barely fork at all. Those years are locked by allocation and contracts, which means the entire investment debate compresses into 2028 and beyond... trade the fork, not the consensus. Second, look at where the downside paths land. Every scenario keeps 2028-30 pricing above the 2023 trough of $0.055 per gigabyte. The base-case floor sits near $0.159, about 2.9 times the trough. The bear floor sits near $0.070, about 1.3 times. That spread, 1.3x versus 2.9x trough, is the single most valuable unknown in the entire model, and it is not a demand question or a supply question. It is a contract question, which is where this piece goes next... after one more stop on the demand side.

The upside has a calendar, and a cap table

What separates this demand stack from a story is that every vector carries a dated gate, a moment when it converts from assumption to measurement, and the whole calendar fits inside 18 months. Two more vectors sit beyond the tornado. Per-user persistent memory is quietly becoming its own funded software category... Mem0, which raised $24 million and became the memory provider inside Amazon’s agent toolkit, processed 186 million memory API calls in a single quarter. Letta grew out of Berkeley’s MemGPT research and pages an agent’s memory between context and disk the way an operating system pages RAM. Zep builds timestamped knowledge graphs so an agent knows what was true and when. Microsoft now ships user-scoped memory inside Azure AI Foundry and Oracle built a memory core into its database. Every fact those layers retain is a write that outlives the session, multiplied by user counts in the hundreds of millions. This is the vector where big and sudden is most likely and least priced, because it changes the demand equation’s very units... inference storage stops being per-query and becomes recurring per-user. Storage turning into a subscription. And behind that sit the video and world-model labs, World Labs, Runway, Luma, Decart, Odyssey, whose persistent interactive worlds hold state that makes text look small... that vector mostly loads 2029 rather than 2028.

The market is pricing 2028 as if the supply is certain and the innovation is hypothetical. The project list says the supply is conditional. The shipping products say the innovation is not.

Look at 2028 from the buyer’s chair

The whole thesis folds into one conditional. If AI capex enters a bear market, all bets are off... the balance breaks through the credit channel faster than any fab can move, and no line on any chart above survives the repricing. That is the honest boundary of this analysis, and the tripwire never changes... spot cracking while contracts hold, credit spreads on datacenter debt widening.

Now walk the other branch, the one Morgan Stanley just marked higher. A hyperscaler planning a multi-year buildout is not studying 2028 balance charts hunting for a year to nitpick price. Memory inside a $49 billion gigawatt is a real cost but a survivable one. A gigawatt of racks sitting idle for want of drives is not. When a single teardown can swing the balance eight points, the rational buyer pays for certainty of supply and treats price as the second-order term. If anything, the move on this branch is to keep signing long-term agreements with flexible terms, locking volume while capping the downside, which is what the producers report the buyers keep asking for... Kioxia’s counterparties are already pushing to extend beyond 2029.

And notice what the buyers are actually doing, because it is stranger than it sounds. The largest, best-informed technology companies on earth are walking into commodity memory suppliers and offering to fund their capital spending, posting billions in cash as security. These are the operators of the biggest AI clusters in existence... nobody sees the next three years of compute demand more clearly than they do. The agreements are untested, and the first soft quarter will test them. But a deposit is a forward view expressed in cash, and the deposits are accelerating.

The floor under 2028 is written in contract law

Here is what that behavior has produced on paper, and it is the genuinely new feature of the cycle... for the first time in memory’s history, the buyers have posted cash. Micron holds 16 strategic customer agreements, five-year take-or-pay, covering roughly a third of its NAND volume, with about $100 billion of cumulative minimum revenue and roughly $22 billion in deposits and letters of credit. SanDisk’s order book runs to about $69 billion, backed by more than $11 billion of enforceable guarantees, across five multi-year agreements covering more than a third of next fiscal year’s output. Kioxia is targeting agreements over roughly half of its 2028 bits, with counterparties asking to extend beyond 2029. If a customer walks, the supplier does not sue for years... it draws on money that already exists.

The deposit design matters more than the headline sums. These are security instruments, held at full value and returned at contract completion rather than drawn down per shipment, so the guarantee’s coverage of what remains owed rises over the contract’s life, from roughly a quarter at signing toward full coverage in the final year. Maximum protection lands exactly where breach risk lives... 2028 and beyond. The collection pace is sitting in the filings, with Micron’s deposit-linked liabilities running from $1.4 billion to $7.1 billion in nine months and SanDisk booking its first $511 million of inflows in April. Customer floors typically sit 10-20% below baseline pricing, which is why the base case’s 2028 digestion prices as roughly a 15% giveback rather than a collapse, why consumer prices crack first while the contracted datacenter tier holds longest, and why the only fast bear runs through the credit channel. Fair warning on the limits... the fixed-versus-floating split inside each contract is largely undisclosed, the floors’ first real test only comes in the first soft quarter, and the same deposits come due for return around 2029-30, a refund cliff timed, by construction, to the arrival of the supply wave. Whether the floors hold on first contact is worth a factor of two on every terminal value in the sector... it is the 1.3x-versus-2.9x-trough spread from the price chart, restated in legal terms.

The balanced close

None of the upside is a promise. Any vector can fail cheaply... a teardown under 400 terabytes per rack halves the biggest demand line, a weak Mercury Research print in late August retires the CPU-server story, HBF sampling as a clever drive rather than a socketed device shrinks the memory-transition prize, and soft demand meeting full supply execution produces a 2028 surplus north of 30 points. But the shape of the debate is now clear. Supply is a band a few points wide with one company holding the pen. Demand is a freshly raised capex curve with an innovation stack on top, and if models keep improving, adoption keeps widening, and use cases keep multiplying, hardware innovation does not stop at the GPU and the CPU... it moves down the memory hierarchy toward wherever state can be held cheaply, because state is what agents accumulate. On the balanced reading, buyers take 2028 as a breather, give back perhaps 15 percent on price against contract floors, and walk into a 2029 demand cohort that nothing currently under construction can meet. The customers with the clearest three-year view are choosing to prepay for supply rather than wait for a better price. Their behavior is a forecast, and it is the one worth weighting.

The scoreboard

The supply is the band. The demand is the debate. The floors are the trade. The calendar settles all of it, one dated event at a time.

What does this mean for Sandisk (SNDK)…?

Subscribe to see…

Subscribe now

Read more

This Friday, SpaceX will begins trading… SPCX… $135/share… raise of about $75 billion… valuation of ~$1.75 trillion. The largest IPO ever. Starlink, with $11.3 billion of 2025 revenue and 10.3 million subscribers, is the near term engine of any fundamental valuation.

Buried in the competition language of that S-1 is a company with seven satellites, $70.9 million of trailing revenue: AST SpaceMobile.

This post is about why those two companies, and for broadband purposes only those two, are racing for the same prize: turning every ordinary smartphone on Earth into a satellite phone. No app. No antenna. No new hardware. The phone already in your pocket, connecting to space when towers cannot reach it.

The market understands roughly half of this race, the Starlink half. The other half is one of the more interesting under-examined setups in public markets. Some institutions have shunned the other half because of the “Space Mob” stereotypes thrown around, the pre-revenue nature, or simply for fear of buying an Elon competitor. What follows is the logic, in seven pictures. I have tried to make every chart honest enough that a Starlink bull could read it without objecting to the facts.

Subscribe now

(Disclosure and method notes at the end. Nothing here is investment advice.)

1. The race almost nobody is pricing

D2D service is already real. T-Mobile sells it today for $10 a month, powered by Starlink. Millions of people used it during the 2025 hurricane season. Apple’s Emergency SOS has quietly routed iPhone messages through Globalstar satellites since 2022.

Here is what the headlines miss: everything live today is narrowband. Texting. Location pings. Compressed voice in beta. The real prize is full cellular broadband from space to an unmodified phone, the thing that actually replaces a cell tower. That category has exactly two credible entrants, and as of this morning, zero occupants.

Chart positions D2D players by service class and deployment status, showing Starlink live in narrowband moving toward broadband, AST SpaceMobile in broadband but pre-commercial, and an empty contested quadrant for live broadband service.

Amazon bought its way to a third seat in April, paying $11.6 billion for Globalstar. But its own D2D system starts deploying around 2028, at best, and likely later given its leading peers have shown it can take multiple years to design and engineer the right satellites for proper service. Skylo and Lynk sell texting. China is building a parallel system closed to Western operators anyway. Through at least 2028, broadband from space to your phone is Starlink versus AST SpaceMobile.

One of those names trades at a $1.75 trillion target. The other is a roughly $35 billion company with a devoted retail following, thin institutional coverage, and near-zero recognition among the general public. That awareness gap is not itself a thesis. It is the precondition for one.

2. Two ways to build a cell tower in space

The physics problem is brutal and identical for both companies. A smartphone transmits about 0.2 watts from a tiny antenna that points nowhere in particular. To serve it from orbit, a satellite has to hear that whisper from roughly 500 kilometers up, then whisper back loudly enough to be heard indoors.

The two companies answered with opposite machines.

Drawn to scale. AST’s answer is the largest commercial antenna ever deployed in low Earth orbit. Starlink’s answer is hundreds more satellites, flying closer.

AST builds enormous satellites: about 2,400 square feet of phased array on a 6,100 kg spacecraft, the largest commercial antennas ever flown in low orbit. Antenna size is receive sensitivity. AST’s array is roughly 35 to 40 times the size of Starlink’s per-satellite D2D antenna. That is what lets one AST satellite deliver up to 120 Mbps per cell (per its FCC filing) and close a link through a roof. Management has guided to 150Mbps per cell and some AST sleuths have shown this number could grow by multiples as they release their new ASIC and bundle additional technology. It also opens a second business for large government contracts in defense and otherwise.

Starlink builds compact panels on mass-produced buses and compensates with numbers: more than 600 D2D satellites launched, flying about 170 km lower, replaced often, on rockets it owns. Its Gen-2 satellites claim five times the antenna and roughly 100 times the data density of today’s.

Any cell, terrestrial or orbital, is a shared medium. AST’s 98.9 Mbps demo is a link-budget triumph, not a capacity claim. Within each satellite cell, bandwidth is shared among every active user, and by my math both constellations deliver a tiny fraction of terrestrial capacity density: on the order of 0.1 Mbps per square kilometer averaged across the US. Satellite D2D is a coverage business. Starlink’s path to more capacity is more satellites and tighter frequency reuse. AST’s is wider spectrum slices and beamforming. Neither will ever replace towers where towers exist, and neither is trying to, so far.

And one asymmetry the antenna chart cannot show: the ground. AST’s design routes every call through a gateway station, so a satellite must see one to deliver service. Continuous coverage needs a parallel build-out of earth stations, with all the permitting and fiber that implies. Starlink’s laser links let satellites hand traffic to each other and come down wherever convenient, which is a genuine architectural edge in some ways and downside in others (see prior posts on data sovereignty). AST’s partial answer is baked into its business model: carriers buy the gateways. Gateway hardware is most of AST’s booked revenue today. That shares the cost without erasing the execution risk.

Neither approach is wrong. They are different bets: physics per satellite versus economics per fleet. But for the specific job of broadband to an unmodified phone, indoors, the antenna math favors the big satellite. Which leads to the more interesting question.

3. The spectrum chess game (think of it like sound)

Radio frequency behaves like sound. Bass travels through walls. Treble does not. Low-band spectrum (700/800/850 MHz) penetrates buildings, cars, and forests. Mid-band S-band spectrum near 2 GHz is crisp outdoors and dies at the drywall.

Now look at who holds what.

US D2D spectrum map, to scale. AST borrowed the bass from the carriers and bought the mid-range cheap. SpaceX bought the treble outright, for about $19.6 billion.

AST’s position is the one the market has not absorbed. In April, the FCC authorized up to 248 AST satellites to operate commercially on 700 and 800 MHz low-band: AT&T’s, Verizon’s, and FirstNet’s own frequencies, leased to AST for revenue share, with zero dollars upfront. No other company on Earth holds an indoor-capable D2D authorization. Not SpaceX. Not Amazon. The carriers own that spectrum, and they chose their partner.

The fine print that bulls skip: the authorization comes with leashes. Under the FCC’s Supplemental Coverage from Space rules, satellite service is secondary to terrestrial networks. Transmit power is capped to protect towers, with coordination back-offs near market boundaries and the Canadian and Mexican borders. The bass advantage is engineered for dead zones, the empty fifth of the US landmass that towers do not reach, not for downtowns, which the capacity math rules out anyway. The moat is real. It is also regulated.

On top of the leased low-band, AST locked up 45 MHz of L-band from Ligado for about $550M upfront plus roughly $80M a year for 80-plus years. Pocket change next to what SpaceX paid EchoStar: about $19.6 billion for roughly 65 MHz of S-band. SpaceX’s spectrum is genuinely valuable, owned outright and globally harmonized. It is also treble, outdoor-grade. And it has a second problem that deserves its own chart.

4. The clock inside your phone

A satellite band is only real once phones support it. This is the most underrated fact in the entire race, and it is where the two strategies diverge hardest.

Three paths to your phone. The carriers’ low-band is already in every handset. AST’s L-band has existed in the 3GPP standard since 2022. SpaceX’s band was born in January.

AST’s primary play, riding the carriers’ low-band, requires no new chipset at all. Every phone sold in the last fifteen years already speaks 700 and 800 MHz. That is what “broadband to an unmodified phone” actually means, and AST has demonstrated it: 98.9 Mbps to a standard handset, native video calls included.

AST’s L-band sits inside 3GPP band n255, standardized in Release 17 back in 2022 and already validated on commercial modem silicon. Management guides for L-band support in “most new phones in a big way” from 2027.

SpaceX’s new S-band holdings only partially overlap the existing standard, so the industry had to create a new band: n252, under Release 19, which got its first commercial-silicon demo at CES this January. When Musk said at MWC that broad chipset support is about two years out, that was not pessimism. It is the normal speed of the standards-to-silicon-to-handset pipeline. Until then, SpaceX’s $19.6 billion band waits.

The honest sequencing: AST’s spectrum works in your current phone. Its second band arrives in next year’s phones. SpaceX’s band arrives roughly with the 2028 model cycle.

5. What they have promised, and what we actually expect

Both companies have put specific guidance on the record. The chart below shows it side by side, along with one adjustment of ours, clearly marked.

Dual timeline from June 2026 to 2028. The AST rail shows launches, continuous service guidance, revenue targets of 150 to 200 million in 2026 and about 1 billion in 2027, plus an adjusted base case of about 30 satellites by year-end 2026 with 45 to 60 shifted to Q1 2027. The Starlink rail shows the IPO, Gen-2 deployment, a 25 million user target, and 2028 chipset and Deutsche Telekom milestones.

AST has guided to: 45 to 60 satellites in orbit during 2026 (BlueBirds 8, 9 and 10 are stacked on a Falcon 9 for a mid-June window); continuous US service beginning in H2; $150 to 200M of 2026 revenue with half already contracted; and roughly $1 billion in 2027, split about 50/50 commercial and government, on roughly 90 satellites. It holds about $3.5 billion of cash and says it is fully funded for the build, at $21 to 23M per satellite. Behind the guidance sits a contracted floor: $1.2 billion of take-or-pay commitments, including a $175M prepayment from STC.

Our adjusted base case, shown on the chart: launch cadence rarely forgives. With New Glenn grounded since its May 28 pad explosion and Falcon 9 manifest slots finite, we pencil in roughly 30 satellites by year-end 2026, with the 45 to 60 threshold reached in Q1 2027. What that one-quarter slip means: continuous service and the uncontracted half of the 2026 revenue guide slide toward 2027, since carriers will not bill retail customers for intermittent coverage. Revenue leans on the contracted floor: gateway sales, prepayments, and government milestones, which usefully scale with satellite count rather than the finished constellation. With $3.5 billion of cash this is not a solvency question, but it reopens the dilution question in 2027, from a weaker share price, before carrier revenue proves out if there are issues getting service running as expected. That is the nature of a launch-shaped thesis: the same binary that can re-rate the stock this autumn can push the story out a year.

Starlink and SpaceX have guided to: 650 Gen-2 satellites within 18 months; about 25 million Starlink Mobile users by year-end (their target); T-Satellite voice out of beta and data expanding; a Deutsche Telekom launch across 10 European countries in 2028; and the IPO itself, which makes the war chest effectively unlimited. One strategic read worth a sentence: the $19.6 billion EchoStar purchase bought independence, the option to operate as a global carrier keeping 100% of the revenue per user rather than splitting it as a wholesale partner. SpaceX traded two years of chipset lead time for permanent margin control. The Deutsche Telekom deal shows it will happily run both models at once. However, DT has also publicly stated they may pursue a dual course strategy with other operators, presumably AST.

The asymmetry matters. AST’s promises are binary and near. Rockets fly and satellites work, or they do not, and we will know within quarters. Starlink’s are gradual and far: chipsets, regulatory transfers, Starship cadence. The next two quarters stress AST harder. The next two years stress Starlink.

And the honest ledger requires this paragraph. AST is behind. It has seven satellites and zero paying subscribers. It buys launch from others, currently including its rival’s Falcon 9. It must deploy, then re-prove at constellation scale what it has so far proven in tests. The hardest engineering work is plausibly done: design frozen, factories running, FCC cleared, carriers signed, capital raised. The hardest operational stretch starts now.

6. The quiet customer

Here is the part of the AST story that gets priced last, and where I will be most careful to separate fact from thesis.

Three-tier chart of AST’s defense business: public-record contracts including a 30 million dollar SDA prime award; partially disclosed items like ten government use cases cited by management; and the explicitly labeled bull’s inference of a Palantir-style re-rating, with SpaceX’s Starshield incumbency shown for balance.

On the public record: AST’s defense subsidiary won a $30M prime contract from the Space Development Agency (HALO Europa Track 2) in February, its first as prime. It holds an MDA SHIELD IDIQ that makes it eligible for Golden Dome task orders. It demonstrated tactical communications to US Indo-Pacific Command: TAK over VPN and secure video, on standard phones. FirstNet’s public-safety Band 14 is written into its FCC grant. And it holds experimental authority at 902 to 928 MHz, the foundation of a radar ambition only a giant antenna can attempt.

Disclosed in outline only: management cites roughly ten government use cases and books government revenue at milestone level. It describes this work without detailing it. Government is roughly half of the near-term revenue plan, and it scales with satellite count, not the finished constellation. It monetizes early.

The bull’s inference, mine, clearly labeled: if that outlined government book converts into visible, reported revenue through 2026 and 2027, the market tends to re-rate companies the way it re-rated Palantir. Opaque government traction becomes printed numbers, and the multiple follows. The caveat is real and I will state it plainly: Palantir re-rated on proven software margins. AST must first fly the hardware. The pattern is plausible.

For balance: SpaceX is already a defense giant at far larger scale. Starshield is largely classified, with a reported $1.8B NRO constellation among its work. The difference is that defense is upside on top of SpaceX’s valuation, while for AST it is a second business the current price arguably does not reflect. Both carry political risk, in opposite directions.

7. The honest scoreboard

Score it honestly and Starlink wins the present on nearly every line. AST’s wins are the forward-looking ones. That is not a tie. It is a duopoly forming.

What would break the AST thesis? I keep a live list: launch cadence slipping past even our adjusted base case into mid-2027 (watch New Glenn’s return to flight, and whether the BE-4 investigation touches ULA’s Vulcan, since both are named AST providers); satellites underperforming at scale what seven units demonstrated in tests; consumer willingness-to-pay disappointing (T-Mobile’s CEO has already admitted satellite usage is running lighter than expected, which cuts at both companies’ consumer math); the FCC’s pending Ligado sign-off stalling; a gateway build-out that lags the constellation; or dilution if “fully funded” proves optimistic.

What would break the Starlink-dominance thesis is simpler: nothing breaks it before 2028. It merely gets bounded. Starlink keeps the present: the revenue, the rockets, the subscriber machine. The question the market has not priced is whether AST keeps the blueprint: the physics, the indoor spectrum, the carrier alignment, the standards head start, and a government customer that pays early.

My bottom line: this is a duopoly forming in plain sight, and only one of its members is priced like a member. Starlink owns the present. AST owns the blueprint and potential stronger path to consumers via their less adversarial structure. Neither can take the other’s ground before roughly 2028, and the next two quarters of launches will tell us whether the blueprint becomes a building.

This week alone: SpaceX lists Friday. AST’s next three satellites launch on a Falcon 9 early next Wednesday morning.

DISCLOSURE

Position: At the time of publication, the author holds a position in AST SpaceMobile (ASTS).

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

The rocket belongs to SpaceX, and the satellites belong SpaceX’s toughest competition in direct-to-device, AST SpaceMobile… just days after the SPCX IPO. What a collision of events! The market will spend the week staring at SpaceX, but it should also be watching the payload fairing.

Subscribe now

The Tesla moment was never the demo

People misremember Tesla’s inflection. It wasn’t the Roadster. By its June 2010 IPO, Tesla had built fewer than 2,500 cars, booked about $150 million of lifetime revenue, and carried $290 million of accumulated losses. The Roadster had already answered the only question it existed to answer (can an electric car be real and desirable?) and the market valued that answer at $1.7 billion.

The Tesla moment was everything after from buying the Fremont plant before the volume product existed, the Model S ramp, the first profitable quarter in Q1 2013, and eventually the Model 3 production hell that nearly killed the company on its way to making it the most valuable automaker on Earth. The demo got Tesla credibility. Industrialization got Tesla everything else.

AST has finished its demo phase. The physics question is retired with a standard, unmodified smartphone pulling 98.9 Mbps from a BlueBird over international waters. The FCC has authorized commercial direct-to-device service in the United States and a constellation of up to 248 satellites. AT&T, Verizon, and roughly sixty carriers representing nearly 3 billion subscribers have signed up, with over $1 billion in contracted revenue commitments reported. The FirstNet Authority literally amended its contract with AT&T to authorize AST’s service for first responders.

What hasn’t happened yet is the industrialization. That’s what June 17 starts.

Everyone forgets the explosions

Here is the part of the SpaceX and Tesla stories that gets airbrushed out of the retrospectives: they failed constantly, in public, for years.

SpaceX blew up three of its first four Falcon 1 rockets and was weeks from bankruptcy when flight four reached orbit in 2008. It then spent two solid years crashing boosters into the ocean and onto drone ships before one finally stuck the landing in December 2015. It lost a Falcon 9 and its NASA cargo in flight in 2015, and blew up another — with a customer’s satellite on top — on the pad in 2016. Starship’s development has been a literal highlight reel of fireballs. None of it mattered, because the factory behind the launch pad kept building rockets faster than the test program could destroy them.

Tesla’s version was the tent: Model 3 production began in July 2017 with a 5,000-cars-per-week target for year-end. It hit that number a year late, in June 2018, partly on an assembly line built under a temporary structure in the Fremont parking lot, with Musk describing the company as “single digit weeks” from death.

AST is now living its own chapter of this. BlueBird 7 was lost this spring when a New Glenn upper stage failed to reach its planned orbit, and Blue Origin (one of AST’s named launch providers) suffered a second major setback within weeks.

That’s a real risk and we’ll come back to it. But the lesson from the two greatest hardware-scaling stories of this generation is that lost vehicles are tuition, not necessarily verdicts. The question that actually decides the outcome is the same one it was for Tesla in 2017 and SpaceX in 2014: is the factory winning?

The factory is the story

This is what the market, fixated on launch dates, keeps skating past:

• AST designs and builds ~95% of its technology in-house including its own ASICs across 500,000+ square feet of facilities with a workforce of 2,250+

• BlueBirds 11 through 33 are in advanced stages of production and assembly right now, with phased arrays completed through BlueBird 28

• The company says it can now manufacture up to six fully equipped BlueBirds per month at an average cost of $21–23 million per satellite for the 90+ bird constellation

• The June 17 flight debuts the stackable architecture of composite carbon structures designed specifically so multiple giant satellites can ride one rocket, which is the unlock for monthly launch cadence across multiple providers

Read that list against Tesla circa 2011: factory acquired before the volume product ships, production line loaded, balance sheet stocked (~$3.5 billion in cash, with management saying no further convertible debt in 2026). The satellites stacking up in Midland are the equivalent of Model S bodies moving down the Fremont line for the first time. The hard, boring, unglamorous middle of the story, and the part that creates essentially all of the value.

And what does June 17 specifically unlock? Three more Block 2 satellites designed to nearly double peak data speeds. The first real-world test of the stacked launch system the entire 2026 cadence depends on. Progress toward the 45-satellite threshold that flips service from intermittent to continuous across the U.S., which is the trigger for commercial service gates, carrier monetization, and the FirstNet beta already being field-tested by the Texas Department of Public Safety, U.S. Customs and Border Protection, and county sheriffs on live BlueBirds. The tests that won the MNO contracts now have to hold up at scale, in the wild. That’s the whole ballgame, and it starts at 2:39 in the morning.

One S-curve, four companies

We built the timeline below to make a single point: aligned by phase instead of calendar year, Tesla, SpaceX, Starlink, and AST are the same story told four times — concept, proof, first product, production hell, payoff — and AST is standing at the exact spot on the curve where the other three went vertical.

Look at the right-hand column. The valuations don’t grow through the demo phase. They grow through the industrialization phase - the one AST is entering this month. Tesla went from $3.5B to $30B while shipping its first product, then $30B to $1T through scaling. SpaceX’s private marks went from $46B to $350B to a $1.7T IPO as Starlink went from a $99 beta to $11.4 billion in revenue and $4.4 billion in operating profit in roughly five years.

That last number deserves its own sentence. Starlink, the supposed ASTS killer, is the single best evidence that ASTS’s market exists. It took a satellite connectivity business from zero to eleven billion dollars of revenue in six years, signed up over 10 million broadband subscribers, and put direct-to-device in front of roughly 12 million users across 22+ countries. The demand question is answered by the competitor.

Now plot those right-column valuations as curves, and the whole thesis fits on one chart. On a linear scale, Tesla and SpaceX are essentially flat lines through their first three phases. All of it, the $1 trillion and the $1.7 trillion, shows up in the back half. The inset magnifies phases 1–3: same track, same slope, a decade apart. ASTS’s dot sits at phase 3, at the foot of the wall the other two climbed.

And notice what the shaded zone says: the scenario range we lay out below — $48 billion from the subscriber napkin alone, up to ~$200 billion in a full duopoly outcome — is 1.4x to 6x from today’s price, and it still barely lifts off the x-axis of this chart. The bull case here doesn’t require believing ASTS becomes Tesla or SpaceX. It requires believing it gets a fraction of the way up a wall two companies have now climbed in public.

The math nobody is doing

Here’s where it gets uncomfortable for the “it’s already priced in” crowd. ASTS trades around $89, a market cap in the neighborhood of $35 billion. Big number. Up 148% in a year. Surely the dream is in the price?

Run three simple sums.

1. The spectrum, marked to market. In 2025, EchoStar sold roughly 50 MHz of nationwide spectrum to SpaceX for ~$17 billion and a similar amount to AT&T for ~$23 billion - call it $340–460 million per nationwide MHz. AST controls 45 MHz of L-band spectrum (40 MHz MSS plus 5 MHz at 1670–1675) under an 80+ year arrangement that cost ~$550 million upfront plus ~$80 million a year, alongside FCC authorization to operate on partners’ low-band across up to 248 satellites. Apply even a steep satellite-spectrum discount to the 2025 clearing prices and the L-band position alone plausibly underpins $10 billion or more of value against a sub-$2 billion cost basis. (Caveat honestly: L-band’s device ecosystem is younger than AWS’s, and spectrum comps are directional, not fungible. But the direction is not subtle.)

2. The FirstNet program, with actual numbers. This isn’t a press-release partnership. The First Responder Network Authority is a federal agency that amended its 25-year contract with AT&T to authorize Supplemental Coverage from Space from AST specifically, on Band 14 spectrum that is licensed nationwide. Public-safety agencies are field-testing voice, data, and mission-critical push-to-talk on BlueBirds in orbit today.

Here’s the scale people miss: FirstNet now supports more than 7 million connections across roughly 30,000 public-safety agencies, including 2+ million IoT devices, and AT&T’s FirstNet chief says the true addressable count (command vehicles, deployables, backup links for 911 centers) is much larger than that. Satellite isn’t a nice-to-have for this user base; it’s the killer feature. Towers fail in hurricanes, wildfires, and earthquakes which is exactly when first responders need the network most, and exactly why FirstNet already fields a fleet of 180+ satellite-equipped deployable trucks as a workaround. AST replaces the workaround with the phone in the responder’s pocket.

So run it at a public-safety-grade price point:

7,000,000 connections × $10/month × 12 = $840M revenue × 80% EBITDA margin = $672M EBITDA × 20× = ~$13.4B of value

That’s more than a third of AST’s entire market cap, from one federal program, at full attach. ARPU could actually be much higher. Nobody has put this in a model because it doesn’t have a revenue line yet. It will.

3. The subscriber napkin. This is the one to tattoo somewhere visible:

50 million subscribers × $5/month net to ASTS × 12 months = $3.0B of revenue. At an 80% EBITDA margin (management guides 90%+ at scale, because the carriers bear customer acquisition, billing, and support which AST sells wholesale capacity), that’s $2.4B of EBITDA. At 20×, a very reasonable multiple for scaling high margin infrastructure, that’s $48 billion of value from this leg alone, against a ~$35 billion market cap today. And 50 million subscribers is less than 2% penetration of the ~3 billion subscribers already under AST’s carrier agreements.

Reasonable people can fight about every cell. Starlink’s own ARPU fell 18% to $81/month as it chased scale - pricing gravity is real, which is exactly why we model $3–8 blended satellite-ARPU and not consumer-broadband numbers. Haircut the margin to 60% and the multiple to 15× and the base case is still ~$27B from subscribers alone before the spectrum, before FirstNet, before the U.S. government business that is already generating revenue today.

The point isn’t precision. The point is that none of these three legs requires AST to take a single customer from Starlink. The carriers did the distribution work already. Starlink did the market-education work already. AST just needs satellites in the sky and proof that the tests which won the contracts hold up in the wild. And here’s the asymmetry on top: every satellite launched widens the distribution moat, because continuous coverage activates dormant carrier agreements country by country — meaning scale doesn’t just defend AST’s position, it progressively improves its odds of taking share later, from a starting point of the widest carrier distribution in the industry.

What would break this

We publish bull cases with the bear case attached, so the thesis breaks if they fail to industrialize manufacturing and launch. If “up to six satellites a month” doesn’t translate into launch cadence because Falcon 9 slots stay scarce, New Glenn stays grounded, or the stacked architecture has a teething failure on the 17th, then continuous coverage slides toward 2028, the 2027 revenue inflection slides with it, and a company burning ~$190M a quarter against $14.7M of quarterly revenue gets re-rated the way pre-ramp hardware companies always do. Tesla’s history says slips of 12–24 months are the normal case, not the disaster case; ASTS’s valuation, unlike 2010 Tesla’s $1.7B, does not have infinite patience priced in. Watch the cadence, not the narrative. Satellites delivered to the Cape per quarter is the only KPI that matters this year.

But that cuts both ways. If the cadence holds, if BlueBirds keep arriving at the pad every month or two the way Roadsters once trickled and Model S’s eventually flooded out of Fremont, then the market is currently valuing the exponential part of this S-curve at roughly the price of its first leg.

Tesla’s IPO buyers got the curve for $1.7 billion. SpaceX’s insiders got Starlink’s curve at private marks that look comical against Friday’s IPO. AST is offering its curve in public, at $89, with the satellites already stacked on the rocket.

June 17, 2:39 a.m. EDT we’ll find out more.

DISCLOSURE

Position: At the time of publication, the author holds a position in AST SpaceMobile (ASTS).

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

Risk Warning: Short selling involves unique and potentially infinite risks, as there is no theoretical limit to how high a security’s price can rise. Past performance is not indicative of future results. You should consult with a qualified financial advisor and conduct your own rigorous due diligence before making any investment decisions.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

I have been involved, in one seat or another, in something like 100 IPOs over a hedge-fund career. If that experience compressed into a single habit, it is this. Before I form any view on an IPO, I ask one question.

Who is on the other side of this trade, and why are they willing to sell it to me now?

The letter everyone forgets is the “O.” An IPO is an offering. Somebody is offering to sell you something. In the ordinary case, the answer to “why now” is benign enough. A company needs growth capital, and the public market is the cheapest place to get it. That framing has trained two generations of retail investors to treat an IPO as an invitation to get in early on the future.

The SpaceX offering does not fit that frame. And the way it fails to fit is the entire point.

A company that does not need the money

Start with the strangest fact in the prospectus, which is a fact of omission: SpaceX does not need to do this.

This is a company with effectively unlimited access to private capital. It runs regular tender offers that mint liquidity on demand. Its private valuation roughly doubled in under six months, from the $800 billion December 2025 tender to a $1.75 trillion-plus IPO target. When a business with that kind of private access nonetheless chooses to sell $75 to $80 billion of stock to the public, the raise is not solving a balance-sheet problem. It is opening a door.

A door for whom? For everyone already inside.

There is an old line on the buy-side. Companies go public when they can, not when they must. “When they can” is a polite way of saying “when sentiment is hottest.” And the moment sentiment is hottest is, by definition, the moment least favorable to the buyer and most favorable to the seller. That is not cynicism. It is just the arithmetic of who controls the timing. The insiders pick the date. They are not going to pick the date that is bad for them.

So the honest first read of the SpaceX IPO is not “the public finally gets access.” It is “the existing owners have finally found a window large enough, and a bid deep enough, to begin converting paper into cash.” Which raises the obvious next question. Why do they want the cash so badly, and why now?

The distribution drought, and why the whole ecosystem needs this to clear

Here is the part the rocket coverage almost entirely ignores, because it has nothing to do with rockets.

The private-capital ecosystem has spent roughly four years in a liquidity desert. Exits are the events that turn fund marks into distributed cash, the IPOs and the acquisitions. They slowed to a trickle after 2021. The result is a system swollen with unrealized value and starved of realized value. There are on the order of 1,900 venture-backed unicorns still private. They represent something like $7.3 trillion in carrying value and an estimated $3 trillion in unrealized gains, sitting on the balance sheets of venture and growth funds.

That sounds like wealth. To a limited partner, it is a problem.

The people whose money actually fills those funds do not run on paper marks. They run on distributions. These are the university endowments, public pensions, foundations, insurance general accounts, sovereign wealth funds, and large family offices. They have spending obligations, payout ratios, and beneficiaries. Their own internal allocators measure them on DPI, which is cash returned over cash invested. For four years that number has been anemic across the asset class. Allocators have been unable to recycle. And the venture model, stripped to its mechanics, is a recycling machine. You harvest cash from your winners, especially at liquidity events like an IPO, and you redeploy it into the next vintage of private bets which, one hopes, achieve power law-driven success. Starve the harvest and the whole machine seizes.

SpaceX is not a participant in this dynamic. SpaceX is the single largest store of unrealized private value on the planet. It is the biggest, ripest harvest in the entire system.

I want to be precise about what I am and am not saying, because this is exactly where people slide into a conspiracy register that I think is both wrong and unnecessary. I am not saying anyone is doing anything improper. I am saying that the entire institutional capital ecosystem has a powerful, structural, entirely rational interest in this IPO clearing well. That includes the funds that hold SpaceX directly, the SPVs stacked on top of them, and the LPs behind both. The interest is not there because SpaceX is a bad company. It is there because a successful SpaceX listing is the largest single liquidity event available to an asset class that has been gasping for liquidity. It re-opens the recycling cycle. It generates DPI. That is a good thing for capital formation broadly. I genuinely want a healthy liquidity cycle, and so should you, Musk fan or not. But “good for the ecosystem” and “good for the marginal buyer at $1.75 trillion” are not the same statement. And the machine has every incentive to blur them into one.

The onion, and the cliff

Two structural features turn that diffuse incentive into concrete selling pressure on a calendar.

The first is the SPV onion. Exposure to SpaceX has been sold, re-sold, and re-wrapped through layers of special-purpose vehicles for years. There are funds of SPVs, feeders into feeders, and retail-adjacent platforms slicing access into ever-smaller pieces, often at marked-up entry prices carrying their own fee loads. Every layer of that onion is a holder with a cost basis, a fund life, and an LP who may or may not want or require liquidity. Many of these structures were built on the implicit promise of an eventual liquidity event. The IPO is that event. When the wrapper can finally unwrap, it will. And here is the uncomfortable part. The aggregate size of that wrapped supply is essentially unknowable from the filings. You can read the lockup schedule to the day. You cannot see the full notional of stock sitting in SPVs and feeders waiting for those gates to open. A precise calendar set against an unmeasurable quantity. That is the overhang that should worry a buyer most, because it is the one you cannot size in advance no matter how carefully you read.

The second is the lockup cliff, and it interacts with float in a way most buyers do not model. Musk is keeping majority control. The company is floating only a thin slice of itself. The new public float is on the order of a few percent of the fully diluted company, and the founder is selling nothing. A deliberately small float against red-hot demand is precisely the setup that lets a stock trade well above any defensible fair value in its first weeks. Too little supply, too much narrative, and price discovery that is really just demand discovery. Then the lockups roll off. The latent supply behind that thin float gets the right to sell into a price the early scarcity helped inflate. That supply is all those funds and SPVs and early holders sitting on 40x and 100x marks. A very important variable for equity returns for the next twelve months here is relationship between that small initial float and the very large supply waiting behind it.

And here the S-1 hands us something far more revealing than the usual boilerplate, because SpaceX did not use the standard single 180-day cliff. It built a staggered, partly performance-triggered early-release staircase, and the design tells you exactly what the deal is engineered to do. Here is how it works, applied to each insider’s pool of eligible locked-up shares. Up to 20% releases after the first post-IPO earnings report. An additional 10% unlocks only if the stock is up at least 30% over the IPO price, measured on five of ten consecutive days before that report. Then 7% releases at each of days 70, 90, 105, 120, and 135. Then a further 28% releases after the second earnings report. The remainder comes free at day 180. The lawyers’ framing is that it is gentler on the market, that it is “probably better that there will not be one big lock-up cliff.” That is true. It is also the tell. A continuous dribble of supply from roughly day 45 onward does not remove the overhang. It spreads it across nearly the entire first six months. There is no single cliff to brace for, and no clean moment when the pressure is finally behind you. The overhang is simply always there.

Look hard at that performance trigger, because it is the most underappreciated clause in the entire filing. The extra tranche unlocks only if the stock runs early. Sit with what that means. The better the stock performs out of the gate, the more insider stock becomes eligible to sell. I do not read intent into that. It is a reasonable way to tie liquidity to performance. But the mechanical consequence is worth holding onto, because it runs against the intuition most buyers carry. A strong open is usually taken as pure good news. Here, a strong open is also the thing that brings forward supply. The schedule leans on earnings-linked and price-linked releases rather than simple calendar dates, and that dovetails with the next layer. The staircase also serves to build tradeable float quickly enough to qualify for accelerated Nasdaq 100 inclusion under the exchange’s new fast-entry rule. That pulls forward a wave of mechanical, price-insensitive index buying. One thing is not disclosed. The total share count the percentages apply to, and which holders dominate the early-eligible pool, are both redacted. So you know the schedule precisely, but not yet the notional behind it.

It is worth drawing out what that index buying actually is, because it is easy to mistake for durable demand. Inclusion is a one-time event. When the funds that track the index add SPCX, they buy a slug of stock once, mechanically, regardless of price. Then they are done until much smaller impact periodic rebalances occur. That demand gets pulled forward by the fast-entry rule. Meanwhile the lockup staircase pushes supply out across the same window. Set the two against each other and the shape of the first six months comes into focus. A front-loaded burst of price-insensitive buying, and once it is spent, it is not there to absorb the steadily rising supply behind it. The demand is scheduled early. The supply is scheduled to follow. At some point the curves cross. A buyer who reads the early index bid as ongoing support is misreading a one-time event as a standing one.

Ask the question again. Who is on the other side when the lockup expires? Disproportionately, it is a fund that has to sell. It sells because its life is ending, or because its LP demanded the distribution, or because the mandate requires trimming a position that has ballooned to an uncomfortable weight. Forced and semi-forced sellers are the best counterparties to buy from. They are the worst to be standing next to.

Just how much is sitting in named hands

It is worth putting a number on the supply, because the number is larger than most people assume. SpaceX is private, so per-fund share counts are not disclosed. But you can triangulate. Some funds mark the position in their own public filings. Some rounds were disclosed with named leads. Some stakes have been reported by the press. Stitch those anchor points together against the roughly $1.75 trillion valuation, and a clear picture emerges of how much of the company sits in identifiable institutional hands.

Here is the build, grouped by type, expressed as estimated economic ownership of the fully diluted company.

Holder group

Names

Est. economic stake

Strategic corporates

Alphabet/Google (~5.0%), EchoStar (~0.6%), NVIDIA (~1.5%)

~7.1%

Top venture firms

Founders Fund (~2.5%), Valor (~4.0%), Sequoia (~2.0%), a16z (~1.8%), Gigafund (~1.2%), DFJ/Draper (~0.6%), Capricorn (~0.4%)

~12.5%

Crossover / mutual funds

Fidelity (~2.2%), Baillie Gifford (~1.5%), T. Rowe (~1.0%), Baron (~0.9%), Coatue (~0.8%), Mirae (~0.7%)

~7.1%

Sovereign wealth

Saudi PIF (~1.3%), ADIA (~0.9%), Qatar QIA (~1.0%)

~3.2%

Pensions

Ontario Teachers’ (~0.5%)

~0.5%

Named institutions, total

~30%

Round it down for caution and you are still at roughly the low 20s as a percentage of the entire company. That is the part you can actually name. Sit with what that means. Set aside Musk’s roughly 42% and the employee equity. What is left over for the public, the unnamed long tail, and the eventual float is not that large. And close to a third of the whole company is held by exactly the cohort with the strongest, most structural reason to harvest into a liquidity event. There are additional funds who we know have participated at some point along the way but we do not have a clear view into the size and timing. Venture funds at the end of their lives. Crossover funds that mark to market and trim winners. Sovereigns and pensions that recycle. These are not diamond hands. These are professional allocators whose job is to turn a 50x or 100x mark into cash their own investors can spend.

So the supply waiting behind the float is not a vague worry. It is nameable, it is large, and it is concentrated in the holders most likely to sell. The exact figures above are estimates, and I would not defend any single line to the basis point. But the shape is robust. A very large slice of SpaceX is held by people who, by the nature of their funds, are going to want out to some degree at some point in time.

The incentive map

None of the participants below is doing anything wrong. That is the point. You do not need anyone to misbehave for the system to point overwhelmingly in one direction. Just follow the money and the airtime.

Participant

What they get from a successful listing

What that does to the narrative

Underwriting syndicate (21+ banks, Goldman lead-left)

Estimated $800M to $1B+ in fees, reportedly the richest underwriting payday in IPO history

Maximum institutional muscle behind a clean, well-bid deal

Sell-side research (same banks)

A vast, recurring coverage franchise on the most-watched stock on earth

Quiet-period ends, then initiations land, and IPO initiations skew heavily to “buy”

Existing funds, SPVs, LPs

The largest liquidity event available to a distribution-starved asset class

Universal, rational interest in the deal clearing high

Financial media

The biggest story of the decade, endlessly monetizable

Saturation coverage, overwhelmingly framed around scale and inevitability

Index & ETF complex

Anticipated inclusion flows, a marquee holding the products need

Mechanical, price-insensitive demand layered on top of narrative demand

Retail

A genuine first chance to own a generational company

Allocated 20 to 30% of the deal, roughly triple the mega-cap norm

Dwell on that last row, because it is the most revealing and the least discussed. Why allocate three times the usual share to retail? The flattering story is democratization, and there is something to it. The mechanical story is that retail is the most narrative-driven and least price-sensitive buyer cohort in existence. If you are bringing an enormous amount of stock to market, both at the IPO and in the supply waves that follow lockup expiry, you want the broadest, stickiest, most price-insensitive base of demand you can assemble to absorb it. Seating that base early, before the institutional supply unlocks, is not sinister. It is just convenient for whoever eventually needs to sell. And it is worth simply noticing, without making too much of it, that two facts sit next to each other. A large, price-insensitive retail base is what tends to produce an early pop. And an early pop is, per the lockup terms above, one of the things that brings insider supply forward. I will leave the reader to decide how much weight that coincidence deserves. Who is on the other side? Increasingly, by design, it is the household.

Business, stock, valuation, multiple. Four different things.

Now the distinction that the entire bullish chorus collapses and that decades of market history refuses to let you collapse.

The business can be extraordinary. The stock is a claim on that business at a price. The valuation is what that price implies about the future. The multiple is the compression spring between today’s reality and that implied future. You can be unambiguously right about the first and lose money for a decade because of the last three.

Look at what the price implies. A $1.75 trillion valuation sits against roughly $18.7 billion of 2025 revenue. That revenue carries large GAAP losses, and it bundles a cash-burning AI segment and the former Twitter into the number through common-control recasting. So you are paying on the order of ninety times sales. And you are paying it for a company in which the public buyer gets pure economic exposure to the growth and little else. Musk’s control is total and by design, and that is a feature to anyone buying, not a scandal. A valuation like that is not a forecast. It is a demand. A demand that more or less everything go right, for a long time.

History is blunt on this. The largest IPOs have produced no clean verdict at all. One recent survey of the record books put it well. The same record-sized listing has launched a 200% rally in one case and a 40% collapse in another. What separated them was never the deal. It was the cycle the deal landed in. Consider the comparison set.

Issuer (year)

What happened after listing

Saudi Aramco (2019), prior record holder

Floated just 1.5%. Leaned on domestic and Gulf demand after foreign investors balked at the price. Never reached the $2T it sought. Not a good comp in many ways.

Rivian (2021)

Largest EV IPO ever. Subsequently traded about 85% below the offer. Not a great comp.

Facebook / Meta (2012)

Broke below its IPO price for a year. Then compounded about 550% over the following decade.

Uber (2019)

Underwater for years before a multi-year recovery.

Snowflake (2020)

Roughly flat-to-down from its first-day close, for years.

Aramco is the uncomfortable structural twin, but lands as a very poor business comp. It was the prior largest-ever listing, a narrative-and-state-backed crown jewel, floated in a deliberately thin slice, priced on enthusiasm its own sponsors could not fully justify abroad. Meta is the bull’s rebuttal. It broke, then it was vindicated spectacularly. But notice what the Meta case actually proves. Even a generational winner handed early buyers a year of pain, and it rewarded only those who bought the business at a price the stock had to fall to first. Cisco was the best-positioned company of its entire era in 2000, and it was dead money for fifteen years from the peak. The business was never the problem. The entry multiple was.

I lived a gentler version of this with Tesla. I was right on the company and still left a great deal on the table to the volatility and the multiple, holding a wonderful business through drawdowns that had nothing to do with whether the business was wonderful. I would own SpaceX. I would not do anything to own it. The difference between those two sentences is the entire discipline.

The live case study: Palantir. You do not need a 2000-era Cisco story to see this. You can watch it happen in real time. Palantir is, by any reasonable read, an exceptional and accelerating business. Its growth rate has gone up, not down, with expanding margins, which is the rarest of large-cap profiles. It posted 70% revenue growth in Q4 2025 and 85% in Q1 2026, the eleventh consecutive quarter of accelerating growth, beating and raising the whole way. And the stock still got cut by more than a third. It peaked at an all-time high of $207.52 on November 3, 2025, trading around 55 times trailing sales, a multiple essentially unprecedented for a company that size. Then it fell roughly 36% to the high $110s. It has only recently begun clawing back, sitting near $156 in late May 2026. The fundamentals never cracked. The multiple did. Even after that derate it still trades in the mid-to-high 40s on forward sales, with analysts noting the market had priced it for perfection. That is the whole lesson in one ticker. When you buy at the top of the multiple, you have pre-paid yourself the next several years of the company’s success. So the company can execute flawlessly, beat every quarter, and you can still lose a third of your money while you wait for the growth to catch up to the price you paid. SpaceX is coming public at roughly ninety times sales. Palantir got punished from fifty-five while accelerating.

The drivers cut both ways, and that is the trap

Let me be the one to make the bull case sharper than the bulls do, because it’s the honest thing to do and because it sets up the most important point in this entire piece.

I can already see several distinct drivers that could have SpaceX beating numbers in the quarters right after listing. The Anthropic compute deal is the clearest. It is worth roughly $15 billion a year, which is $1.25 billion a month through May 2029, about $45 billion in total. And it was explicitly disclosed as ramping from a discounted rate during the May to June 2026 window up to full billing thereafter. So that revenue line steps up mechanically into the first couple of reported quarters, regardless of anything else. Colossus II carries stated but undated headroom on top of that. Management has flagged a “next phase” bringing at least 220,000 additional next-generation GPUs and 400-plus megawatts online, with no committed date. So a new build or a switched-on tranche could juice 2027 numbers at a time of management’s choosing. Starlink has been pushing through price increases that drop onto a high-incremental-margin subscription base. And the company says it anticipates entering into additional similar services contracts, so more Anthropic-style compute deals could simply appear. Layer on the recurring tender cadence and the brand’s gravitational pull on demand, and the path to a string of headline beats is not hard to draw.

Here is the trap. It is the same mechanism that took a third out of Palantir while it was accelerating. At ninety times sales, the beats are already in the price. A stock valued for perfection does not re-rate up on a beat, because it was already priced for the beat. It re-rates down the moment the beat is merely good instead of spectacular, or the moment the cycle turns, or the moment a lockup tranche meets a market that has run out of fresh narrative. Good news that is already discounted is not a catalyst. It is a coupon you already paid for. The drivers I just listed make a beat more likely. And that makes the valuation more dangerous, not less, because they raise the bar the company must clear just to avoid disappointing a price that already assumes them.

And then there is the opaqueness. SpaceX reports three radically different businesses, Space, Connectivity, and AI, rolled into single consolidated figures. The recast folds in xAI and the former Twitter under common control. Segment detail is not cleanly broken out quarter to quarter. And the filing itself cautions that its installed-compute number “does not represent actual power consumption or utilization.” All of that hands management wide latitude over the timing and framing of when revenue appears. It is worth being concrete about where the slack lives. The AI segment is the clearest case. The Anthropic contract steps up from a discounted rate to full billing, so the first couple of quarters carry a pre-baked ramp that reads as accelerating AI revenue whether or not anything new is signed. The undated Colossus II expansion is capacity management can switch on when it chooses. Launch revenue is lumpy and milestone-driven, which gives discretion over which quarter a number lands in. The recast muddies year-over-year comps. And as a brand-new filer, SpaceX sets its own initial guidance bar. None of that makes a beat fake or the business weak. Starlink is a genuinely excellent, high-margin franchise, and I concede that cleanly. The point is narrower. A new issuer with multi-segment, recast, partly timing-controlled revenue has more room than most to clear an early bar. And the oldest move in the post-IPO playbook is to guide conservatively into the first prints and let the beat-and-raise narrative do the work. So in these specific quarters a beat carries less information than it appears to. At ninety times sales, it may already be in the price. That is precisely the environment in which a priced-for-perfection multiple can be sustained longer than it should be, and then unwind faster than anyone expects.

A note on where the oxygen goes

One last observation, offered carefully, because it’s the one most easily caricatured.

Attention is a finite resource, and so is sell-side coverage, and both flow toward the largest fee pool. I do not believe anyone is conspiring to suppress competing stories. I believe something more mundane and more powerful. When the biggest underwriting payday in history is on the table, the gravitational pull of that fee pool bends coverage, conference airtime, and narrative real estate toward a single name. It bends them away from smaller companies that may be doing genuinely differentiated work. No coordination is required for the distortion to exist. Emergent incentives are quite enough.

The example I happen to know, and here I disclose plainly that I am long the stock, is AST SpaceMobile. Ask a roomful of well-informed technologists at the mega-cap firms whether they have heard of it, and you will mostly get blank looks. That is striking for a company that may well beat StarLink to properly defined direct-to-device satellite connectivity and with a much larger MNO partner subscriber base to sell into while StarLink takes a somewhat adversarial approach. I want to be fair about what that anecdote does and does not prove. It is consistent with “under-covered relative to merit.” It is also consistent with “pre-revenue, satellites not yet fully deployed, genuinely not yet load-bearing.” Both can be true at once. The honest reading is that obscurity is evidence of where the oxygen is going, not proof of what anything is worth. I raise it only as an illustration of the broader mechanic. In the gravitational field of the largest IPO ever, attention is not distributed by merit. It is distributed by fee pool.

The questions I’d want answered first

I do not have a price target, because the honest answer is that several of the variables that determine the trade are not yet knowable. So instead of a verdict, here is the homework. These are the questions a disciplined buyer should be able to answer, or at least price, before committing capital. Many of them will only be resolved in the final S-1 amendment, at pricing, or in the first few earnings cycles.

On the deal itself:

• What is the actual price range, and what fully-diluted share count does it imply? The S-1 left price blank.

• What is the true initial free float, as a percentage of fully-diluted shares?

• How much of the offering is secondary, meaning existing holders cashing out, versus primary new capital? This is the single most important undisclosed number in the whole piece. It tells you directly how much insider selling is happening at the IPO itself, versus how much is deferred to lockup expiry. The preliminary S-1 leaves it blank, so it will not resolve until the pricing amendment. But there is a clean yardstick to hold it against. A healthy growth IPO runs 70 to 90% primary. Once insiders are selling more than about 30% of the deal, you ask why. And there is a deeper version of the question worth sitting with. SpaceX already runs a recurring tender channel that has given employees and early holders liquidity at an $800 billion valuation, with no public listing required. The late-2025 tender existed precisely so the company would not need an IPO to let insiders sell. So why go public at all? Either the tender machine can no longer absorb the scale the cap table now wants to monetize, or the public listing unlocks a far larger and more permanent exit at lockup expiry. Both answers point back at the same spine. This is a liquidity event first.

• What are the exact lockup terms? How many tranches, at what intervals, releasing what share volume at each step?

• Is the 20 to 30% retail allocation a fixed carve-out, or is it demand-dependent?

• Has any major existing holder signaled an intent to sell, or to hold?

On the business beneath the consolidated number, which this piece deliberately does not try to litigate, but which you should:

• The fundamentals deserve their own analysis. That means Starlink’s standalone unit economics, the AI segment’s cash burn and whether it is a temporary drag or a standing claim on Starlink’s cash, and what the company looks like stripped of the xAI and X recast. One note on the supply side, though. SpaceX has strong Starlink cash flow and ample credit access. It already carries some debt and signed a fresh bridge loan in early 2026. So future capital needs are far more likely to be met with leverage than with a flood of new equity. The supply that matters for your trade is the stock that already exists and becomes sellable, not hypothetical new issuance.

On the market it is landing in:

• What cycle does this list into? Per the record books, that single variable separated the +200% mega-IPOs from the negative-40% ones, and it cannot be known in advance, so I will not pretend to call it. What I will note instead is structural and direction-neutral. SpaceX is going first, while the window is open, into a hot tape with a deep pool of retail dollars looking to redeploy gains from elsewhere. That is intelligent issuance timing. It is exactly what you would choose if the priority were a large, cleanly absorbed offering. Smart timing for the seller is not the same as a good entry for the buyer. But it is not a market-top prediction either. It is just worth seeing the deal arriving into strength, by design.

• When does index inclusion hit, and how much price-insensitive buying does it pull forward versus leave as future support?

• How large is the latent SPV supply that becomes sellable at lockup expiry? This is likely unknowable from the filings, and it is the overhang that matters most.

If you cannot answer the secondary-versus-primary question and the lockup-schedule question, you do not yet know who is on the other side of your trade. Which means you are not yet ready to take it.

What this is, and isn’t

So, to be unmistakable. This is not a bear case. I think SpaceX may well be one of the defining enterprises of the century. I would be thrilled to own it, at a valuation that pays me for the cycle I would be buying into, rather than one that demands I supply the upside to the people selling. Or perhaps this is actually a great trade from opening price for a period.

The case is only this. An IPO is a liquidity event before it is anything else. This one arrives carried by an ecosystem that needs it to clear. It is structured to seat price-insensitive demand ahead of a large and patient supply. It is priced at a level that is a demand rather than a forecast. And it is wrapped in a narrative manufactured by everyone who gets paid when it works. None of that makes the business less remarkable. All of it should make you ask the only question that has ever mattered.

When you buy this stock, who is on the other side, and why are they so happy to sell it to you?

Not investment advice. For research and educational discussion only. Please see ABOUT page for additional disclosures and disclaimers. The author holds a position in ASTS and may hold or transact in other names mentioned, subject to a publisher’s-exclusion trading blackout around publication. Figures are drawn from SpaceX’s S-1 (filed 20 May 2026) and contemporaneous reporting. The Anthropic contract terms (about $1.25B per month, about $45B total through May 2029) and the underwriting-fee range (about $800M to over $1B) are as reported. Private valuations, segment detail, and float and lockup terms are subject to change before pricing. Some estimations were made in triangulating capital structure figures.

The consensus on MLCCs is simple and half right. The bull case is that AI servers consume staggering quantities of high-end MLCCs, that Murata and Samsung Electro-Mechanics control that segment, and that the resulting shortage drives pricing power. This piece is about what comes next, and it has four parts that build on each other.

First, I am going to close the door on the most common pushback to the bull case: the claim that the broad MLCC industry can simply redirect automotive capacity into the AI server segment and relieve the shortage. This argument is wrong at the level of physics and manufacturing, and I will show you exactly why using the manufacturers’ own spec sheets.

Second, I will reiterate the greenfield economics, because understanding why new capacity does not arrive is the foundation of the entire thesis. The supply curve in MLCCs does not behave the way most investors assume.

Third, the new analytical contribution: the shift from AI training to AI inference is structurally CPU-intensive, server CPUs draw their MLCCs from the same shared mid-cap pool as automotive and industrial, and that pool is heading for deficit even under conservative assumptions. If the high-end AI segment is already ripping, this is the second act that pulls the commodity end of the market up with it.

Fourth, I will connect this to the names that get hurt: downstream manufacturers with heavy MLCC and memory exposure and weak pricing power, who have told the market the shortage is handled before their customers have agreed to pay for it.

PART 1: Auto MLCCs Cannot Become GPU MLCCs

The Pushback, and Why It Matters

Every time the MLCC bull case comes up, someone makes a version of this argument:

“There are six or more MLCC manufacturers. They all supply the automotive market, which has enormous volume and strict reliability requirements. Auto-grade MLCCs are qualified for harsh conditions, so they are good enough for AI servers. The capacity is more elastic than you think. The shortage will resolve.”

This matters enormously for the thesis. If automotive MLCC capacity can flex into the AI server segment, then the supply curve is elastic, pricing power is temporary, and the whole investment case has a short shelf life. If it cannot, then the bottleneck is structural and the pricing power is durable.

The argument is wrong. Not partially wrong, but wrong at the level of physics and manufacturing process. Here is the proof, working entirely from the manufacturers’ own published technical documentation.

Same Manufacturer, Two Products, Different Worlds

The cleanest single piece of evidence comes from Samsung Electro-Mechanics, which published two technical papers six weeks apart in early 2026, describing the MLCCs it builds for two different markets.

On February 23, 2026, SEMCO published its AI server MLCC strategy. The flagship part, CL05X476MS6N9W#, has these specifications:

• Case size 0402 (1.0 x 0.5 mm)

• Capacitance 47 microfarads

• Rated voltage 2.5 volts

• X6S Class 2 dielectric

• Positioned within millimeters of GPU silicon, decoupling the 0.8V GPU core

On April 15, 2026, SEMCO published its electric vehicle powertrain MLCC paper. The part there, CL32C223JIV3PN#, has these specifications:

• Case size 1210 (3.2 x 2.5 mm)

• Capacitance 22 nanofarads

• Rated voltage 1000 volts

• C0G Class 1 dielectric

• Positioned in the 800V battery bus and inverter snubber circuits

The difference between these two parts is not incremental. The capacitance differs by a factor of 2,136. The voltage rating differs by a factor of 400. The case footprint differs by 16x. The dielectric chemistry is fundamentally different. These are not variations on a theme. They are different products that happen to share a category name.

For the Non-Technical Reader: An Analogy

If the spec sheet language is unfamiliar, here is the intuition.

Think of MLCCs like containers for water. The AI server part is like a thin, wide, shallow tray designed to hold a large volume of water (high capacitance) at very low pressure (low voltage), and to release it instantly when needed. The EV part is like a narrow, thick-walled pipe designed to hold a small volume of water (low capacitance) at extremely high pressure (high voltage) without bursting.

You cannot use a shallow tray as a high-pressure pipe. It would burst. You cannot use a high-pressure pipe as a shallow tray. It holds almost nothing and is far too bulky. The two are engineered for opposite problems. The fact that both are “containers” tells you nothing about whether one can substitute for the other.

That is precisely the relationship between AI server MLCCs and EV MLCCs.

Physical Scale Makes It Concrete

The AI server part is a 0402 case, one millimeter by half a millimeter. The EV part is a 1210 case, more than three times longer and five times wider, with sixteen times the board footprint.

This matters because of density. A single NVIDIA GB200 NVL72 rack contains roughly 440,000 MLCCs, the vast majority in the 0402 size class or smaller, packed tightly around the GPU silicon. You physically cannot fit that many 1210-size parts in the same board area. The geometry forbids it. The space simply does not exist on a GPU module for capacitors that are sixteen times larger.

So even setting aside the electrical specs, the substitution fails on physical packaging alone.

The “800V Is 800V” Confusion

The more sophisticated version of the substitution argument goes like this: “NVIDIA is moving to 800V power architecture. EVs run on 800V battery systems. Both convert high voltage down to roughly one volt. The MLCCs must be similar.”

This conflates the system-level voltage label with where the MLCC actually sits in the power chain.

In NVIDIA’s architecture, 800V is the rack-level distribution voltage. The power is then stepped down through multiple conversion stages: 800V to 48V to 12V to 0.8V at the GPU core. The MLCCs that decouple the GPU sit at the 0.8V end of that chain. They are 2.5V-rated parts. The high-voltage parts in NVIDIA’s power supply units are a completely different component (a Class 1 C0G resonant capacitor, which I will return to).

In an EV, 800V is the battery bus voltage, and the high-voltage MLCC sits right there at 800-1000V in the inverter and on-board charger. The vehicle separately steps down to its own 48V and 12V buses with different parts.

So both systems have “800V” on the label, but in the AI server the GPU-adjacent MLCC is four conversion stages downstream at 0.8V, while in the EV the MLCC is at the 800V bus. Same number, three orders of magnitude apart at the actual component location. They cannot be the same part.

The Physics That Forbids One Part Doing Both Jobs

There is a fundamental engineering tradeoff in MLCC design between capacitance and voltage. An MLCC stores charge in many thin layers of ceramic stacked between electrodes. To handle high voltage, each ceramic layer must be thicker so it does not break down. Thicker layers mean fewer layers fit in a given package, which means less capacitance. On top of that, the high-voltage Class 1 dielectrics have far lower dielectric constants than the high-capacitance Class 2 dielectrics, for fundamental material reasons.

The result: you cannot build a single MLCC that is both high-capacitance and high-voltage. The chart above plots real products on capacitance versus voltage axes. The AI parts cluster in the upper-left (high capacitance, low voltage, small case). The EV parts cluster in the lower-right (low capacitance, high voltage, larger case). The upper-right region, high capacitance and high voltage together, is physically empty. No MLCC exists there because the materials do not permit it.

This is not a manufacturing limitation that engineering will overcome next year. It is the physics of dielectric materials.

A Single AI Server Uses Five Different MLCC Types

There is one more layer to this, and it actually concedes a small point to the substitution argument before taking it back.

“AI server MLCC” is not one part. Per TDK’s December 2025 application note on data center power systems, a single AI server uses at least five distinct MLCC families: Y-caps for EMI filtering, bypass caps rated 630V and above, snubber caps with surge tolerance, LLC resonant caps in Class 1 C0G rated to 1.25kV, and the GPU decoupling caps in X6S/X7T at 2.5V.

Here is the honest concession. The high-voltage Class 1 parts used for snubbers and resonant circuits in AI server power supplies are actually closer to EV powertrain parts than the GPU decoupling caps are. There may be some genuine flexibility there. Murata’s December 2025 launch of a 15nF 1.25kV C0G part explicitly targets both EV chargers and high-end power supplies.

But that is not where the binding constraint sits. The shortage and the pricing power are concentrated in the GPU decoupling segment: the 47µF and 100µF, 2.5V, 0402 and 0603, X6S and X7T parts. That category has no EV equivalent, no automotive equivalent, and no commodity equivalent. It is built by Murata and SEMCO on dedicated lines with bespoke equipment, and nothing in the automotive supply base can substitute into it.

Part 1 Conclusion

The claim that automotive MLCC capacity can relieve the AI server shortage fails on four independent grounds: electrical specs differ by three orders of magnitude, physical packaging is sixteen times different in footprint, the components sit at opposite ends of the power conversion chain, and the capacitance-voltage physics forbids a single part from serving both roles. The manufacturers themselves publish these as entirely different products.

The bottleneck in high-end AI MLCC is structural. It does not resolve through capacity reallocation from autos. That is the foundation everything else rests on.

PART 2: What Greenfield Economics Actually Require

Why New Capacity Does Not Simply Arrive

If the high-end segment is so profitable and so constrained, why does new capacity not flood in? This is the question that determines whether pricing power is durable or fleeting, and the answer is in the capital and time economics of building MLCC capacity.

The hard numbers, from industry sources:

Building new MLCC production capacity takes 18 to 24 months from the moment capacity is committed to first output, per 773 Group and Mordor Intelligence. A full greenfield plant runs three to five years. The capital intensity is $750 million to $1.5 billion per advanced production line, per Mordor Intelligence. And per McKinsey’s capital projects research, the average large capital project of this type runs roughly 60% over schedule and more than 70% over budget.

This is not a fast-response supply curve. Unlike semiconductors, where process node advances drive rapid efficiency gains, MLCC manufacturing improvements are incremental and the equipment is specialized.

The ROIC Hurdle

Here I need to be explicit that the following is my own analytical framework, not a number published by Murata or any sell-side analyst. I am reasoning from Murata’s disclosed capital intensity and return targets to estimate what pricing is required to justify greenfield expansion. Treat it as a directional argument, not a precise figure.

Murata’s emergency capex announcement of ¥80 billion adds roughly 10 to 15% capacity at the high end. From the capacity added relative to the capital spent, I estimate brownfield capital intensity in the range of $200-300 million per billion units of annual AI-grade MLCC capacity. Greenfield is typically two to three times more capital-intensive, because you must build the building, the clean rooms, the utilities, and ramp yield from scratch. That puts greenfield in the range of $500-900 million per billion units of annual capacity.

To clear a 12% post-tax ROIC hurdle on a ten-year asset at those capital intensities, with current AI MLCC gross margins, my math suggests you need annual revenue per billion units of capacity in the range of $130-150 million, which implies an ASP roughly 3 to 5 times current levels.

The point is not the precise multiple. The point is the direction: at current ASPs, greenfield AI-grade MLCC capacity does not clear incumbent return hurdles. The first round of price hikes in March 2026 (15-35% from Murata) is not nearly enough to incentivize the wave of new capacity that would relieve the shortage. The market needs a far stronger and more sustained pricing signal before greenfield supply arrives, and even once the signal comes, the capacity is 18-24 months behind it.

Murata’s Own Capital Discipline Reinforces This

This is supported by Murata’s stated capital allocation framework. Murata’s Medium-Term Direction 2027 switched its primary return metric from pre-tax to post-tax ROIC and made capital efficiency a core KPI. The company’s FY2026 ROIC guidance is 12.3% against a weighted average cost of capital around 7%.

A company managing explicitly to post-tax ROIC, with a disciplined history of under-building in upcycles when peers over-built, does not flood the market with speculative capacity. It builds only when the pricing signal clears the hurdle, and it returns excess cash rather than chasing volume. That discipline is exactly what keeps the supply response slow and the pricing power durable.

Part 2 Conclusion

The supply curve in high-end MLCC is slow (18-24 months minimum), expensive ($750M-$1.5B per line), and gated by return hurdles that current ASPs do not clear. The incumbent with 60% share manages to post-tax ROIC and has every incentive to keep the market tight rather than flood it. New capacity is not coming fast enough to break the shortage in the thesis window. This is why the pricing power is structural rather than cyclical.

PART 3: The CPU Tightening Thesis

What Nobody Is Pricing

Everything to this point has been about the high-end, GPU-adjacent segment, which is a genuine duopoly. Now I want to make a different and, I believe, novel argument about the commodity and mid-tier end of the MLCC market, the segment that everyone currently dismisses as oversupplied.

The thesis in one sentence: the shift from AI training to AI inference is structurally CPU-intensive, server CPUs draw their MLCCs from the same shared mid-cap pool as automotive and industrial electronics, and that pool is heading for deficit even under conservative recovery assumptions for the consumer markets.

If I am right, the commodity end of the MLCC market, which the bears point to as proof there is no real shortage, tightens over the next several years for the first time since 2018. And unlike 2018, the driver this time is structural rather than cyclical.

Let me build this in four logical links, and verify each one.

Link 1: Inference Will Carry Much Higher CPU-to-GPU Ratio Than Training

This is confirmed by primary management commentary, not speculation.

On Intel’s Q1 2026 earnings call, CFO David Zinsner stated that training workloads run at 7 to 8 GPUs per CPU, while inference tightens to 3 to 4 GPUs per CPU. CEO Lip-Bu Tan added that the ratio has already moved from 1:8 to 1:4, and could reach 1:1 in agentic scenarios, or tilt even further toward CPUs. SemiAnalysis corroborates from the architecture side, noting Microsoft’s Fairwater datacenter runs a 1:6 CPU-to-GPU power ratio, and that future generations like Rubin may require an even higher ratio.

The mechanism is intuitive. Training is massively parallel matrix math, which is what GPUs excel at. Inference, especially agentic inference with tool-calling, orchestration, retrieval, and sequential decision-making, leans far more on general-purpose CPU compute. As the workload mix shifts toward inference, the CPU share of the system rises.

Link 2: Inference Is Becoming Dominant, and the CPU Runway Is Enormous

Inference is becoming the dominant share of AI compute. It accounted for roughly one-third of AI compute in 2023, half in 2025, and is projected at two-thirds in 2026, per Introl and Gartner data. Gartner sees inference at 65% or more of AI-optimized infrastructure spending by 2029.

The CPU demand implications are large. Arm estimates that traditional AI data centers require around 30 million CPU cores per gigawatt, but that demand could rise to 120 million cores per gigawatt in the agentic era, a fourfold increase. AMD, on May 6, 2026, raised its server CPU total addressable market outlook to $120 billion by 2030, at a 35%+ CAGR. IDC pegged the x86 server market at $283.9 billion in 2025, up 39.9%, with ARM-based servers growing 70% to reach 21.1% of shipments. Yole projects data center server semiconductor value reaching $500 billion by 2030. TrendForce notes that Google and Microsoft are specifically ramping general-purpose (CPU) server procurement to handle inference traffic from Copilot and Gemini.

The summary: if you are bullish on AI, you are bullish on CPUs. The inference and agentic future is more CPU-intensive than the training era was, and every major research house confirms the runway.

Link 3: Server CPU MLCCs Come From the Same Pool as Auto and Industrial

This is the crux, and it is stronger than mere substitutability. CPU MLCCs are not a separate category that happens to resemble auto MLCCs. They occupy the identical electrical envelope: mid-capacitance (1 to 100 microfarads), mid-voltage (4 to 100 volts), X5R/X6S/X7R dielectrics, case sizes 0402 to 1210.

The clearest proof is the DDR5 memory transition. Per Power Electronics News, DDR4 server memory used 10µF/6.3V MLCCs, while DDR5 requires 22µF/25V MLCCs in the 0805 case size. That 22µF/25V 0805 part is exactly the same specification class used in automotive body electronics, ECUs, and infotainment systems. Yageo’s high-capacitance MLCC series (1 to 220µF, 0201 to 2220 case sizes, 4 to 100V) is explicitly marketed for “Server, AI Server, Industrial, Computing” applications all in the same product family.

So when server CPU demand rises, it does not draw from some dedicated CPU MLCC supply. It pulls from the same production lines that make automotive body electronics capacitors and industrial capacitors. This is competition for shared capacity, which is more direct than substitution.

One important friction to name explicitly, because it actually strengthens the case. “Same electrical envelope” does not mean “same line, flipped overnight.” Automotive-grade MLCCs require AEC-Q200 certification: 1,000-hour high-temperature life testing, extreme thermal shock cycling, extended burn-in, and DC-bias ageing validation that IT-grade parts never undergo. A manufacturer cannot convert an IT-grade server line to an auto-grade line, or vice versa, without dedicated QA processes and a fresh qualification cycle that runs 18 to 24 months. This cuts both ways and both ways favor the thesis. When AI server CPU demand pulls on the IT-grade mid-cap pool, suppliers cannot instantly backfill from auto-grade capacity, and when they do reallocate, the qualification friction slows it to a crawl. The shared pool is therefore even stickier than the raw spec overlap suggests. The capacity is genuinely fungible at the materials and equipment level but genuinely sticky at the qualification level, which means demand shocks translate into shortages faster, not slower.

This distinction is what separates the CPU thesis from the GPU thesis. The GPU decoupling part is bespoke and duopoly-controlled. The CPU mid-cap part is commodity-to-mid-tier, made by everyone, and shared with the largest MLCC end market in the world: automotive. But “made by everyone” comes with a tiering caveat that matters enormously for the supply math, which I turn to next.

Link 4: Shared Pool Flips to Deficit

I built a supply and demand model for the shared mid-cap MLCC pool, breaking out the five demand segments that draw from it (server CPU, automotive, PC, phone, industrial) against the available mid-cap supply.

A critical modeling choice, flagged explicitly: I deliberately modeled only MODEST growth and recovery for the automotive, PC, and phone segments. All three are currently in cyclical down or soft patches. PCs and smartphones are in a demand trough, and automotive production is roughly flat with EV growth decelerating in the West. Rather than assume a sharp recovery, I assumed automotive grows at 7.2% CAGR (driven by EV content mix, not unit volume), PCs at 4.1%, and phones at 3.5% through 2030. These are conservative assumptions. If the consumer markets recover sharply, the pool tightens faster than I show. I would rather understate the case.

Here is the first output, the structural driver in isolation.

Server CPU MLCC demand inflects from roughly 19% CAGR over 2018-2025 to roughly 33% CAGR over 2025-2030E. It rises from about 30 billion units per year in 2025 to roughly 125 billion units per year by 2030. This inflection is driven by two compounding factors: more server CPU units (the inference shift) and more MLCC content per socket (DDR5, higher core counts, more power rails).

Now the shared pool, all five segments stacked against supply.

The shared mid-cap pool runs a comfortable surplus today, roughly +40 billion units in 2025. But under my conservative assumptions, the surplus shrinks every year and the pool flips into deficit around 2028, reaching a deficit of roughly 164 billion units by 2030, which is about 11% of demand. The deficit appears even though I modeled the consumer segments modestly, because the structural CPU driver and steady automotive and industrial growth outpace the slow supply additions.

Here is where the growth comes from, and what the supply response looks like.

Of the roughly 444 billion units of incremental mid-cap demand from 2025 to 2030, automotive contributes the largest absolute share at +195 billion (44%), but server CPU is the fastest-growing segment at 33% CAGR, contributing +95 billion (21%). The key insight is that CPU is the new, structural, accelerating driver layered on top of an automotive base that was already going to grow. It is the marginal demand that tips the balance.

On the supply side, the announced capacity additions are real but slow, and a reader should immediately ask the obvious question: Walsin alone is scaling from 600 billion units per year toward 1.5 trillion by 2028, and Fenghua is adding a $1 billion-plus plant at 540 billion units per year. How does a 164 billion unit deficit survive a Chinese supply wave measured in the trillions?

The answer is the qualification and yield tiering, and it is the single most important nuance in the supply analysis. Raw Chinese MLCC volume is enormous, but it is concentrated in commodity smartphone and consumer parts where it does not compete for the sockets that matter here. Per Mordor Intelligence, Chinese entrants like Fenghua and Sunlord “move aggressively on price in commodity smartphones, underbidding Japanese peers by 15 to 25 percent, but remain excluded from automotive and data-center sockets that demand AEC-Q200 compliance and low-ESL metrics.” That is the crux. The deficit I am modeling is in the AEC-Q200 and server-qualified mid-cap tier, not in the raw commodity tonnage. Walsin’s 1.5 trillion units is a total-capacity figure spanning commodity to mid-tier; only a fraction is qualified for the auto and server sockets that define the shared pool, and Walsin and Yageo are pursuing automotive qualification largely through M and A (Yageo’s KEMET acquisition, Walsin’s facility build-outs) precisely because organic qualification is so slow.

Three things therefore blunt the Chinese supply wave against the specific deficit I am modeling. First, the qualification wall: a large share of announced Chinese capacity targets commodity sockets that do not relieve the AEC-Q200 mid-cap tier, and the parts that do qualify lag in the high-capacitance, low-ESL nodes that server and auto demand. Second, the Japanese and Korean leaders (Murata, SEMCO, Taiyo Yuden) are actively reallocating their own qualified mid-cap capacity OUT of the shared pool and INTO high-end AI, which removes qualified supply even as Chinese commodity volume grows. Third, as established in Part 2, any genuinely qualified new capacity takes 18 to 24 months to arrive and runs over schedule. The trillions of Chinese units are real, but they are mostly the wrong units in the wrong tier, and that is why the deficit math holds.

Why This Is Not 2018

The last MLCC cycle, in 2017-2018, was a broad cyclical tightening driven primarily by the smartphone supercycle (the iPhone X era), early EV adoption, and 5G preparation. The entire market tightened together because demand rose broadly across one connected pool. Then it corrected hard in 2019 when smartphone demand rolled over. The driver was cyclical, so the tightening was cyclical.

This time the structure is different and, for a sustained cycle, better. The high-end AI GPU segment is a separate, duopoly-controlled market ripping on its own. And the mid-cap CPU segment is now layering a second, structural demand driver onto the shared automotive and industrial pool. The CPU driver does not roll over like smartphones did, because it is tied to the secular shift toward inference and agentic AI compute, which is just beginning.

So the bull case is two independent demand surges, the bespoke GPU surge and the shared-pool CPU surge, hitting a supply base that is already reallocating away from commodity and cannot add capacity quickly. If both hold, you get broad MLCC price increases for the first time since 2018, but with a far more durable demand driver underneath.

The Major Assumptions, Stated Plainly

I want to be explicit about what could make this wrong, because the model depends on judgment calls.

The softest assumption is MLCC content per CPU socket. There is no published per-socket MLCC series. I built the ramp from the DDR5 transition, core-count growth, and power-rail trends. If content per socket rises more slowly than I assumed, the inflection pushes out past 2028.

The consumer recovery timing is the biggest cyclical swing factor. I modeled modest recovery for PC, phone, and auto. If those markets stay in trough longer, the pool stays looser longer. If they recover sharply, the pool tightens faster than shown. I chose the conservative path.

The Japanese and Korean reallocation rate is the biggest supply swing factor. How much of Murata’s roughly 1,100 billion units per year of total capacity they point at high-end versus mid-cap is a management decision I modeled as a smooth glide path. It could move either way.

EV penetration drives the slope of the automotive line. I assumed steady EV content-mix growth. A sharper EV slowdown would soften the automotive contribution.

Raw material inflation is absent from the unit model entirely, and it is a tailwind I left out. Nickel, palladium, barium titanate, silver, and copper have all seen double-digit price swings. Rising input costs raise the cost floor on even commodity MLCCs, which supports broad pricing independent of the supply and demand balance. Leaving this out makes the pricing case conservative.

The honest framing of the thesis is therefore not “the pool deterministically flips in 2028.” It is this: the shared mid-cap pool is tightening structurally even while three of its four demand drivers sit in cyclical troughs. The structural driver, AI CPU, is just beginning. When the troughs end and the structural driver compounds, the pool tightens hard. The timing depends on the cyclical recovery, but the direction is not really in question.

Part 3 Conclusion

The inference shift is real and CPU-intensive (confirmed). The CPU runway is enormous (confirmed by AMD, Arm, IDC, Yole, TrendForce). CPU MLCCs are drawn from the same pool as automotive and industrial (confirmed by spec overlap and the DDR5 transition). And the shared pool flips to deficit around 2028 even under conservative consumer assumptions (my model). This is the second act of the MLCC squeeze, and it extends the pricing thesis from the bespoke high end into the broad commodity market.

PART 4: The Shorts That Will Pay for It

Below we’ll discuss names that could suffer greatly from MLCC tightening along with memory shortages in the coming years. I have put this behind the paywall as it is not suitable for most investors. I previously spent 10 years at long/short hedge funds where I spent a substantial portion of my time looking for alpha shorts (as opposed to just hedges). These carry tremendous risk that is not suitable outside of most controlled, defined, institutional settings. I plan to continue to work this theme in the coming months/quarters, along with other thematic short themes given the large and shifting secular trends that are presenting lots of opportunities. Please see disclaimer at end of publication for additional information regarding risks.

Read more

Three months ago I laid out the case for BeWhere as a quiet compounder approaching its most catalyst-dense window in company history. Q1 2026 landed this morning and changes the analytical job in one specific way. Management put public numbers on the multi-year plan for the first time, and those numbers line up with the published base case almost exactly.

The headline numbers

Q1 revenue C$4.7M, up 12% year over year, a record first quarter. Q1 Adjusted EBITDA C$653K, up 96%, also a record first quarter. Q1 gross margin 45.5%, the highest in company history, a 750 basis point jump year over year and a 1,000 basis point jump versus Q4. Adjusted EBITDA margin 14% versus 8% in the prior year, a 600 basis point expansion. ARR C$9.7M, up 16% year over year and up from C$8.9M exiting Q4. Twenty-sixth consecutive quarter of positive Adjusted EBITDA.

The unusual feature of this print is that revenue growth was the slowest in eight quarters while gross profit dollars hit an all-time high. However, this should not be surprising given the product launch-driven nature of growth cycles that has occurred multiple times (see here for original post detailing this dynamic). Operating leverage finally showed up in the financials as a printed number rather than a forecast.

The new disclosure: Vision 20/20 Plus

For the first time, management published a multi-year financial target. Three-year objectives exiting 2028:

1. ARR above C$20M, versus C$9.7M today

2. Adjusted EBITDA margin 20% run-rate, versus 14% in Q1

3. Path driven by organic growth (new products, new geographies, new verticals) plus strategic acquisitions

The original post explicitly modeled a base case of approximately 25% revenue CAGR through 2028 with meaningful margin expansion as recurring revenue mix grew, and 40%-plus EBITDA CAGR through 2028. That base case sat in the post without crediting AST SpaceMobile, Vodafone, or European expansion. Vision 20/20 Plus reads the same way. The satellite and carrier optionality is not in the targets.

How Vision 20/20 Plus compares to the published view

Working through the math, recurring goes from C$9.7M to above C$20M by end of 2028, which implies roughly a 28% recurring CAGR. The original base case implied recurring growth in the 25 to 30% range as DaaS and the product cycle layered in.

Adjusted EBITDA scales from a Q1/26 annualized run-rate near C$2.6M to 20% of a much larger revenue base. If total revenue reaches roughly C$35 to C$40M by 2028 (a reasonable derivation given recurring above C$20M and the historical mix), Adjusted EBITDA at 20% margin is C$7-8M. From the FY2025 print of C$2.25M, that math implies roughly 45 to 55% EBITDA CAGR over three years.

In plain language, management just publicly committed to a financial plan that exceeds the published base case on EBITDA growth and broadly matches it on revenue trajectory. None of this requires the satellite story to work.

What Q1 actually demonstrated

A few KPI movements worth flagging against the original thesis.

Operating leverage is now tangible, yet again. Revenue up 12%, gross profit up 34%, EBITDA up 96%. The thesis required this mechanic. Q1 was the cleanest demonstration of it, including in a quarter where unit shipments were essentially flat year over year. The gross margin jump to 45.5% means the supply chain pivot (CUSMA compliance, Albania manufacturing, plus a second international contract manufacturer onboarded in Q4) is delivering more than tariff neutralization. It is restructuring the unit economics.

The DaaS book continues to scale. Long-term trade receivable grew from C$1.13M at year-end to C$1.45M in one quarter, up 29%. The February raise was sized specifically to support this expansion. The working capital math is starting to look correct.

Moore Installs flipped accretive. Contributed C$439K of revenue and a C$60K net profit in Q1 versus a C$39K net loss in the year-ago stub period. The dilutive-acquisition concern from the FY25 update reversed in one quarter.

Recurring crossed 52% of revenue. New high. The original thesis mapped the rotation from hardware-led to recurring-led. Q1 was the first quarter where recurring is a majority of the revenue mix.

What worsened and what to watch for

Two items moved the wrong direction.

First, revenue growth decelerated to 12% from 19% in Q4 and 21% in Q3. Hardware revenue declined 3% year over year for the first time I can recall, with management language of “relatively flat device shipments year over year.” The benign reading is that customers held back ahead of the BeBatt launch on February 9 (mid-quarter) and the B5-BeSol+ refresh coming in Q2. If Q2 hardware shipments reaccelerate, this is a non-event. If Q2 hardware is still flat or down, the BeBatt cycle is pushing demand out rather than pulling it forward, and the deceleration story becomes harder to dismiss.

Second, recurring revenue growth itself has decelerated from a 51% peak in Q4/24 to 11% in Q4/25 to 14% in Q1/26. The mix is at a new high, dollar growth is record, but the YoY recurring growth curve has compressed. To hit Vision 20/20 Plus organically, recurring needs to compound at roughly 28%. The trailing run-rate is closer to 14%. The math closes only if the BeBatt and B5 cycle pulls device-to-recurring attach materially higher, or carrier and satellite channels add a step-function in 2027-28, or M&A contributes meaningfully. Management explicitly invoked all three. The acquisition lever in particular is now a public part of the plan, which is new.

Where the stock can go

BeWhere has been in the C$0.80 to C$0.90 range. Fully diluted share count post the February raise is approximately 100M, putting the equity at roughly C$85M and enterprise value near C$76M after netting C$9.2M of cash and a small government loan. Against trailing revenue of C$21.5M, that is about 3.5x trailing sales, versus an IoT/SaaS peer average closer to 8x.

The Vision 20/20 Plus targets translate fairly cleanly into a multi-year price framework. By the end of 2028, if management delivers what they just committed to publicly, the company should be running at C$35 to C$40M of revenue with Adjusted EBITDA in the C$7-8M range. Three scenarios are worth laying out.

In a conservative case where the company trades at 5x forward sales (still a discount to peers despite a higher recurring mix and better EBITDA profile), market cap exits 2028 near C$175 to C$200M, or roughly C$1.75 to C$2.00 per share. That is a double from the current C$0.85.

In a base case at 6x to 7x forward sales (compressing the peer discount but not closing it entirely), market cap is C$210 to C$280M, or C$2.10 to C$2.80 per share. That is 2.5x to 3.3x from here.

In a re-rated case where the recurring mix above 60%, the 20% EBITDA margin, and the disclosed three-year plan justify trading closer to the IoT/SaaS peer average of 8x sales, market cap reaches C$280 to C$320M, or C$2.80 to C$3.20 per share, roughly 3.5x to 4x from here.

The 2028 EBITDA exit at C$7 to C$8M cross-checks the framework. At a 20x EBITDA multiple (modest for a company at this growth rate and recurring mix), market cap is C$140 to C$160M. At 25x, C$175 to C$200M. At 30x, C$210 to C$240M. The two methodologies bracket each other in a consistent range of C$1.40 to C$3.20 per share over a three-year horizon, on management’s own publicly committed numbers.

The satellite scenario sits above all of this. The original post laid out a path where European and Middle Eastern expansion via Vodafone / AST SpaceMobile / Satellite Connect commercialization could push revenue toward C$100 to C$150M by 2029-30 with 25 to 35% EBITDA margins. At 8 to 10x forward revenue, that implies an enterprise value in the C$800M to C$1.5B range, or 10x to 20x upside from today. That scenario remains contingent on AST execution and is still optionality rather than a forecast, but the value of that optionality is the same as it was three months ago. Nothing in Q1 changed it for better or worse. The GSMA Foundry whitepaper still names BeWhere as one of two companies rolling out integrated solutions, and the Vodafone board seat still sits where it sat.

Why the thesis is on track

The compounding base is doing exactly what the thesis required. Gross margin re-rated to 45%. EBITDA margin expanded 600 basis points. Recurring crossed 50% of revenue. The DaaS book is recognized on the P&L upfront and funded on the balance sheet via the February raise. Management committed publicly to a three-year financial plan that broadly matches the published base case and exceeds it on EBITDA growth.

What remains is execution on the product cycle. BeBatt launched February 9. B5-BeSol+ is scheduled for Q2, B5-BeWired+ for Q3. Every prior step-function in BeWhere’s revenue trajectory traces back to a product cycle landing in market, and the 2025-26 cycle is the first to combine a new low-cost form factor with a full platform refresh and the embedded satellite-readiness via firmware update. If the BeMini ramp from 2023-24 is the template, the visible financial impact of the current cycle should be most pronounced in the second half of 2026 into 2027. That is when ARR growth re-accelerates from the current 14 to 16% range back toward the 25 to 30% trajectory required by Vision 20/20 Plus.

In short, the operating story has done its work. The valuation story now waits for product cycle revenue to land and for the recurring re-acceleration to begin showing in the prints. Q2 is the first read on that.

What I would ask management

Three questions matter most… 1) What does the Q2 unit shipment cadence look like, and how is BeBatt sell-through tracking against the BeMini ramp pattern from 2023? 2) Of the C$10M-plus ARR uplift implied by Vision 20/20 Plus, what is the organic versus M&A split management is underwriting? 3) And Canadian revenue declined 11% in Q1 after declining for the full year 2025, so what is driving the Canadian market softness given Bell Canada relationships at the board level?

DISCLOSURE

Position: At the time of publication, the author owns BeWhere.

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

Vodafone delivered FY26 at the upper end of guidance and, for the first time in years, put a multi-year target back on the table. The stock fell on German profit guidance - understandable. The market is paying for the quarter and getting the strategic optionality for free. The more important news for Vodafone came from the US, where the three largest carriers agreed to build a neutral, carrier-controlled direct-to-device (D2D) satellite platform whose architecture (predominately low bandwith spectrum) fits AST SpaceMobile and sidelines Starlink. They did so just as Starlink’s exclusivity with T-Mobile runs out and weeks ahead of their SpaceX IPO. That is a preview of the fight heading to Europe in 2027, and Vodafone is increasingly on the right side of it. (They also stand to materially financially benefit from their ASTS investment should this logic hold.) The multi-year thesis holds, and the satellite leg of it is stronger than it was a month ago.

Key points:

• The print was not the problem. FY26 landed at the top of the guided range on both profit and cash. The selloff was about Germany, where management was explicit that profit keeps falling into FY27.

• FY27 consensus falls high single digits. FY27 guidance sits above FY26 on both adjusted profit and adjusted free cash flow, the UK synergy ramp is contracted and visible, and management chose to reinstate a medium-term double-digit free-cash-flow growth ambition. Given the track record of this management team, they should get the benefit of the doubt, for now.

• The satellite optionality barely registered. Not one analyst question and not one management sentence on the call touched AST SpaceMobile or the European JV. In the results deck it appears as a single line on a portfolio timeline. The market is valuing it at roughly zero.

• The US carriers drew the blueprint. AT&T, Verizon and T-Mobile’s new D2D venture pools low-band spectrum into a neutral, multi-provider wholesale platform. Low-band cellular broadband from space is AST’s lane, not Starlink’s.

• Starlink got boxed. Its one-year T-Mobile exclusivity lapses in June. Rather than let Starlink expand to all three networks, the carriers built a layer they control. The same week, the FCC handed Starlink its own exclusive nationwide spectrum, which sharpens the single-point-of-control worry rather than easing it.

• Europe is the main event. Deutsche Telekom’s CEO has said plainly he will not let Starlink become a “kingmaker.” The EU’s 2 GHz satellite-spectrum licenses expire in May 2027, and Brussels wants a sovereign, European-controlled answer. The Vodafone and AST joint venture is built to be exactly that.

  This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

1. The quarter and the guide: what is actually moving

FY26 itself was clean and close to a non-event for the thesis. Group service revenue growth held above 5% in the fourth quarter, profit grew at the top of the guided range, and free cash flow extended the upward trajectory of the past three years. Della Valle opened the call by calling this “a new chapter” and “a simpler and stronger business,” and the framing is fair. The portfolio is now scaled in every market it keeps, the balance sheet is repaired, and the dividend is rising again under a progressive policy.

The print is not what moved the stock. Shares fell roughly 6% on the day, and the reason was entirely forward and entirely German. Management was candid that German profit will decline again in FY27. As Della Valle put it, “we expect EBITDA to remain under pressure in Germany,” with the mobile market “fundamentally unchanged” and the price reset of the past two years still flowing through the base. Germany is the largest single profit pool in the group, so a guided decline there sets the tone regardless of what Africa or the UK do. That is the bear case, and it is real. It is also already known, already guided, and already in the price.

FY27 guidance sits above FY26 on both adjusted profit and adjusted free cash flow. The UK is the visible swing factor: FY27 is the first year of meaningful VodafoneThree synergies, the cost savings are contracted rather than hoped for, and UK capital spending peaks this year and falls thereafter. Africa just posted its strongest service revenue growth in close to two decades, and the emerging-markets businesses are managed for euro growth. Net of the German drag, the group still guides higher.

The more telling signal is what management chose to do with the multi-year outlook. After years of refusing to give one, they reinstated a medium-term ambition of double-digit organic free-cash-flow growth. A reinstated long-range target is a statement about conviction in the floor. Asked directly why now, Della Valle pointed to a fully transformed portfolio operating “only from strong scaled position” in every market. So the risk around the forward numbers is lower than it was a year ago, not higher. The downside, Germany, is identified and bounded. The upside, UK synergies plus Africa plus capital spending rolling off, is contracted or structural. And the satellite optionality is not in any of those numbers at all.

2. The US carriers drew the blueprint, and it is AST’s

On May 14th AT&T, Verizon and T-Mobile, three bitter enemies, announced an agreement in principle to form a joint venture for satellite-based D2D. The stated purpose is to end wireless dead zones by pooling scarce spectrum, building shared ground infrastructure, and writing common industry specifications so satellite operators can plug into terrestrial networks in a standard way. The carriers call it a “technology-neutral innovation platform.” T-Mobile CEO Srini Gopalan framed it as a way to “make it easier for satellite operators to deliver a broader range of direct-to-device experiences.” Both AST SpaceMobile and Skylo welcomed the announcement.

Look past the neutral language and the architecture is specific. The venture is built around pooling low-band cellular spectrum, aggregating traffic to avoid a fragmented market, and routing satellite traffic into each carrier’s own core network so the customer experience never changes. It is a design in which satellite is an extension of the terrestrial network, and the carriers, not the satellite operator, own the standard and the customer.

That is AST SpaceMobile’s design. AST describes its own system as a cell tower in space. The radio access network stays on the ground, the satellite uses the operators’ existing low-band spectrum, and traffic hands straight down into the carrier’s core. It does not impose a proprietary routing layer. Low-band broadband to an unmodified phone is the one thing AST is purpose-built to do, while Starlink’s direct-to-cell service has leaned on dedicated mid-band and, increasingly, its own satellite spectrum. AT&T and Verizon already hold definitive commercial agreements with AST and are strategic investors, and AST shares jumped on the news. The carriers built a platform whose specifications happen to match one provider’s network.

The honest caveat is that the JV is officially technology-neutral and names no provider. It courts multiple operators, and Skylo’s endorsement is a reminder AST is not the only candidate. T-Mobile, importantly, is not an AST customer; its satellite partner is Starlink. The implicit-AST read is an interpretation. But it rests on the physics of low-band spectrum, on the two carrier relationships AST already has, and on the architecture the venture describes, not on hope. And the fact that T-Mobile, Starlink’s own partner, chose to join a neutral multi-provider platform is itself the signal.

3. Starlink, boxed

The timing is the whole point. T-Mobile’s exclusivity on Starlink’s US D2D service runs one year from commercial launch, which means the window that tied Starlink to a single US carrier lapses soon. That was the moment Starlink could, in theory, have expanded to AT&T and Verizon.

Instead the three carriers built a venture they jointly control. T-Mobile, Starlink’s own launch partner, chose a neutral multi-provider platform over deeper dependence on one satellite operator. The practical effect is to push US D2D through a carrier-governed layer in which no single provider sets the terms.

The contrast sharpened the same week. On May 12th, the day of Vodafone’s results, the FCC cleared EchoStar’s spectrum exit and assigned a large block of mobile-satellite spectrum to SpaceX. For the first time Starlink holds a contiguous, exclusive-use nationwide D2D spectrum position of its own. Pair that with Musk’s recurring public musings about a “Starlink phone” and Starlink evolving into a full mobile carrier, and the question every operator now has to answer becomes obvious. Is the satellite layer something you rent, or something you are feeding? The US carriers answered by building their own. That answer travels.

4. Bent pipe versus black box

Strip away the commentary and the entire debate reduces to one engineering choice.

AST’s model is a neutral relay, a bent pipe. The operator keeps its spectrum, its subscribers, its core network and, critically, its data. Traffic originates and terminates inside the operator’s own network and its own jurisdiction. AST sells wholesale capacity that extends coverage without inserting itself between the operator and the customer. Control of the network stays with the operator by design.

Starlink’s model is a vertically integrated proprietary stack. SpaceX builds the satellites, owns the constellation, increasingly owns the spectrum, and runs processing on the satellite itself. For a mobile operator the relationship looks closer to roaming onto, or reselling, someone else’s network. It works, it is first to market, and it is efficient. It also creates a dependency, on a counterparty that has openly mused about becoming a carrier itself.

For a commercial buyer, neutral versus proprietary is a question of pricing power and who owns the customer. For a government or a regulator it is a question of who controls a strategic communications layer and where citizens’ data physically sits. That second framing is the one about to dominate Europe.

5. Europe is the main event

Deutsche Telekom is the cleanest read on where Europe is heading. DT brought Starlink Mobile to Europe, and yet its CEO Tim Höttges has been strikingly blunt about the limits of that relationship. On DT’s most recent earnings call he told investors: “I do not want to throw my destiny into one hand, nor do I want a Starlink which is a kingmaker of the destiny of our businesses.” He has said DT will work with other D2D providers, and has noted that “the Starlink people are very aware about the political role and the power we have as a brand in Europe.” His framing is a network of networks, with satellite as one input and never a single dependency.

That is the trojan-horse concern, stated by a CEO who is himself a Starlink customer. A service sold as a complement can quietly become a dependency, and a US-controlled proprietary stack embedded in a European operator’s coverage map is a strategic exposure no matter how friendly today’s commercial terms look. Höttges is not refusing Starlink. He is refusing to be captured by it, and he is signaling that he wants a credible alternative to exist.

The regulatory clock makes this urgent. The EU’s 2 GHz mobile-satellite-service band, the spectrum best suited to D2D, sits under licenses that expire in May 2027. The European Commission has to decide whether to renew the incumbents or run a fresh selection process, and it has signaled real wariness of a straight auction, on the grounds that the cash-rich bidders are mostly American and an auction risks handing European spectrum to US balance sheets while crowding out European players. Brussels has said it wants to favour European players and weight the outcome toward sovereignty and security.

Two facts about that process belong side by side. AST SpaceMobile has made an explicit pitch for the band, backed by a European constellation plan and a German operations center. Starlink did not respond to the EU consultation at all. A company that did not engage when Brussels asked the question is not well placed to be Brussels’ answer.

This is why the US story is a preview rather than a sideshow. In the US, EchoStar’s spectrum flowed to Starlink and the carriers responded by building a neutral layer they control. In the EU the equivalent decision is still open, and the bloc has both the motive and the mechanism to steer it toward a European-operated, sovereignty-aligned vehicle.

6. Why this is a Vodafone story

Vodafone sits on the right side of both the financial and the strategic ledger.

Financially, Vodafone is one of AST’s largest and earliest backers. On AST’s own account, Vodafone has invested three times and holds over $1bn of AST stock, alongside a commercial framework that runs into the next decade. As AST re-rates, on the US JV, on an FCC authorization clearing commercial US service across a constellation of up to 248 satellites, on a partner roster of nearly 60 operators covering more than 3 billion subscribers, and on a take-or-pay backlog of around $1.2bn, Vodafone’s stake marks up with it. AST is still pre-commercial, with first-quarter revenue of $14.7m against full-year guidance of $150m to $200m, but it is funded through deployment on roughly $3.5bn of cash. The point is that this is real balance-sheet value that no Vodafone model currently carries.

Strategically, the larger asset is the joint venture. Satellite Connect Europe, the 50/50 Vodafone and AST venture once known as SatCo, is now operational. It is headquartered in Luxembourg, run from a control center in Germany, staffed by a dedicated European management team, and building ground stations across Germany, the UK, Spain and France. It is a wholesale vehicle. It sells sovereign D2D capacity to European operators rather than competing with them, and it carries a five-year mutual exclusivity with AST across Europe and Africa. It has already drawn agreements from operators including Orange and Telefónica, signed roughly ten new partners at Mobile World Congress, and, on AST’s disclosure, fielded interest from operators in 21 of the EU’s 27 member states. AST president Scott Wisniewski has been blunt about how far ahead the broadband-first service tier sits relative to earlier text and emergency offerings, calling the gap “apples and aircraft carriers.”

Put the pieces together. Europe needs a satellite connectivity layer. Its regulators and its largest operators have made clear they will not accept a US-controlled proprietary stack as the only option. The EU’s defining spectrum decision lands in 2027. And Vodafone has spent the past year quietly assembling the one vehicle purpose-built to be the European, sovereignty-preserving, neutral-wholesale answer, alongside the technology partner whose architecture the US carriers’ own blueprint implicitly endorses. This is the defensive telco playing offense, in concrete form, and it is currently valued at close to nothing.

7. Thesis holds…

… and on balance it is stronger than it was a month ago.

The multi-year thesis rests on two legs. The first is the restructuring story: a simpler, scaled Vodafone whose cash flow compounds. Management reinstated a multi-year growth target, and the one genuine weak point, Germany, is identified and already in guidance. The second leg is the satellite optionality, and that leg strengthened materially. The US carrier JV validated AST’s architecture, the regulatory and competitive dynamics in both the US and the EU moved AST’s way, and Vodafone’s own vehicle for Europe is up and running.

The risks are still real and worth stating plainly.

AST execution is the largest. The deployment plan is aggressive, around 45 satellites in orbit by year-end, and it depends on a launch cadence split between Blue Origin’s New Glenn, recently grounded after an anomaly, and SpaceX’s Falcon 9. Some independent analysts doubt the year-end target, and first-quarter revenue of $14.7m implies a steep second-half ramp. A material slip pushes the JV’s revenue to the right.

The US JV is genuinely technology-neutral. It names no provider and courts several. If Skylo or others take meaningful share, the implicit-AST read weakens.

The EU outcome is undecided. Brussels has not chosen between renewal, auction and beauty contest, and the process can run past 2027. A sovereignty-weighted outcome favours the Vodafone and AST vehicle, but it is not guaranteed.

Vodafone’s near term is genuinely soft. German profit falls again in FY27, the German mobile market is not yet repaired, and the derate reflects real pressure, not imagined pressure. The optionality does not pay the dividend. The operating business does.

And Starlink is formidable. First to market, but with a superior offering versus what AST’s satellites can support. However, they now own spectrum, and effectively unlimited capital. Boxed in the US is a structural read, not a victory.

None of this breaks the core point, which is asymmetry. The share price already carries the German drag and carries almost none of the satellite optionality. The risks above are reasons the option could be worth less than the bull case. They are not reasons it should be worth zero.

Bottom line

The market spent the last week marking Vodafone down for a German profit decline it had already been told to expect. On the same day the FCC redrew the US satellite-spectrum map. Two days later the three largest US carriers sketched an architecture that fits Vodafone’s satellite partner and sidelines that partner’s main rival. Deutsche Telekom’s CEO has said out loud what every European operator is now thinking, and the EU’s defining spectrum decision is about a year away. Vodafone owns half of the vehicle built for that moment. You are being asked to pay for the quarter. The option comes with it.

This was buried in a long earnings deck and most US-based readers have not seen it. The Japanese-language coverage from Nikkan Kogyo Shimbun (Japan’s leading industrial trade publication) is the cleanest version of the story, and it includes management quotes that change the tenor of the thesis materially.

What Management Said

President Norio Nakajima at the FY2025 results announcement on April 30, 2026, as quoted in Nikkan Kogyo Shimbun (May 6, 2026 edition):

「各ボトルネックの工程を埋め合わせることを優先する」

“We need to prioritize filling each bottleneck process.”

「十分な能力を持って需要に対応できたかというと、まだまだ不十分。急ぎ設備投資を決めた」

“As to whether we have had sufficient capacity to respond to demand: the answer is still very much insufficient. We hurried to decide on this capital investment.”

The language matters. 「急ぎ」(isogi) means “in haste” or “rushed.” Japanese corporate communication, especially from a 76-year-old industrial blue-chip like Murata, almost never uses this word about capex. It signals that the decision was made under operational pressure, not as part of a routine medium-term plan.

「まだまだ不十分」(mada mada fujuubun) translates to “still very much insufficient” or “still far from sufficient.” The doubled “mada mada” is an emphatic construction. A direct English equivalent is “we are nowhere close to having enough capacity.” For a company that has historically guided 15-25% below initial-year actuals to publicly say their capacity is “still very much insufficient” is unusual.

This is the single largest MLCC supplier in the world telling investors and customers that they are losing the supply battle, and they are spending money to catch up because they have to.

To corroborate the demand picture, Nakajima had previously told Bloomberg in February 2026:

「同社のMLCCの引き合いも供給能力に対して倍ぐらいの水準になっている」

“Customer inquiries for our MLCCs are running at roughly twice our supply capacity.”

「AI自体は産業革命と同等の変化であり、一時のブームではない」

“AI itself is a change comparable to an industrial revolution, not a temporary boom.”

What’s Embedded in the FY2026 Guidance That Most Missed

The FY2026 forward-looking section of Murata’s earnings deck contains a dataset that, when read carefully, validates the supply/demand thesis at the segment level:

Despite all of this, the headline FY26 operating profit guide is ¥380 billion, which is what consensus ran with. The guide reflects Murata’s habitual conservatism, not the trajectory of the underlying segment data they themselves disclosed.

There is also a tell in the FY2025 challenges-and-achievements slide of the earnings deck. Under “Acquiring demand for AI server power supplies,” management wrote:

“We had secured orders for secondary modules for hyperscalers; however, the orders were subsequently dropped due to defects caused by a firmware update.”

Murata is openly admitting they lost AI server orders due to operational issues, while at the same time announcing emergency capex. The combination (AI orders flooding in, some lost due to defects, now rushing to expand) is exactly what a constrained supplier does in a tight market.

Tying MLCC Demand to AI Capex: The Numbers The Market Is Actually Watching

The top 5 hyperscalers (Microsoft, Google, Amazon, Meta, Oracle) spent $448B on capex in 2025. April 30 earnings calls put combined 2026 spending at $700-725B, with Microsoft alone tracking to $190B versus a $120B initial plan. Bank of America and Evercore both now have 2027 above $1 trillion. Goldman Sachs has 2025-2027 cumulative hyperscaler capex at $1.15T, more than double the $477B spent in the prior three years.

Two data points from the April 30 prints matter for the MLCC thesis specifically:

Microsoft attributed approximately $25B of its $190B 2026 capex to component price inflation. That is 13% of total capex coming from component pricing alone, not from buying more units. Hyperscalers are openly acknowledging that components are taking a bigger share of the bill because suppliers can charge for it.

AI capex is rising faster than MLCC supply can. MLCC content per AI capex dollar is somewhere between 0.5% and 1.0%, with content rising as boxes get denser (Blackwell to Rubin to Rubin Ultra). Multiply: AI MLCC TAM goes from roughly $2.7B in 2025 to roughly $13B+ by 2030E. Murata at 60% AI MLCC share captures the largest single slice of that growth. And, as mentioned in our last post on Murata Part 1, the spread between supply and demand is set to grow for multiple years, compounding the imbalance.

Why the Pricing Case Just Got Stronger

Our original model assumed AI MLCC ASP rising from ¥3.0 in FY24 to ¥4.8 by FY28E, with one additional round of price hikes after the March 2026 round. After everything Murata put on the table April 30, that pricing trajectory looks materially too conservative for several reasons.

First, the shortage is bigger than 2018. The 2017-2018 cycle was a shortage of everything (commodity and high-end MLCCs), but only acutely tight for 12-18 months. The current cycle is a shortage of premium AI-grade MLCCs specifically. It is narrower in segment but larger in percent terms within that segment, and the duration is structurally longer because Rubin, Rubin Ultra, and Feynman are all designed with MLCC-heavy power delivery, and the demand ramp runs through 2030.

Second, capacity additions cannot keep up. Each new AI-grade MLCC production line takes 24-30 months from board approval to commercial yield. Murata’s ¥80B emergency capex adds 10-15% capacity. SEMCO’s Philippines plant ramps in late 2027. Taiyo Yuden and TDK are doing incremental adds. None of these are sized for what’s coming.

Third, the market needs a much stronger pricing signal. While not disclosed, our back-of-the-envelope math suggests greenfield capacity for high-end MLCCs requires roughly 4-5x current ASPs to clear the ROIC hurdle at incumbent levels of capital intensity. The first round of price hikes (15-35% in March 2026) is not enough. The 2018 cycle saw four discrete rounds of hikes (Q1 2017, Q3 2017, Q1 2018, Q3 2018), and Murata’s MLCC ASP roughly doubled trough-to-peak. That is the historical floor, not the ceiling, for what is possible in this cycle.

Fourth, hyperscalers can absorb every plausible price increase. A Blackwell NVL72 rack contains 441,000 MLCCs at roughly $0.30 average ASP. That is $130,000 of capacitors in a rack that costs $3-4 million all-in. MLCCs are 3-4% of BoM today. At the asymmetric scenario peak ASP (¥8.5/unit, roughly $0.55), MLCC content rises to ~$240,000, still only 6-7% of rack cost. Even a 3x price hike from current ASPs leaves MLCCs at less than 10% of rack BoM. Hyperscalers will not delay GPU deployment to save a few percent on capacitor pricing. They will pay. This is the underlying reason multi-round pricing is sustainable: the customer base genuinely cannot push back.

The Pricing Scenario Framework

We now model four scenarios based on the number of price hike rounds through FY30:

Per-round price increase on AI MLCCs assumed at 18%, which is conservative versus the 20-35% range seen in 2017-2018. The Bear case sits below the 2018 cycle in cadence. The Base case roughly matches it. Bull and Asymmetric run above 2018 because the AI MLCC demand growth structurally outpaces what smartphone-driven demand did then.

The pricing trajectory chart shows how each scenario plays out against the prior v7 path and the 2018 cycle reference (red dashed line at 2.0x). The Asymmetric case reaches ¥8.5 by FY30, a 2.83x trough-to-peak that exceeds the 2018 cycle but is justified by the longer demand ramp and structurally tighter supply response.

The Supply / Demand Gap Persists Through 2030

The reason pricing pressure continues to build is that capacity additions do not catch demand even by FY30 under reasonable assumptions:

Annual deficit: -20B units (2026) → -80B (2027E) → -120B (2028E) → -150B (2029E) → -160B (2030E). The gap widens, it does not close. For supply to materially catch demand, the industry would need 3-4 new high-end MLCC plants approved in the next 12 months. None are. The capex math simply doesn’t work at current ASPs.

This is the inversion that gets the asymmetric pricing case to over 7 rounds of hikes. The market has to send a much stronger price signal to incentivize the capacity additions required. Until it does, the existing incumbents (Murata, SEMCO, Taiyo Yuden) keep capturing rent.

Headline Financial Outcomes by Scenario

Why The Base Case Alone Is Compelling, And Why The Asymmetric Case Is Where The Conviction Sits

The base case gives 25% IRR over 18 months on what is now a much better-supported assumption set than what was in place at original publication. The asymmetric case at 76% upside on FY28E is where the conviction really sits, because the supply/demand gap supports continued pricing power well beyond FY28E.

The Asymmetric Case Through FY30

Extending the asymmetric case to FY30 captures the durability of the cycle:

Per the framework table above, this gets to MRAAY $53.77 at a 22x P/E multiple (+249% upside, +43% annualized IRR).

This is what a multi-year structural pricing cycle in a high-fixed-cost industry with disciplined incumbents looks like in the financial model. It is not a one-year pop.

Where the Cash Goes (and Why More Buybacks Are Highly Likely)

Murata’s balance sheet was already underlevered before the buyback. Even after the ¥150B buyback announced April 30 (largest in company history), the asymmetric case has the company sitting on net cash of $10-12B USD by FY30. That is more cash than they need for any plausible capex or M&A program.

Three factors converge to make additional buybacks highly likely through the cycle:

1. Underlevered balance sheet. Debt-to-equity of 0.02. They have essentially no leverage to optimize, so excess cash sits there.

2. Improving Japanese corporate capital allocation. Murata’s Medium-Term Direction 2027 explicitly switched ROIC measurement from pre-tax to post-tax and set capital efficiency as a primary KPI. Their FY26 guide is ROIC of 12.3% post-tax (up from 9.7%), with WACC at roughly 7%. They have publicly committed to capital returns “with the aim of improving capital efficiency.”

3. Disciplined capex history. Murata has historically targeted ROIC well above WACC and has consistently under-built in cyclical upcycles when peers over-built. This is the company that lost AI server orders to firmware issues and is now doing emergency capex, not the company that builds speculative capacity. That discipline is bullish for pricing because it means industry capacity additions stay constrained.

The asymmetric case explicitly bakes in ¥900B of cumulative buybacks FY26-FY30 (¥150 + ¥200 + ¥250 + ¥300 = compound rate growing with the cash flow), taking the share count from 1.95B to 1.62B by FY30. That assumption can be conservative if cash builds faster than modeled, which it likely does in the bull and asymmetric pricing scenarios.

This is the underappreciated angle. Most cyclicals destroy capital allocation at the peak. Murata is set up to compound capital efficiency through the cycle because management is doing the right things on both sides of the balance sheet.

What the Capex Means for Competitive Dynamics

This is where the read-through is most important and the news is most under-appreciated.

There are four real producers of AI-grade MLCCs globally. Here is the capacity expansion timeline:

Three observations:

1. SEMCO is at 99-100% utilization right now. Korean media (Seoul Economic Daily, March 25, 2026) confirmed SEMCO’s MLCC factory utilization rates have “effectively reached 100%.” Their next material capacity addition is the third plant in Calamba City, Philippines, with groundbreaking in H1 2026 and commercial production starting July 2027 at the earliest. SEMCO publicly stated their MLCC production for next year is “already sold out.”

2. Murata’s ¥80B incremental capex widens the supply gap in 2027 specifically. SEMCO’s Philippines plant doesn’t ship until late 2027. Murata’s incremental ¥40B in FY26 + ¥40B in FY27 spending hits existing facilities (much faster ramp than greenfield), with most output coming online through 2027. There is now a ~12-month window in 2027 where Murata is adding capacity faster than the market overall.

This is the period where Banyan Lane’s model has Murata’s effective AI MLCC share nudging higher to the high-50s percent in FY27 before settling back as SEMCO’s Philippines plant ramps in late 2027 and 2028.

3. None of this fixes the supply/demand gap inside the thesis horizon. Total incremental capacity from Murata’s ¥80B is ~10-15% of their existing MLCC base. Across the industry, even with SEMCO Philippines online by mid-2027, capacity additions through end-2028 are estimated at 25-35% above today’s level. Banyan Lane’s model has AI MLCC demand growing at 80%+ CAGR through 2028. Capacity additions of 25-35% don’t close a 4x demand gap. The shortage remains the central feature of the trade.

The competitive read-through: Murata is using its capex flexibility to take advantage of SEMCO’s slower ramp. They’ve also stated publicly their share is roughly 60% of AI MLCCs and they have multi-year long-term agreements with most major customers. The window where Murata gets to set the price unilaterally is wider than the headline competitive structure suggests.

Will an MLCC Shortage Inhibit AI Chip Output? Probably Not, But Worse for Hyperscalers

A reasonable question raised in the comments to the original post: if MLCCs are this tight, will the shortage actually hold back AI chip shipments?

The honest answer: almost certainly not for tier-1 hyperscalers, but yes for parts of the broader market.

Three reasons MLCC shortage doesn’t break NVIDIA shipments through Rubin:

1. HBM and CoWoS are the binding constraints, not MLCCs. NVIDIA management has stated repeatedly that HBM3E supply is fully allocated through 2026. CoWoS-L packaging capacity is “oversubscribed through at least mid-2026” per TSMC. These are physical bottlenecks at $9-15B fab-scale facilities. MLCCs at 3-4% of rack BoM are economically immaterial in comparison, even at peak ASPs.

2. Hyperscalers are tier-1 priority customers. During the 2017-2018 MLCC shortage, Apple, Samsung Electronics, and Tesla all received full allocation. The line-stops happened at tier-2 and tier-3 OEMs (GoPro publicly admitted under-producing cameras due to MLCCs; Sony PS4 production was constrained). Today’s hyperscalers (Microsoft, Meta, Google, Amazon, Oracle, xAI) are explicitly prioritized. Murata management said multi-year LTAs with these customers mean “supply is not a concern.” Murata is taking care of the priority tier first.

3. MLCC production is more flexible than HBM/CoWoS. Even during peak 2018 shortages, MLCC manufacturers maintained allocation regimes that delivered some product to most major customers. Existing line capacity expansion takes 18 months; emergency capex like Murata’s ¥80B can be online inside 12-18 months on existing buildings. HBM and CoWoS expansions take 36-48 months.

Where shortages may actually bite:

• Mid-tier server OEMs without long-term agreements (Dell, HPE, Supermicro non-priority lines)

• Industrial computing (Honeywell, Schneider, ABB) which competes with hyperscalers for the same high-capacity parts

• Automotive Tier-1s during the 2027 EV cycle ramp, especially Chinese and European players

• Smaller AI chip makers (Cerebras, Groq, SambaNova) which cannot command priority allocation

The pattern from 2018 holds: the shortage is real, but it allocates pain to tier-2/tier-3 customers while tier-1 customers pay through the nose to maintain supply. That dynamic is what gives Murata pricing power. It’s not that AI chip output gets capped by MLCC availability; it’s that AI chip output gets supplied at MLCC prices that go up 25-50% per round of negotiations.

How Often Did Prices Rise in Past Cycles?

This is the question that sets up the next round of model upgrades.

In the 2017-2018 super cycle, prices on standard-spec MLCCs rose 5-10x over 18 months (BlockBeats analysis), with lead times moving from 4-8 weeks to over 30 weeks. The cadence of price increases:

• Q1 2017: First round of hikes, 5-15% on commodity grades

• Q3 2017: Second round, 15-25% on standard grades, larger on specialty

• Q1 2018: Third round, 20-35% on most grades, 50%+ on supply-constrained sizes

• Q3 2018: Fourth round in some categories, smaller magnitudes

• 2019: Hikes stopped as demand collapsed (post-iPhone X, ahead of trade war)

Murata explicitly raised prices multiple times per cycle when the market was tight. Taiyo Yuden, Samsung Electro-Mechanics, and TDK followed within 1-2 quarters each time. The 2018 cycle saw four discrete rounds of hikes, and Murata’s reported MLCC ASP roughly doubled from FY16 to FY19 peak.

The current cycle started its first round of hikes in March-April 2026 (Murata: 15-35%; Taiyo Yuden: 6-13%; SEMCO: 5-10% in negotiations). Historically, the cadence between rounds 1 and 2 was 2-3 quarters. That puts the next round of price increases somewhere between September 2026 and February 2027 and well within the thesis horizon, and likely larger than the first round given that book-to-bill remains above 1.0 and lead times are still extending.

Goldman Sachs noted on March 18, 2026 that “the reported price hikes for MLCCs in particular, if accurate, would likely have positive implications for Murata Mfg., Taiyo Yuden, and the industry as a whole, largely because we believe most investors have factored in Murata Mfg’s prior comment that it would consider price hikes from mid-2026 onwards.” Murata moved earlier than the Street expected. We think they will move again, also earlier than the Street is currently modeling.

What Would Change The Updated View

Things that would make Banyan Lane more confident in the upgraded targets:

• Q1 FY27 print (late July 2026) showing Murata gross margin above 40% and operating margin above 22% (model has 41.7% / 20.8% by FY26 average)

• Second round of Murata price hikes announced between September 2026 and February 2027, magnitude 20-35% on AI parts

• Order backlog continuing to grow above ¥446B for two more quarters

• SEMCO Philippines Plant 3 ramp delay beyond July 2027 (would extend Murata’s window)

Things that would force a downgrade:

• Murata book-to-bill drops below 1.0 for two consecutive quarters

• Hyperscalers guide flat-to-down 2027 capex in late-2026 prints

• NVIDIA confirms eDTC adoption for Rubin Ultra (would pull substitution risk forward by 12 months)

• SEMCO publicly cuts AI MLCC prices to win share

The Balance Sheet and Capital Returns: A Structurally Underutilized Lever

The pricing case is half the story. The other half is what Murata does with the cash that piles up. Two charts make the point.

Net Cash Has Compounded for Over a Decade

Murata has been in net cash position consistently for 15+ years. Net cash grew from $2.6B in FY15 to $8.1B by FY24 even through one industry cycle and a global financial crisis. Net debt / EBITDA hit -4.3x in FY24, deepest in the company’s history, because cash kept accumulating while EBITDA was at cycle-trough levels.

In the asymmetric forecast case, net cash reaches $12.1B by FY30E even after ¥1,030B of cumulative buybacks (more on that below). Net debt / EBITDA stays at -1.1x even as EBITDA grows 6x from current levels. Even with aggressive capital returns and substantial capex through the cycle, Murata cannot meaningfully spend down their cash position.

This is structurally unusual for a Japanese industrial. A typical company in this category would be 0x to +1x net debt / EBITDA. Murata’s position is roughly 2-3 turns below that range. There is plenty of room to either accelerate capital returns or pursue M&A.

Buybacks Can Run at 2-3% of Market Cap Annually

The April 30 buyback announcement (¥150B, the largest in company history, retiring 4.1% of shares) is the start of a meaningful capital return program, not the end. In the asymmetric scenario, we model cumulative buybacks of ¥1,030B from FY26 through FY30, which equals roughly 10% of the current market cap.

Bottom Line

Murata announced ¥80 billion of emergency MLCC capex on April 30, 2026, citing capacity “still very much insufficient” against demand. The bigger update is that the demand picture ties directly to hyperscaler capex now exceeding $700B and heading above $1T by 2027, with Microsoft openly attributing $25B of its 2026 capex to component price inflation. The AI MLCC shortage is structurally larger and longer-duration than 2018, and the supply/demand gap widens through 2030, not closes. Banyan Lane Capital now runs four pricing scenarios based on number of price hike rounds. Base case (4 rounds, FY28E EPS ¥304) gives MRAAY $21.58, +40% upside, +25% IRR. Asymmetric case (7 rounds, extended to FY30E EPS ¥758) gives MRAAY $53.77 on 22x P/E, +249% upside, +43% annualized IRR. Net cash builds to $12B by FY30E even after ¥1,030B (10% of market cap) of cumulative buybacks. Murata has been net cash for 15+ years, with current net debt / EBITDA at -3.3x, and the company has publicly committed to capital efficiency under Medium-Term Direction 2027. This is not a compounder story. It is an extreme supply/demand cycle with a disciplined capital allocator at the center. The thesis got stronger this week, not weaker.

The frustrating part of these trades has always been that demand eventually disappoints. Steel demand mean-reverts. Iron ore consumption peaks. Cardboard ships less when retail is slow. The supply story is real but the demand story is just a cycle around a flat-to-modest growth trend.

This thesis is exactly like the cyclical commodity setups we’ve all seen for years, with one critical difference: for once, there is a true secular demand driver underneath the cycle, and the emergence of product differentiation! The supply-side analysis is identical to copper or cardboard or anything else with long capex lead times. But the demand side is genuinely structural, driven by AI infrastructure buildout that has years left to run. That combination is unusually attractive.

This note also leans on the three-axis framework Banyan Lane uses for evaluating opportunities. A great trade typically lines up on at least two of these. This one lines up on all three:

• Cyclical: The MLCC industry is in the early phase of a multi-year up-cycle. Lead times have stretched from 8 weeks to 24-40 weeks. Price hikes were announced April 2026 (Murata +15-35% on AI/auto-grade) and May 2026 (Taiyo Yuden +6-13%). Samsung Electro-Mechanics is signaling 5-10%. This cycle is not a forecast - it is happening now.

• Secular: AI compute demand is creating a new product category (high-cap, hi-rel MLCCs for power delivery on accelerators) that did not meaningfully exist five years ago. NVIDIA’s Blackwell NVL72 rack uses ~441,000 MLCCs. The upcoming Rubin VR200 NVL72 is estimated at ~600,000+. This is structural, not cyclical.

• Idiosyncratic: Murata-specific factors that don’t apply to peers, including ~60% share of AI-server-specific MLCCs (vs. ~40% overall MLCC share), the cleanest US-listed exposure (MRAAY, an ADR), a ¥150B buyback announced May 2026 retiring ~4% of shares, and a culturally conservative guidance practice that sets up serial beat-and-raise quarters.

A few of the figures in this note are estimates or triangulations from industry data, customer disclosures, and the SemiAnalysis ecosystem. Where exact numbers are not publicly disclosed (specifically AI MLCC volumes and ASPs by tier, and Murata’s AI-specific market share), we’ve built bottom-up estimates using BoM disclosures, server unit forecasts, and announced price hikes. These are flagged where relevant. Happy to take better inputs if you have them!

An important caveat on share assumptions: Murata’s overall MLCC share is roughly 40% (a disclosed industry figure). Their share specifically of AI-server-grade MLCCs is harder to verify and is the single largest sensitivity in this thesis. Industry sources put it between 50% and 70% depending on what you count. Banyan Lane uses 60% as the working assumption throughout this note, with explicit downside scenarios at lower share. The math works at 60%. It still works at 50%. Below that, the thesis weakens materially.

Reading time: ~30 minutes.

Note: additional reading suggested by Nutty (@nuttycld), who covers the technicals very well and beat me to the punch.

Subscribe now

Share

Part 1: The Punchline Up Front

Murata Manufacturing (Tokyo: 6981.T, ADR: MRAAY) is currently a roughly $65 billion market cap Japanese components company (similar in scale to Lam Research). It produces ceramic capacitors, an old, slow-growing, mostly commodity industry. The stock trades around $15.41 on the ADR (¥5,138 in Tokyo) as of early May 2026.

Banyan Lane’s view is that Murata’s earnings power by FY28 (March 2029) is 40-90% above current Wall Street consensus at a 60% AI MLCC share assumption. FY28E EPS lands at ¥307 vs. consensus implying ~¥210, driven by an asymmetric supply/demand setup in high-end MLCCs that the market has not yet fully credited.

Two valuation lenses, both pointing the same direction:

P/E framework on FY28E EPS ¥307:

• Base case (22x): MRAAY $21.77, +41% upside, ~26% annualized IRR over 18 months

• Bull case (28x): MRAAY $27.71, +80% upside, ~48% IRR

• Asymmetric (32x): MRAAY $31.66, +105% upside, ~62% IRR

EV/EBITDA framework on FY28E EBITDA ¥819B / $5.3B:

• Base case (11x, mid-cycle median): MRAAY $18.36, +19% upside, ~12% IRR

• Bull case (13x, cycle peak): MRAAY $21.30, +38% upside, ~24% IRR

• Asymmetric (15x, structural rerate): MRAAY $24.24, +57% upside, ~35% IRR

Note these are point-in-time targets on FY28E earnings power. The 18-month IRR assumes the market starts crediting that earnings power as the beat-and-raise dynamic plays out through 2026-2027 prints, well before FY28 actually closes.

Three things make the potential upside larger than the headline target prices suggest:

1. MLCCs are a trivial share of AI server BoM. A Blackwell rack with 441,000 MLCCs at peak ASP of roughly $0.30 each is only $130,000 of MLCCs in a $4 million GPU box. That is 3% of BoM at the absolute high-water mark. If Murata pushed prices another 50-100% on AI parts, hyperscalers would still pay rather than lose AI training share for a fraction of a percent of total cost. The pricing assumptions in Banyan Lane’s model are deliberately conservative. Murata president Norio Nakajima has publicly stated that customer inquiries for the company’s MLCCs are running at roughly twice their available supply capacity (Bloomberg, early 2026). When demand is 2x supply, the supplier sets the price.

2. Lead time and qualification dynamics in this market are more like memory than people realize. A new high-end MLCC line takes 24 to 30 months from capex commitment to first revenue. Existing line capacity expansion takes 18 months. Customer qualification on top of that adds another 6 to 12 months. Compared to DRAM/HBM, which most investors are watching closely, MLCC is faster and cheaper to add but the absolute supply is also dramatically smaller and more concentrated. The cycle should be durable.

3. Capacity expansion timing favors Murata in the near term. Murata announced its Izumo plant in March 2024 and started shipping in April 2026 (25 months). SEMCO’s Korean expansion was announced in 2025 and is not expected to ship until mid-2027. SEMCO’s Philippines (Calamba City) line started ramping early 2026 but is smaller. SEMCO’s Tianjin plant has been running 24/7 at full capacity since early 2026 with no expansion room. This means Murata’s share of AI MLCCs likely rises modestly in 2027 before SEMCO’s bigger Korean expansion catches up in 2028. The model holds 60% throughout to be conservative.

Part 2: What’s an MLCC, and Why Should You Care?

A multilayer ceramic capacitor (MLCC) is a tiny battery that charges and discharges thousands of times per second. Its job is to keep voltage steady when a chip suddenly demands more power.

Analogy: Think of a capacitor as a small water tank next to a faucet. When you turn the tap, you don’t want the pressure to drop. The tank releases water immediately, then refills slowly from the main pipe. Modern AI chips pull enormous amounts of current and need stable voltage delivered with microsecond precision. So they need hundreds of thousands of these tiny tanks placed right next to them.

The MLCC market is structurally split into two products that share a name but are fundamentally different businesses:

Type Capacitance Where it goes Price each Maker count Commodity MLCC 0.001 to 1 µF Toasters, cars, smartphones, everything $0.0003 to $0.003 20+ globally High-end MLCC 10 to 470 µF High-performance chips, AI servers, EV inverters $0.05 to $0.50 3 to 4 globally

That’s a 100 to 1,000x price spread between the two. They are called the same thing but are as different as a Toyota Corolla and a Ferrari. The Corolla is built from parts you can buy from anyone. The Ferrari has specialty components from one of three workshops in the world.

This distinction is the entire investment thesis.

Part 3: The Macro and Micro Structure of Supply and Demand

This market is unusual because it has both macro and micro economic structures that work in favor of the highest-end producers.

Macro Structure

At the commodity end of the market, supply is elastic. If demand rises, Yageo, Walsin, Sunlord, and a dozen other Taiwanese and Chinese players can add capacity in 12 to 18 months. Pricing power is limited. This is a normal cyclical commodity business.

At the high-end (AI server, automotive grade, high-cap parts), supply is structurally inelastic. Only Murata, Samsung Electro-Mechanics, and to a lesser extent Taiyo Yuden and TDK can produce them. The reason is that making a 100 µF MLCC the size of a grain of sand requires stacking 500 to 1,000 ceramic layers, each less than a micron thick. The yield curve is brutal. Every 100 layers added drops yields by 5-10%. The dielectric powder (barium titanate) comes from 3 to 4 qualified suppliers globally. The stacking equipment comes from one company, Toray. From capex commitment to first revenue is 24 to 30 months.

So when AI demand spikes, no one can add high-end capacity for two years. This is a oligopolistic supply structure inside a market that looks competitive at the surface.

TrendForce’s framing of the current moment is useful: “Leading suppliers such as Murata, along with other major high-end Japanese and Korean manufacturers, are largely adhering to a ‘profit-first’ strategy. Competitive price bidding has become more disciplined to preserve overall ASP levels.” The high-end producers are coordinated on price, not competing.

Micro Structure: The Demand Side

The micro story is where the secular driver lives.

A standard server in 2018 had about 1,500 MLCCs. An NVIDIA H100 box has 25,000. A Blackwell NVL72 rack has 441,000. Rubin (VR200 NVL72), shipping next year, is estimated at 600,000+ (Korean media reports, ~30% above GB300 platform). That’s a single rack containing as many MLCCs as 300 traditional servers.

Why so many? Because a Blackwell GPU draws about 1,000 watts at less than 1 volt. That’s over 1,000 amps of current swinging on and off thousands of times per second. Every nanosecond of voltage instability is a computational error or a thermal event. The only way to deliver clean power at that scale is hundreds of thousands of capacitors arranged in a precision power delivery network around the chips.

The Supply/Demand Math

Here is what the market has yet to discount. The chart below shows AI server MLCC demand vs. supply in billions of units per year, plus the net balance (negative = deficit).

The 2024 and 2025 picture was balanced or slight surplus. The shift happened in 2026. As Blackwell volumes ramped and Rubin orders entered the queue, demand jumped from roughly 60 billion units to 130 billion units in a year. Supply, constrained by physical capacity, only rose from 70 to 110 billion units. The market flipped from surplus to a 20 billion unit deficit.

Banyan Lane’s model has the deficit peaking at roughly 120 billion units in 2028 before new capacity from Murata’s Izumo plant and SEMCO’s Korean expansion starts to close the gap in 2029. This is a 3 to 4-year shortage. Long enough for sustained price increases. Short enough that the trade has a defined endpoint to position around.

Lead Times and Pricing Hikes Are Already Happening

This is not a forecast. The cycle has begun.

• Lead times: Stretched from 8 weeks (normal) to 24 to 40 weeks (current) through 2026 (TrendForce, Murata customer notices)

• April 1, 2026: Murata raises AI/auto-grade MLCC prices 15-25%

• May 2026: Taiyo Yuden raises 6-13%

• April-May 2026: Samsung Electro-Mechanics signaling 5-10% hikes, with discussions ongoing with major clients

• TrendForce data: AI server MLCC spot prices up 15-20% year-to-date 2026, projected up 30-40% for the full year on high-end parts

• SEMCO Q1 2026 print: Operating profit up 39.9% YoY, pursuing long-term supply agreements with Big Tech, launched 47µF MLCC for AI servers (double prior capacity)

The price signal is in the market. Banyan Lane’s model assumes these price increases flow through to reported financials with a 1 to 2 quarter lag, which means the first earnings prints showing the impact will be in late July 2026 (Murata Q1 FY27).

Part 4: Time and Cost to Add Supply (Why This Cycle Lasts)

Many investors are watching DRAM and HBM closely. Memory has had massive price moves and is the more famous AI shortage story. So a useful comparison is: how does adding MLCC capacity compare to adding DRAM/HBM capacity?

A few observations:

MLCC capacity is faster and cheaper to add than DRAM/HBM. A new high-end MLCC line costs roughly $1.5 billion and takes 30 months. A new HBM-capable DRAM fab costs $9 to $15 billion and takes 4 years (Micron’s $9.6B Hiroshima fab, announced May 2024, expected first output 2028 per Nikkei reports).

That’s the bear case for MLCCs. Capacity will arrive faster than in DRAM. The cycle will be shorter.

But the absolute supply is dramatically smaller and more concentrated. There are only 3 to 4 companies in the world that can make AI-grade MLCCs. There are 5 to 6 companies that can make HBM. More importantly, MLCCs do not have a substitute path within the same product. DRAM has a known “node migration” path where existing fabs deliver more bits per wafer through process improvements. MLCCs do not have an analogous yield-gain path. Adding bits per fab is constrained by the physical layer-stacking process. (We will discuss the OUT-OF-CATEGORY substitute path, eDTC and HD-MiM, in the risk section. That’s a real long-term threat but not a near-term one.)

And here is the kicker: Murata announced its Izumo plant in March 2024 and started shipping in April 2026 (25 months). SEMCO’s Korean expansion was announced in 2025 and is expected to ship mid-2027. Even with the price signal screaming since 2024, the actual capacity additions land in 2026 to 2027 and won’t ramp meaningfully until 2028. The shortage cannot be fixed inside the thesis horizon. That’s what makes the cycle durable.

For perspective on the math: total AI-capable MLCC industry capacity today is roughly 80 to 110 billion units per year, of which 50-60% is contracted to non-AI uses (auto, industrial, medical). Available for AI is maybe 30 to 50 billion units. AI MLCC demand in 2026 is already at 130 billion units and rising fast. There is no near-term supply response possible. That structural scarcity, in front of a multi-year secular demand driver, is the entire trade.

Part 5: The Pricing Lesson From History

In 207-2082018 Apple was launching the iPhone X. Japanese suppliers were exiting low-end MLCC production to focus on high-margin parts. Demand exploded, supply was stuck, and the high-end ASP for a reference part (100 µF / 0402 X5R) went from $0.04 to $0.30 in 18 months, a 7.5x move.

It crashed back when Chinese capacity arrived in 2019, but only commodity capacity. The high-end stayed elevated. The 2022 cycle (5G, COVID, EV) saw a smaller move because supply had been added in the meantime.

Now look at the blended industry ASP across 15 years:

The blue line shows the historical industry blended ASP. It has been rangebound at $0.0024 to $0.0040 for fifteen years. The 2018 super cycle pushed it from $0.0027 to $0.0040, a 1.47x move over two years.

The green dashed line is Banyan Lane’s forecast. From the 2024 trough of $0.0029, blended ASP rises to $0.0061 by 2029E. That’s 2.07x, meaningfully above 2018.

Why higher than 2018? Three structural reasons:

1. Mix shift, not commodity price hikes. In 2018, commodity ASPs spiked because of capacity tightness. This cycle, commodity stays flat-to-up modestly. The pricing is happening in the high-end, where AI MLCC ASPs go from $0.10 to $0.30+ per unit. As high-end mix rises in the blended number, blended ASP doubles even if commodity barely moves.

2. AI is structural demand, not a single product cycle. The iPhone X drove the 2018 cycle. AI infrastructure is a multi-year buildout across multiple generations of accelerators. Duration matters: a 4-year cycle accumulates more cumulative ASP gains than a 2-year cycle.

3. Customer concentration favors suppliers, not buyers. In 2018, Apple eventually negotiated MLCC prices down by playing suppliers against each other. In 2026, six hyperscalers are spending $300B+ on capex and panic-locking long-term agreements at the offered prices. None will lose AI training share to save 0.01% of capex on capacitors. This is the reverse dynamic of 2018.

The pricing assumption is justified by the supply/demand imbalance. Now let’s see what happens when we run that through a real income statement.

Part 6: Why Murata Specifically?

There are five real players in MLCCs globally.

Market shares triangulated from industry reports, TrendForce data, and customer BoM disclosures. AI MLCC share specifically is the largest data uncertainty in this thesis. Banyan Lane uses 60% for Murata; the model would still work at 50% and weakens materially below that.

Murata is the cleanest play. They have spent the last decade walking away from the lowest tier of the commodity market and pouring capex into high-end. Industry sources estimate they hold around 60%of AI-server-specific MLCCs (with some sources putting this as high as 70% for the very highest-cap parts). Their cleanroom infrastructure (Class 100-1000), proprietary BaTiO3 powder synthesis, and 1,000-layer stacking technology is genuinely 1 to 2 nodes ahead of anyone else.

Samsung Electro-Mechanics is interesting for operating leverage (lower margin base means more cycle torque). SEMCO’s Q1 2026 print showed operating profit up 39.9% YoY with revenue crossing ₩3.21T (~$2.2B) for the first time in company history. They launched a 47µF MLCC for AI servers, doubling prior capacity. Their CEO is positioning the company as the “World’s Only AI Core Component Solutions Provider,” which signals price discipline rather than commoditization. They are pursuing long-term supply agreements with Big Tech, not undercutting on price. SEMCO is following Murata’s playbook, not breaking it.

Taiyo Yuden has higher beta in absolute terms but the stock is illiquid in the US (TYOYY <20K shares/day with 8% spreads).

For US investors, MRAAY is the cleanest expression. Approximately 150,000 shares per day of liquidity, 5 to 10 basis point spreads, and 0.5 ADR ratio (one ADR equals half a Tokyo share). The Tokyo direct (6981.T) is preferable for institutional sizing where liquidity matters more.

The idiosyncratic axis is also where the most concentrated upside lives:

• AI MLCC is becoming most of Murata’s earnings. In FY24A, the MLCC division was roughly 50% of revenue. By FY28E in Banyan Lane’s model, MLCC is 67% of revenue and roughly 90% of operating profit. AI MLCC alone reaches 25% of revenue. This is operating leverage from a single product line that no peer can match.

• Net cash balance sheet of roughly $8 billion, supporting buybacks. The May 2026 ¥150B buyback retires roughly 4% of shares.

• Conservative guidance culture. Murata has historically guided 15-25% below initial-year actuals in cycle years. The April 2026 FY27 guide of ¥380B operating profit looks deliberately conservative against the price hikes already announced.

• Capacity expansion timing. Murata’s Izumo plant is shipping now (April 2026). SEMCO’s larger Korean expansion is mid-2027. This 12-18 month head start should let Murata gain 1-3 share points in 2027 before settling back.

Part 7: Building the Income Statement Bottom-Up

The thesis stands on three legs: volume × ASP × margin. Each is built explicitly so the model is falsifiable.

Step 1: Revenue from volume × ASP

Banyan Lane splits Murata’s MLCC business into three product categories with completely different unit economics:

Total Murata MLCC volume grows from 1,700B to 1,830B units, an 8% expansion driven by the Izumo plant ramp and follow-on capacity additions. This is not a story about Murata “selling many more MLCCs” but rather about volume growing modestly while mix shifts dramatically. What changes dramatically is the mix:

• AI server MLCCs: 14B units (FY24A) to 120B units (FY28E) at 60% AI MLCC share. 8.5x growth.

• Auto/industrial: 400B to 470B. EV and ADAS demand drives 18% growth.

• Commodity: 1,286B to 1,240B. Murata stays in commodity selectively but lets the bottom of the market churn.

ASP per category:

• AI MLCC ASP: ¥3.0 to ¥5.2 per unit. Reflects Apr-26 price hikes (15-35%) plus a likely second round in 2027 if shortage persists. Conservative vs. the BoM-share argument.

• Auto MLCC ASP: ¥0.92 to ¥1.18. EV demand drives modest pricing power.

• Commodity ASP: ¥0.32 to ¥0.37. Stable.

Blended ASP rises from ¥0.48 to ¥0.92 per unit, a 92% increase. Volume grows 8%. So MLCC division revenue grows from ¥821B to ¥1,611B, a 18% CAGR.

When stacked with the other Murata segments (non-MLCC components, Devices & Modules, Other), total revenue grows from ¥1,638B to ¥2,372B (or $10.6B to $15.3B in USD at 155), a 10% CAGR.

The shape is what matters. AI MLCC goes from a sliver to the largest single revenue category. Devices & Modules (the lower-margin, lower-growth piece, including the SAW filter business they just took an impairment on) shrinks. The mix is shifting toward Murata’s best products.

Step 2: Gross Profit per Unit (Where the Thesis Lives)

This is the structural story:

A single AI MLCC sells for ¥3.0 today and costs about ¥1.50 to make, a 50% gross margin. By FY28E, ASP rises to ¥5.2 and the cost structure stays roughly stable around ¥1.55 (yield improvements offset by complexity). Gross profit per unit goes from ¥1.50 to ¥3.65, a 2.4x expansion in absolute gross profit per unit. Gross margin moves from 50-70%.

This is what defines a structural cycle: price rising faster than cost. You don’t get this in commodity businesses where price compression and cost compression race each other. You get it when supply is genuinely constrained and the buyer cannot substitute.

When Banyan Lane aggregates the per-segment gross profits, the company-wide gross margin moves from 35% to 50% over four years.

Step 3: Operating Expenses (in Absolute Dollars, Not %)

Most cycle models assume operating expenses scale with revenue at a fixed percentage, resulting in underestimating margin expansion. SG&A and R&D grow in absolute terms but slower than revenue, because Murata is producing more output from existing infrastructure rather than building a new sales force or doubling R&D headcount.

Absolute OpEx assumptions:

• SG&A: ¥150B to ¥200B (7.5% CAGR)

• R&D: ¥125B to ¥180B (9.5% CAGR, investing in AI MLCC capacity)

• D&A: ¥80B to ¥130B (12.9% CAGR, capex ramp drives D&A growth)

• Other: ¥5B flat

Total OpEx grows from ¥360B to ¥515B, a 9% CAGR vs. revenue growing at 10%. That gap is the operating leverage (and is arguably quite conservative).

Step 4: Operating Margin (Derived, Not Assumed)

The result:

Operating margin moves from 13% in FY24A to 30% in FY28E. That’s well above Murata’s prior peak (FY22: 23.4%). For context, that prior peak was driven by a normal cyclical recovery. This cycle’s margin peak is structurally higher because the underlying MLCC mix is structurally more profitable.

Step 5: Net Income and EPS

Below the operating line:

• Net financial income: ~¥3 to 5B/year (Murata has $7-8B net cash, earns interest)

• One-time items: FY25A had a ¥43.8B SAW filter goodwill impairment. Strips out for FY26+.

• Tax rate: 23-25% (Japan corporate rate is 30%, Murata gets R&D credits)

• Minority interest: ~¥4 to 6B/year

• Diluted shares: 1.95B today, going to 1.80B by FY28E (¥150B buyback announced May 2026)

Net income: ¥149B to ¥552B (or $1.0B to $3.6B USD). 3.7x in four years.

EPS: ¥77 to ¥307. 4x in four years. 41% CAGR.

This is the entire engine. Volume × ASP × margin × buyback equals the EPS trajectory. At 60% AI MLCC share. The model is conservative.

Part 8: Cash Generation (Why a Capital-Intensive Business Deserves Better)

Murata is a capital-intensive business. They are spending ¥220B+ per year on capex (raised from a ¥100B target back in 2022). That capex shows up as growing depreciation, which reduces reported earnings. P/E framework alone undersells what’s actually happening.

The honest way to look at this kind of business is EBITDA and free cash flow:

Three observations:

1. EBITDA grows 2.8x in four years. From ¥291B to ¥819B (or $1.9B to $5.3B USD). The EBITDA margin expands from 18% to 35%. That’s the cycle leverage compounded over four years.

2. FCF grows nearly 5x even with capex peaking at ¥250B. From ¥89B (FY24A) to ¥409B by FY28E. FCF margin rises from 5.4% to 17.3%. By FY28E, Murata generates ¥409B (~$2.6B USD) of free cash flow per year, equivalent to a ~4% FCF yield on the current $65B market cap. Not high yet, but trending right.

3. Net cash holds at $7-8B USD throughout the cycle. Capex consumes ~¥250B. Dividends ramp with earnings (~¥175B by FY28E). The ¥150B May-26 buyback and follow-on capital return programs absorb the rest. Net result: net cash position stays roughly stable through the heavy investment phase, then starts inflecting up post-2028 as capex tapers.

The result is even after ~$1.6bn of capital returns to shareholders (dividend + repurchases) each year going forward, or ~2.5% on current market cap, the business will be materially underlevered. While we have incorporated no upside for incremental returns to shareholders, the current wave in Japan pushing corporates to deploy cash efficiently might yield another larger buyback being implemented on top of what we have already forecasted.

Compare the Banyan Lane model to current Street consensus:

Why is the gap so wide?

First, consensus is anchored on Murata’s own conservative guidance. Murata guided FY27 OP of ¥380B in late April 2026. Japanese companies notoriously guide conservatively. Murata in particular has a history of beating initial forecasts by 15 to 25% in cycle years.

Second, the price hikes aren’t fully in numbers yet. Murata’s April 1, 2026 hikes (15 to 35% on AI/auto-grade) flow through with a 1 to 2 quarter lag. The first prints showing the impact will be late July 2026 (Q1 FY27). Those prints will very likely surprise to the upside, with consensus revisions following.

Third, AI MLCC volume ramp is faster than consensus models. Street estimates AI server MLCC content per box, but most models assume 25,000 to 50,000 MLCCs per AI server. The reality on Blackwell NVL72 is 441,000 per rack, and Rubin estimates are 600,000+. The arithmetic implies 2 to 3x more AI MLCC volume than consensus carries.

Fourth, mix shift to high-end is faster than modeled. Consensus assumes gradual mix shift. Reality is hyperscaler procurement teams locking long-term agreements at high-end specs, which pulls mix shift forward.

Fifth, the second round of hikes isn’t priced in. More than likely there will be another 25-30% AI MLCC ASP increase between mid-2026 and end-2027 if shortage persists. Murata’s customer demand running at 2x available supply and SEMCO already signaling LTAs at premium pricing both suggest this is realistic.

The setup: Murata earnings power is ¥719B operating profit by FY28E ($4.6B USD). Consensus is at ¥380B ($2.5B USD). One of these is wrong.

Part 10: The Valuation - Two Lenses

Lens 1: P/E Framework

FY28E EPS of ¥307. Murata has historically traded between 18x and 32x forward earnings:

• 18x: Cycle troughs, when markets price the business as a commodity

• 22x: Long-term mean

• 28x: Cycle peaks, when markets price normal earnings power

• 32x: Special situations (HBM-style “this is a structural rerate” multiples)

At MRAAY ~$15.41 (USD/JPY 155, 0.5 ADR ratio):

Lens 2: EV/EBITDA Framework

For a capital-intensive business that’s investing heavily, EV/EBITDA is arguably the more appropriate framework. Murata’s 10-year EV/EBITDA range is 5.2x to 15.2x. Current ~9.0x is mid-cycle on TTM, which means the market is currently pricing Murata at its long-run median multiple despite a structural mix shift in front of it.

On Banyan Lane’s FY28E EBITDA of ¥819B ($5.3B), here’s how the multiples translate:

Reconciling the Two Lenses

The two frameworks point in the same direction but EV/EBITDA gives more conservative absolute targets:

Why the gap? Murata is in heavy capex ramp. D&A is growing at at 13% CAGR vs. revenue growing 10%. EBITDA captures this; reported earnings get artificially boosted as the depreciation lags the actual cash burden of building out capacity.

The EV/EBITDA framework is more honest for a capital-intensive business and gives you a cleaner read on cash earning power. A reasonable way to triangulate: the EV/EBITDA bull case ($21.30 at 13x cycle peak) is roughly equivalent to the P/E base case ($21.77 at 22x mean). Both methods agree the stock is worth roughly $20+ on reasonable FY28E numbers.

In market cap terms, the MRAAY base cases imply $77B-92B USD market cap (vs. current $65B). Bull cases imply $90B-117B. Asymmetric cases imply $102B-133B.

Part 11: Munger Inversion - How This Could Fail

Charlie Munger always said: “Invert, always invert. Tell me where I’ll die so I don’t go there.”

So here’s how the thesis breaks. We have explicitly modeled the largest non-cyclical risks below.

Risk 1: Substitutes (Silicon Capacitors, eDTC, HD-MiM, IVRs)

TSMC has been building silicon-based capacitor technology directly into its CoWoS advanced packaging for years. The relevant technologies are:

• HD-MiM (high-density metal-insulator-metal): A capacitor placed in the silicon interposer between Metal1 and Metal2 layers. Capacitance density of roughly 17 fF/µm². TSMC introduced this at IEDM 2014.

• eDTC / iCAP (embedded deep trench capacitor): TSMC’s vertical-trench capacitor technology, introduced at IEDM 2019. Capacitance density up to 340 nF/mm², roughly 20x higher than HD-MiM. TSMC’s own published research describes eDTC as a direct replacement for “MLCC LSCs and similar components.”

• Integrated Voltage Regulators (IVRs): Power regulation moved onto the die itself. Intel’s FIVR shipped 11 years ago. TSMC is positioning IVR + eDTC as the path forward at a system level.

These technologies are already in production. TSMC eDTCs are in CoWoS packages today. They were used in Apple’s A10 (2016) for InFO packaging where they explicitly replaced MLCC land-side capacitors. They are being scaled into AI accelerator packaging now. TSMC’s own positioning at the 2025 NA Tech Symposium: eDTC + UHPMIM “can support 50% more power density” for next-gen AI accelerators.

The honest assessment:

• The 441K MLCCs in a Blackwell rack split roughly into three tiers:

  • ~30-40% are package-level decoupling close to the die. At highest risk of eDTC/HD-MiM displacement.

  • ~40-50% are mid-distance bulk decap (the “land-side” MLCCs directly under the package). TSMC’s LSC technology already targets these.

  • ~20-30% are board-level bulk caps that need physical capacitance for low-frequency response. Hardest to replace.

• In a worst case, eDTC and adjacent technologies could displace 50-70% of MLCC content over time.

• But the timing matters enormously. Blackwell is shipping now with MLCC-heavy designs. Rubin (R100/VR200, 2026-2027) is design-frozen. Murata’s content per box is locked through at least Rubin Ultra (2027-2028).

• The substitution risk really lands for Feynman generation (2028+) and beyond.

Quantified downside: If eDTC and adjacent technologies displace 15% of Murata’s AI MLCC content per box by FY28E, FY28E EPS drops from ¥307 to ¥281. At 22x P/E, that’s MRAAY $19.92 (+29% upside). The thesis bends but does not break.

For substitution to actually break the thesis, displacement would need to exceed 30-40% inside the FY28E window, which would require Rubin Ultra and Feynman to use materially different power delivery architectures than Blackwell. Possible but not likely on this timeline given that designs are typically frozen 18-24 months before production.

Risk 2: Commodity Price War (Yageo, Walsin, Sunlord)

Important distinction: A price war can only happen in the commodity segment. AI-grade and high-end automotive MLCCs are physically different products that Yageo and Walsin cannot make at meaningful volume. They have not qualified for AI server use cases. Sunlord, Three-Circle, and Walsin are all 2-3 nodes behind on layer count and yield. They are aggressively investing but qualification timelines are years long.

The risk is that as Yageo/Walsin add commodity capacity into a softening commodity market, commodity ASPs come under pressure. Murata’s commodity revenue is roughly 19% of MLCC revenue and 11% of total revenue.

Quantified downside: A 20% commodity ASP decline (more severe than Banyan Lane’s base case of stable commodity pricing), with raw material costs (BaTiO3, palladium, nickel) staying flat in a true price war, costs Murata roughly ¥85B of FY28E gross profit. That takes FY28E EPS from ¥307 to ¥267. At 22x, that’s MRAAY $18.97 (+23% upside). The commodity segment can lose more than half its profitability and the AI thesis still works.

Risk 3: Both Risks Combined

What happens if BOTH substitute pressure AND commodity price war hit simultaneously? FY28E EPS drops from ¥307 to ¥241. At 22x, MRAAY target is $17.13, still +11% above current ($7 IRR over 18 months). Even in this combined-risk scenario, the trade still has positive expected return.

Risk 4: AI Capex Digestion in 2027-2028

This is the single biggest cyclical risk. Hyperscaler capex peaks in 2026-2027 and starts to digest in 2028. If digestion is sharper than modeled, AI MLCC volume growth flattens earlier. Mitigant: long-term agreements blunt the near-term, and the model doesn’t assume digestion until FY29+. Watch for hyperscaler 2027 capex guides starting in late 2026.

Risk 5: Murata’s AI Share Is Lower Than 60%

The single largest data risk. If Murata’s AI MLCC share is actually 50% rather than 60%, FY28E EPS drops from ¥307 to ¥278. At 22x, that’s MRAAY $19.72 (+28% upside). At 40% share (= overall MLCC share, very pessimistic), FY28E EPS drops to ¥249, implying MRAAY ~$17.68 at 22x (+15% upside). Even at 40% share the trade still works.

Risk 6: SEMCO Margin Compression Using Captive Samsung Foundry Relationships

A skeptic would argue that SEMCO could use cross-subsidization from Samsung Foundry to undercut Murata on AI-grade pricing. The current evidence runs the other way. SEMCO’s Q1 2026 results show them following Murata’s pricing playbook, not breaking it by pursuing long-term supply agreements with Big Tech, signaling 5-10% price hikes themselves, positioning the brand around premium AI MLCCs (”World’s Only AI Core Component Solutions Provider”). SEMCO’s MLCC operating margin is roughly 9-10%, lower than Murata’s 13-16%. They cannot afford to undercut without going into operating losses. Their incentive structure aligns with maintaining pricing discipline through this cycle.

If this changes (signs would be: SEMCO publicly announcing price cuts to win share, or aggressive price disclosures in customer LTAs), it’s a real thesis risk.

Other Meaningful Risks

• Architectural shifts that reduce MLCC count per server. NVIDIA’s Rubin generation may use higher-voltage power delivery that needs fewer MLCCs per chip. Counts could drop 20-30%, but ASPs may more than offset.

• Hyperscaler buying power. If Apple-2018 dynamics return and hyperscalers force prices down via long-term agreements, the ASP curve flattens. Counter: AI is a supplier’s market right now, not a buyer’s market.

• Murata-specific execution risk. New plants ramping (Izumo started Apr 2026), capex digestion in their own P&L. Murata is operationally excellent historically, but execution is never zero-risk.

What Would Change The Thesis

• Murata book-to-bill drops below 1.0 for two consecutive quarters (currently above 1.0)

• Hyperscalers collectively guide flat-to-down 2027 capex in their late-2026 earnings

• Chinese supplier qualifications accelerate and ByteDance/Alibaba publicly approve them for AI use

• TSMC discloses substantial eDTC/HD-MiM adoption commitments from NVIDIA on Rubin Ultra or Feynman

• SEMCO publicly announces price cuts to win AI share

Until any of these happens, the path is intact.

Part 12: Bottom Line

Murata Manufacturing makes a tiny ceramic component that AI servers need by the hundreds of thousands. Demand is exploding because of AI infrastructure buildout. Supply is structurally constrained because making the high-end versions requires technology only 3 to 4 companies in the world have, and adding capacity takes 24 to 30 months. As a result, prices are rising and margins are expanding, and Murata’s mix is shifting toward exactly these high-end products. By FY2028, Murata will earn meaningfully more than Wall Street expects (40% to 90% more in operating profit), generate $2.6B of free cash flow per year, and deserve a multiple closer to cycle peaks than cycle troughs. The base case implies MRAAY at $18-22, a 19-41% total return or 12-26%annualized IRR over 18 months. Bull cases get to $21-28 (24-48% IRR). Even under combined-risk scenarios, MRAAY upside stays positive.

This setup hits all three Banyan Lane axes:

• Cyclical: Lead times stretching from 8 to 24+ weeks. Price hikes already announced and flowing through. Classic cyclical inflection.

• Secular: AI infrastructure is a multi-year buildout creating a new product category (high-cap MLCCs for power delivery). For the first time in years of covering cyclical industries, there is a true structural demand driver.

• Idiosyncratic: Murata’s ~60% share of AI-server-specific MLCCs vs. 40% overall, the cleanest US-listed exposure (MRAAY), the conservative guidance culture setting up beat-and-raise prints, an $8B net cash balance sheet supporting buybacks, and FCF inflecting from $0.6B to $2.6B in four years.

Catalysts to Watch

Near-term (next 2-4 quarters):

• July 2026: Murata Q1 FY27 earnings, first full quarter showing April price hikes

• August 2026: US hyperscaler Q2 earnings, read-through on AI capex pace

• October 2026: Murata Q2, book-to-bill, AI mix, lead time updates

• Late 2026: Hyperscaler 2027 capex guidance (the big one)

• April 2027: Murata’s FY28 guidance, the moment of truth

Medium-term (12 to 24 months):

• Second round of Murata price hikes (likely 2027 if shortage persists)

• Chinese supplier qualification status

• NVIDIA Rubin (VR200) and Rubin Ultra MLCC content disclosures

• TSMC eDTC/HD-MiM adoption signals from NVIDIA/AMD

• SEMCO Korean expansion ramp timing and pricing behavior

DISCLOSURE

Position: At the time of publication, the author owns Murata Manufacturing.

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

Q1 2026 missed badly. Revenue SEK 60.1 million versus SEK 90.9 million prior year. EBIT swung from positive SEK 9 million to negative SEK 20.4 million. ARR dropped sequentially from SEK 181 million to SEK 157 million. Cash at quarter end was SEK 0.4 million. The equity closed down approximately 40% on April 29, settling near SEK 6 from a recent base in the high 8s. The stock rebounded to SEK 6.60 the following session as buyers stepped back in, but is still down materially from where it traded into the print. By any normal reading, that is a quarter that broke the bull case.

What followed inside the same twenty-four hours is harder to dismiss. Four named insiders, the CEO, the Chairman via Hedskog Equity AB, and two board members, purchased a combined 228,615 shares for approximately SEK 1.48 million (~USD 153,000). The Chairman’s family vehicle absorbed a 100,000-share off-market block at SEK 6.3844, the day’s lowest print. On-exchange insider buying represented roughly 6.8% of the 1.9 million shares that traded in the session, which itself was nineteen times average daily volume. Stack that on the SEK 22 million in shareholder loans the company drew down during the quarter, plus the open-market buys some of these same insiders made in March in the SEK 8.42 range, and cumulative personal capital insiders have committed in roughly sixty days exceeds SEK 25 million (~USD 2.6 million, roughly 10% of current market capitalization), all of it deployed at progressively lower prices.

The honest version of the story is that both things are true. The cash position is genuinely tight and the quarter was genuinely bad. And the people closest to the company are betting their personal money that the cash problem gets solved without a dilutive raise. Below we work through both and what Q2 needs to deliver to make the asymmetry real.

Q1 Results

Net sales fell 34% reported, 28% FX-adjusted. The Q1 2025 comparison period included a sizable US software transaction that does not repeat, but this is not a comp problem alone. Management acknowledged in the report itself that several defense contracts they had expected to close in Q1 slipped, specifically a NATO award, US COTS deals, and an award in one European market. Software revenue collapsed 36% to SEK 31.9 million. Software mix dropped to 53%.

EBITDA went from positive SEK 18.3 million to negative SEK 9 million. EBIT from positive SEK 9 million to negative SEK 20.4 million. The cost reductions announced after Q3 2025, which target an annualized OpEx reduction of approximately SEK 40 million, only began materializing in March because most of the thirty-five departures landed late in the quarter. The full-quarter benefit shows up in Q2, not Q1.

Then there is the revenue recognition change, which deserves its own paragraph. From Q1 2026, the company is recognizing less revenue upfront on license deliveries and more across the contract period. Management framed this as aligning revenue recognition with how customers actually buy in 2026 and with their own faster development cadence. Reported revenue, in management’s own words, will now track cash conversion more closely. The Q1 hit was approximately SEK 12 million. The change is being applied prospectively.

It is not just an administrative cleanup. It is a tacit acknowledgment that the prior IFRS 15 framework was producing reported revenue that ran ahead of underlying cash economics, the exact gap the bear case has pointed at for two years. The earned-but-unbilled mechanic is still real and still represents future cash. But the catch-up will now flow more gradually and through ARR rather than chunky license revenue. That has implications for the modeled bridge to profitability.

Cash Position

Cash at quarter end was SEK 0.4 million. Total available liquidity, including the unutilized portion of the overdraft, was SEK 7.3 million. Net debt of SEK 161 million versus SEK 53 million a year earlier. Net debt to LTM EBITDA at 6.7 times.

SEK 22 million in new shareholder loans were drawn during the quarter, taking the cumulative shareholder loan balance to SEK 37.5 million. New financing was negotiated with Svensk Exportkredit and Exportkreditnämnden, which is the Swedish state-backed export financing structure used by Boliden, Electrolux, and Mölnlycke. Size and committed status of that facility were not disclosed and would be the single most useful detail to extract from IR before publication.

For context, the Q1 cash flow statement shows operating cash burn of SEK 29 million driven by an SEK 18 million working capital build. With SEK 7.3 million of available liquidity at the end of March, the company has roughly one quarter of runway at Q1’s burn rate before either contract assets convert materially, the SEK/EKN facility draws down, or something else happens. That is the operating constraint the equity is now pricing.

Positives

Order book reached SEK 364 million, a new record, up 10% versus Q4 2025. Order intake of SEK 91 million was clearly weighted toward defense, with approximately SEK 70 million of that figure coming from defense customers. Two new US defense contracts were signed in the quarter for combined value just over SEK 40 million, including a five-year Exonaut agreement valued at approximately SEK 23.9 million. The Canadian Department of National Defence extension added another SEK 20 million over five years. The Swedish Armed Forces issued a SEK 20 million call-off order for Exonaut customization and support. NATO extended Exonaut usage for training and experimentation activities under the TALOS framework.

The EEAS expansion stands out separately. The European External Action Service expanded its Resilience contract during the quarter at over 20% higher annual recurring revenue, and the company spent meaningful airtime on the call describing how Exonaut coordinated EU citizen evacuations from the Iran-affected region in real time. That is exactly the proof point the Resilience-as-cash-positive segment thesis required.

Headcount was reduced from 200 to 165 actual employees by quarter end. The cost reduction is landing. Q2 is when it becomes visible in the P&L.

The pipeline by management’s own description was qualitatively intact. No deals were lost. They slipped. The trade show season just opened.

ARR Question

This is the load-bearing data point that needs to be flagged honestly. Under the new ARR definition, software ARR went from SEK 181 million at Q4 2025 to SEK 157 million at Q1 2026, a SEK 24 million sequential decline in a single quarter. Year-on-year growth dropped from positive 73% to positive 7%. Currency explains some of it, given USD weakness against SEK, but not all. This needs a forensic explanation before the SaaS-transition framing can carry weight. Possibilities include FX retranslation of foreign-currency annual subscriptions, a contract artifact at renewal under the new revrec policy, or genuine customer rationalization. Management did not address the sequential decline directly on the call, framing it as continued stable development. That framing is generous. The company gets one quarter to clarify this. If Q2 ARR rebases meaningfully higher with renewal flow, the question resolves. If it does not, the recurring revenue narrative needs to be rewritten.

The Insider Tape

On April 29, 2026, the same day the company reported the quarter and the equity collapsed roughly 40%, four named insiders bought stock. Three of the four bought on-exchange, absorbing 128,615 shares of actual market selling. Reported on-exchange volume that day was approximately 1.9 million shares, roughly nineteen times the average daily volume, though actual total volume including off-exchange and dark venue prints could be higher. Named insiders absorbed approximately 6.8% of reported on-exchange volume on a capitulation tape. The Hedskog block, executed off-market at SEK 6.3844, sat below the on-exchange range of SEK 6.50 to SEK 6.62. That structure means a specific seller wanted out and the Chairman’s family vehicle stepped in to take the other side at the day’s lowest print.

Stack the April 29 buys on the March 2026 purchases (Fransson at SEK 8.42 for ~SEK 421,000, Jonsson at similar levels) and the SEK 22 million in shareholder loans drawn during Q1. Cumulative insider commitment over sixty days exceeds SEK 25 million (~USD 2.6 million, roughly 10% of current market capitalization), all deployed at progressively lower prices. None of these insiders sold a share into strength when the equity was at SEK 17.50 a year ago.

The timing matters under EU MAR. Insiders cannot trade while in possession of material non-public information, and a decided-upon equity raise at depressed levels would unambiguously qualify. Four independent insiders including the CEO and Chairman, coordinating on a panic day with publicly-filed PDMR notifications, is not a structure compatible with a near-term raise being on the board’s agenda. The inference has limits: it does not preclude a raise that is hypothetical or conditional on Q2 execution, and it does not certify management is right. What it cleanly shifts is the worst-case scenario the market priced at SEK 6, a panic raise at SEK 5 within weeks, into the materially-less-likely column. The medium-term cash question still resolves through Q2 and Q3 execution.

A second signal is incoming. Several of 4C’s largest holders typically update reported holdings around month end. April 30 closes the books on a month where the equity finished down materially. Adds from any named long-term holder, particularly Grenspecialisten given Martin Gren’s Axis Communications track record, would reinforce the directors’ tape. Trims would soften the conviction read without invalidating it.

Valuation at SEK 6.60

At the SEK 6.60 close, market capitalization sits near SEK 253 million (~USD 26 million) on 38.27 million shares outstanding. Add net debt of SEK 161 million and enterprise value lands around SEK 414 million.

Against that:

Order book of SEK 364 million already contracted. Software ARR of SEK 157 million, contractually recurring. LTM revenue of SEK 322 million, putting EV/Sales at approximately 1.3 times. Framework agreements stack on top, in addition to the order book, measured in the hundreds of millions.

For a software-led defense business with NATO accreditation, a record order book, growing defense exposure (now 65% of net sales but a higher share of intake), and a structural tailwind from European defense budgets, 1.3 times EV/Sales is the multiple distressed industrials trade at, not embedded mission-critical software. The peer set, Systematic, MASA, Hadean, and the simulation and training stacks of the primes, would not transact anywhere near this multiple in private markets.

The Q4 2025 base case I had drafted (SEK 37 to SEK 42 per share at 3 times EV/Sales on SEK 450 to 500 million of revenue with 15-20% EBIT margins) no longer holds with confidence. A more defensible base case after Q1 is SEK 280 to 320 million in 2026 revenue with EBIT margin in the 5-10% range, which at 2.5-3 times EV/Sales translates to roughly SEK 18 to 26 per share. That is still a 3-4 times return from SEK 6.60.

The prior bull case (SEK 45+) is not dead. It comes back into view if 2026 closes with the order book converting cleanly, US Army pipeline penetration expanding from 6 to 20+ commands, and 15-20% EBIT margins becoming the run rate. But it requires something 4C has not yet delivered: an established track record of execution. The company has missed against its own near-term guidance in each of the last several years. Plans get reset, prove-it years become bridging years, and the bull case keeps shifting twelve months to the right. The market is now pricing that pattern as the central case rather than an exception. The bull case requires that pattern to break, not just the next quarter to print well. The bear case (sub-SEK 5) requires Q2 to confirm a structural rather than timing problem, plus a forced raise at depressed levels. The insider buying argues directly against the bear path.

What Q2 Has to Show

The print lands in mid-July. Five tests, in roughly ascending order of importance.

Operating expenses visibly lower as the headcount reduction flows through a full quarter. This is essentially mechanical and should happen.

Defense revenue rebound from the SEK 39 million Q1 figure toward the SEK 70-80 million range. This is what management implicitly guided when they said no deals were lost, only postponed.

The slipped contracts named in the CEO letter (the NATO award, US COTS deals, the European award) actually closing. One slipping further would be tolerable. Two would be problematic.

Cash flow from operations turning positive or near zero. The SEK 29 million Q1 operating cash burn cannot continue at this revenue level without a raise. Working capital release from contract asset conversion is the lever.

ARR stabilizing or rebasing higher. This is the test for whether the SaaS framing survives. The SEK 24 million sequential drop needs an explanation that points to something other than secular customer rationalization.

Hit four of five and the equity rerates and the raise question moves into 2027 or off the table entirely. Hit two of five and SEK 6 was not the bottom.

Conclusion

The piece I had drafted before April 29 framed 4C as a forensic accounting case where reported revenue was depressed by IFRS 15 timing and would catch up to a record order intake. That framing was partially right and is now partially obsolete. Management’s revenue recognition change has reshaped how the catch-up flows. The ARR sequential decline introduces a question that did not exist last quarter. The cash position is now genuinely a near-term operating constraint rather than a forecast risk.

What did not change is the underlying business. The order book is at a record. Defense intake is accelerating. The Canadian, US, Swedish, and NATO contracts signed in Q1 are real revenue locked in for years. Exonaut’s embedding in NATO doctrine workflows, the symbiotic rather than competitive relationship with Palantir, and the structural tailwind from European defense budgets are all intact. The cost base has been reset.

What also did not change, and may be the more useful signal, is that the people running the company and the people on its board are buying with their own money on the worst day. They are not posturing. They are deploying meaningful personal capital at progressively lower prices, with the Chairman absorbing a private block at the day’s lowest print, on a session where the equity collapsed 40% on volume nineteen times the average. In a regulatory regime where MNPI restrictions are real and personal, that pattern is informative.

At SEK 6.60, after a one-day rebound from the panic low, the market is still pricing a forced raise at SEK 5 as a meaningful probability. The insider tape says management thinks otherwise. Q2 will adjudicate. The risk is real and so is the asymmetry.

Disclosure: Banyan Lane Capital and the author hold a position in 4C Group AB. This is not investment advice. See prior Disclosures & Disclaimers.

That company is 4C Group AB (4C.ST). Its software is called Exonaut.

Here is the pitch: Exonaut is mission-critical defense software employed by NATO headquarters, the British Army, the Australian Defence Force, and now, after a decade of patient US market entry, the US Army’s 1st Cavalry Division and 2nd Infantry Division. The Resilience segment has been restructured, with SEK 40 million in annualized costs removed. The order backlog is SEK 332 million and growing, roughly equal to the entire market capitalization. The stock has been severely punished by IFRS 15 revenue recognition lumpiness, a dilutive capital raise, and passive fund rebalancing. The downside from here, if the company muddles through for a year, is roughly 25 to 30%. The upside, if management executes on the backlog in front of them, is 3 to 4x in one to two years and potentially 5 to 8x in three.

Subscribe now

The Return Potential: How We Get to 3-4x and 5-8x

Before diving into the business, it is worth being explicit about the assumptions behind those upside figures, because they require scrutiny rather than faith.

The entry point today is approximately SEK 8.70 per share. Enterprise value is roughly SEK 450 million given approximately SEK 120 million in net debt. That implies roughly 1.3x EV/Sales on FY2025 revenue of SEK 352 million.

Base case (3 to 4x, 2027 to 2028): Revenue reaches SEK 500 to 550 million, driven by approximately 50% of the SEK 332 million confirmed backlog converting in 2026, continued 20% organic growth in the defense segment as NATO framework agreements generate call-offs, and the SEK 40 million annualized cost savings lifting the EBIT margin to 15 to 20%. At 3x EV/Sales, where the stock traded in 2022 into 2023 when growth was strong and margins 10%+, enterprise value reaches SEK 1.5 to 1.65 billion. At SEK 1.5 billion EV with net debt paid down toward SEK 60 to 80 million, equity value is roughly SEK 1.42 to 1.59 billion on approximately 38 million shares, implying SEK 37 to 42 per share. That is 4x from today. The multiple is not aggressive: the peer group of Nordic defense software companies trades at an average of approximately 28x EV/EBIT. A company generating 15 to 20% EBIT margins on SEK 500 million in revenue, with sub-2% churn and 80% software gross margins, reaching 3x revenue requires a sustained discount to those peers.

What this base case does not require: any US Army contracts beyond the four DoD organizations already signed. Any material Resilience recovery. Any blue-sky AI monetization from the Hadean partnership. The base case is purely: execute on the backlog in front of you.

Bull case (5 to 8x, 2028 to 2029): Revenue reaches SEK 650 to 800 million. This requires meaningful US pipeline conversion. Of the 130 potential Army and National Guard commands identified as addressable, 4C has signed 6. Getting to 20 to 30 signed commands at an average annual contract value of SEK 10 to 15 million would add SEK 140 to 225 million in high-margin US ARR alone. It also assumes the Resilience segment contributes positively rather than draining resources, as the Swedish PTS framework agreement (up to SEK 100 million) and similar civilian resilience contracts convert. At EBIT margins of 20 to 22% on SEK 700 million in revenue, and a 4 to 5x EV/Sales multiple reflecting the re-rating that comes when a small Nordic software company becomes a recognized name in NATO’s procurement ecosystem, enterprise value reaches SEK 2.8 to 3.9 billion. Per-share value: SEK 70 to 100+.

What the bull case does require: the US DoD procurement environment staying intact. At least partial conversion of the 130-command US pipeline. Continued NATO rearmament driving European call-offs. And management delivering on the 2026 cash-flow-positive commitment, which is the threshold event that removes the financing risk overhang from the stock entirely.

What kills it: Another dilutive capital raise, persistent cash flow negativity through 2026, or the US pipeline stalling again under a new government shutdown cycle. These are real risks, addressed in the red team section at the end of this piece.

The asymmetry is the point. The bear case, as modeled, implies roughly SEK 6 to 8 per share. The base case implies SEK 37 to 42.

Share

Why Military Readiness Is a Software Problem Now

Before diving into the company, you need to understand why this matters to the Pentagon, to NATO, and to every allied defense ministry writing checks right now.

The Western military model depends on a concept called “Force Generation,” the process of training, evaluating, and certifying military units before they can be deployed. This is distinct from “Force Employment,” which is the act of commanding forces in combat. Palantir, Anduril, and others operate in Force Employment, the sharp end of the spear. But none of those systems matter if the units wielding them are not ready.

Readiness is not a vague concept. It is a measurable, certifiable status. Before a NATO brigade deploys to the Eastern flank, before a US Army division rotates through a combat training center, before a UK battlegroup is declared operational, each must pass a Mission Rehearsal Exercise (MRX). These are massive, multi-domain events lasting days or weeks, involving thousands of personnel across land, air, sea, cyber, and space domains. They are graded against specific doctrinal standards. The evaluation determines whether the commanding general signs the certification or sends the unit back for more training.

This process has historically been managed with a combination of institutional knowledge, manual record-keeping, and ad hoc tools. A training exercise involving 5,000 soldiers across three countries generates thousands of data points: movement orders, fire missions, logistics flows, communications patterns, decision timelines. Traditionally, teams of evaluators tracked this on whiteboards and spreadsheets, wrote narrative assessments, and filed reports that were rarely digitized or compared across exercises.

The problem is that modern warfare does not allow for this anymore.

There is also a macro timing dimension that most investors miss. Defense spending follows a specific sequence, what 4C’s CEO Jonas Jonsson calls the “three-wave cycle.” First, countries replenish ammunition and basic gear. Second, they buy major platforms: tanks, ships, planes. Third, they invest in capability, the training, evaluation, and readiness infrastructure that turns hardware into fighting power. 4C’s software is a third-wave product. This explains why the company’s revenue remained flat from 2022 to 2024 despite the war in Ukraine and the largest European defense spending increase in a generation. The ammunition and platform waves came first. The capability wave, where training software contracts are signed, is only now reaching procurement stages in 2026 and 2027.

Operational tempo has accelerated. The time between “alert” and “deploy” has compressed. NATO is now running simultaneous exercises across multiple fronts. The US Army needs to rotate divisions through certification faster. Allies need interoperable training standards so that a Danish battalion can plug into a British brigade and both can be graded against the same doctrinal framework. Live ammunition is being diverted to active conflicts, pushing more training into synthetic environments where the evaluation layer becomes even more critical.

This is where Exonaut enters. It is the only NATO-accredited software platform that manages the full lifecycle of military readiness, from planning the exercise, to executing it, to grading the performance, to certifying the unit, to capturing the lessons for next time. And it has been doing this for over twenty years.

What Exonaut Actually Does, and Why It Can’t Be Ripped Out

Exonaut is not a point solution. It is a modular platform with six defense modules, each addressing a different phase of the readiness cycle.

Planning and Programming aligns long-term operational objectives with training requirements and resource allocation across an entire force structure. At the NATO level, this module coordinates training plans across dozens of member nations with different force structures, calendars, and capability requirements.

Collective Training and Exercise Management is the operational core. It manages the full lifecycle of an exercise, from the initial planning document to the Main Events List to the real-time scenario injection. This is the module that the evaluators, the White Cell operators, and the training audience all work within simultaneously during the exercise itself.

Training Measurement and Evaluation is where performance gets scored. Individual and collective performance is measured against doctrinal benchmarks. The module generates the readiness grades that determine whether a unit passes. This is the module with the deepest switching costs: the grading templates, the readiness baselines, and the historical performance data are all stored inside the platform. Switching means starting from scratch with no historical context.

Special Forces Selection manages the highly structured, legally and operationally sensitive evaluation pipeline for special operations candidates. The data sensitivity and compliance requirements here make migration almost inconceivable.

Wargame and Simulation Management is the integration layer connecting Exonaut to the simulation ecosystem: MASA SWORD, MAK VR Forces, BAE Systems’ OneArc, and others. This is where the AI integration with Hadean sits, described in detail in a later section.

Lessons Management is where after-action reviews are digitized, stored, and systematically incorporated back into future exercise designs. This module creates the institutional memory flywheel: every exercise makes the next exercise better. The data accumulated across twenty years of NATO exercises is effectively irreplaceable.

The architecture creates a moat that compounds over time. To understand why Exonaut is not ripped out, consider what a defense ministry would lose in a migration: twenty years of readiness baseline data, the exercise templates calibrated to their specific force structure, the doctrinal grading criteria built and validated through operational experience, and the tribal knowledge of 4C’s military-background staff embedded in their evaluation teams.

A precise word of clarification on the “they own the doctrine” framing, because precision matters here. 4C does not own NATO doctrine. No company does. NATO’s doctrine is developed by Allied Command Transformation and codified in publicly available publications. What 4C has done is operationalize that doctrine into structured, digital evaluation frameworks, and accumulate twenty years of exercise data, readiness baselines, and assessment templates that no competitor can replicate without starting from scratch. The moat is cumulative, built on data, accreditation, and operational trust, not conceptual.

Inside the Walls: Proof Points from Twenty Years of Deployment

The customer roster is the single most important fact about 4C Group. It is not a startup trying to sell into defense. It is already embedded in the evaluation infrastructure of the world’s most capable militaries.

NATO headquarters. Exonaut is the platform used by Supreme Allied Commander Europe (SACEUR) and Allied Command Transformation for managing NATO-level exercises. The NATO TALOS program, a multi-year contract for Exonaut development and maintenance covering trials, experimentation, and capability evaluation, was extended in early 2026 through 2029 at USD 2.4 million. This is the platform-of-record designation at the top of the NATO pyramid.

United Kingdom. The British Army uses Exonaut across 22 separate contracts, covering multiple formations and headquarters. The UK MoD’s JCAST (Joint Command and Staff Training) program is delivered through 4C. The British Army’s Land Training School awarded Exonaut the LTS Quality Mark accreditation, the formal certification that the platform meets the British Army’s training standards. The UK relationship exemplifies the land-and-expand model: what started as a single headquarters engagement has grown to cover most of the British Army’s collective training apparatus.

Norway. The Norwegian Armed Forces are one of 4C’s longest-standing customers, with Exonaut embedded across the joint force structure. Norway’s elevated readiness posture on NATO’s northern flank, directly facing Russia, has made this relationship a strategic reference point for other Nordic and Baltic nations.

Australia. The Australian Defence Force adopted Exonaut as its readiness management platform. The AUKUS alliance context is relevant here: the operational and training interoperability requirements that come with AUKUS create a strong pull toward shared evaluation frameworks with US and UK forces, both of which also use Exonaut.

United States. The US beachhead deserves its own section, covered next. But the headline is that after a decade of patient market entry, 4C now has signed contracts with four US DoD organizations, including the 1st Cavalry Division, the 2nd Infantry Division, and two additional commands. US ARR exceeds SEK 30 million.

Emerging markets. Three additional NATO countries completed successful Exonaut tests in 2025. Demand is growing in countries including Spain, the Netherlands, and Austria as they align with NATO readiness standards. A new European public defense entity signed a 3-year contract worth SEK 14.1 million base with potential SEK 26 million over five years. A second EU defense entity signed a 5-year agreement worth up to SEK 26 million.

This is the critical point that the market capitalization obscures: 4C is already inside the walls. The software is already running the exercises. The data is already accumulating. The question is not whether militaries will adopt Exonaut. They already have. The question is how fast the footprint expands within each customer, and whether the financial statements catch up to the operational reality.

The Order Book: Reading the Backlog With Eyes Open

One of the most important features of 4C’s business model is the distinction between framework agreements and the reported order book.

The reported order book at year-end 2025 was SEK 332 million, up 50% year-over-year. That number already looks impressive relative to the company’s SEK 352 million in annual revenue. Framework agreements totaling an additional SEK 578 million sit outside the reported backlog.

In defense procurement, a framework agreement is essentially a hunting license. The customer, typically a defense ministry, has agreed that 4C is an approved vendor for a defined scope of work over a multi-year period. The framework specifies maximum values and terms. But no money changes hands until the customer issues a “call-off order,” an actual purchase order against the framework. Frameworks do not appear in the reported backlog until call-offs are issued.

An important caveat that bulls tend to gloss over: framework agreements guarantee exactly zero dollars in revenue. Governments routinely sign large framework agreements to pre-vet vendors, only to let them expire after issuing a fraction of the maximum amount in actual call-off orders. The SEK 578 million figure represents a ceiling, not a forecast. Treating uncommitted framework maximums as guaranteed future revenue is a classic trap in defense sector investing.

That said, the reported order book alone, SEK 332 million, trades at approximately 1x the market capitalization. This is the more conservative way to frame the setup: confirmed, contracted backlog that roughly equals the equity value, in an environment where NATO rearmament is accelerating and the company’s customer relationships are deepening.

Approximately 50% of that SEK 332 million backlog is expected to convert to recognized revenue in 2026. The revenue recognition lag is the central accounting artifact that has caused the market to misprice this company. Order intake grew 32% in FY2025 to SEK 501 million. Revenue grew only 3%, to SEK 352 million. That divergence is not a sign of business deterioration. It is the direct result of IFRS 15 milestone-based revenue recognition applied to defense procurement contracts, where revenue is recognized at specific contract milestones rather than ratably. The earned but unbilled revenue sits on the balance sheet as “contract assets,” growing the asset base while suppressing reported revenue. The economic activity is real. The accounting timing is an artifact of how governments structure their contracts.

The US Beachhead: A Decade of Patience

The US market deserves its own section because it is both the largest opportunity and the most misunderstood element of the investment case.

The timeline tells the story of methodical, decade-long market entry.

2016 to 2018: Established Washington DC and Orlando offices. Obtained facility security clearances enabling 4C to handle classified information and pursue classified defense contracts. Began building relationships with the US Army training community at Fort Leavenworth and the Combined Arms Center.

2019 to 2021: Won subcontract through CESI on the US Army’s $192 million Synthetic Training Environment (STE) program. Gained initial operational credibility within the DoD procurement ecosystem.

Late 2023: Hired Brigadier General (Ret.) Guy Jones as President, North America Defense. Jones brought direct relationships within the Army training establishment and the credibility of a senior retired officer running evaluations for institutions where his former colleagues remain in command.

2024 to 2025: Continuing Resolutions blocked “New Starts,” freezing new software contracts regardless of commander demand. The October 2025 government shutdown froze deal conversions during the quarter where 4C expected its largest bookings. The dam broke in late 2025, contributing to the 50% backlog explosion. By then, the market had largely stopped paying attention.

2026: US Facility Clearance has been upgraded, enabling Prime contractor status on classified programs. Previously, 4C had to work through prime contractors as a sub. Prime status removes the intermediary, improves margin, and gives 4C direct relationships at the contracting level.

The US pipeline today: 130 potential Army and National Guard commands identified as addressable. 6 have signed. US ARR already exceeds SEK 30 million across four DoD organizations.

The theoretical US TAM is approximately $150 to $200 million annually, based on approximately 100 relevant commands at an average annual contract value of $1.5 million. A precise caveat on that number: if TRADOC (US Army Training and Doctrine Command) were to pursue a centralized enterprise license agreement, the bottom-up math could compress significantly. The realistic near-term transformative target is not $150 million. It is $20 to $40 million in US ARR, which would represent roughly 4x the current US ARR base and a step-change in the revenue mix. Even that more conservative target would dramatically change 4C’s growth profile and valuation.

The frustration, and the reason the stock has been punished, is that US federal budget mechanics have repeatedly throttled conversion. But the contracts were never at risk. The work continued. The invoices queued. The bureaucracy eventually processed them.

The AI Integration: What 4C Built, and What Its Partners Built

In late 2023, 4C signed a memorandum of understanding with Hadean, a UK-based spatial computing company backed by Epic Games. By April 2024, the partnership had produced a live product.

Here is what the integrated system does: generative AI automates the “White Cell,” the group of human operators who traditionally populate military exercises with realistic civilian activity, social media chatter, and adversary behavior. Hadean’s PopulAI engine generates the AI-driven civilian traffic patterns, social media panic, and virtual riots. Hadean’s physics engine calculates the real-world consequences of military decisions. Exonaut manages the exercise timeline (the Main Events List and Main Incidents List), the scenario injection, and the auto-grading of unit performance against NATO doctrine.

Credit where it is due: the generative AI and spatial computing engine driving this capability is Hadean’s technology. The 3D simulation is provided by MAK VR Forces. In the December 2025 UK SJFHQ exercise, the overall delivery was managed by MASS as prime contractor. 4C’s role in this federated architecture is specific and important, but it is not the entirety of the stack. Exonaut is the platform that ties the components together for exercise design and doctrinal evaluation. It is the administrative and evaluative layer, not the AI engine itself.

The product delivered to the UK MoD is called JCAST, Joint Command and Staff Training. The result: approximately 70% less human manpower required to run a full-scale command exercise. A note of analytical rigor: the 70% figure comes from a specific command-post pilot study for the JCAST UK MoD contract, not army-wide deployments. But the mechanism for savings is validated and meaningful. The traditional White Cell, a large team of human operators who manually simulate civilian traffic, adversary social media, and non-combatant behavior, represents the single largest labor bottleneck in military exercise design. The digitization of this function through generative AI eliminates that bottleneck.

The economic implications extend beyond cost savings for militaries. For 4C, an AI-integrated exercise product commands premium pricing relative to legacy database and consultancy offerings. The market is currently pricing 4C as the latter. The Hadean partnership is optionality priced at zero.

The Competitive Landscape Is Not What You Think

The instinctive objection is competition. Palantir, Anduril, and others dominate defense tech coverage. Surely they will eat 4C’s lunch.

The reality is more nuanced.

Palantir is not a competitor. It is structurally symbiotic. Palantir is Force Employment: it operates in the live operational environment, providing command and control for real-world missions. 4C is Force Generation: it certifies that units are ready before they enter the fight. These are different customers, different budget lines, different procurement offices, and different NATO command structures (Allied Command Operations versus Allied Command Transformation). The readiness scores that Exonaut produces could feed directly into Palantir’s operational picture. Where relevant, 4C has noted that Exonaut cooperates and shares data with platforms like Palantir. Competitive threat: zero.

Systematic/SitaWare is the most direct competitive threat, and requires the most careful analysis. SitaWare is the dominant C4ISR solution for several NATO land forces. Systematic has introduced “SitaWare Aspire,” a digital training platform that integrates directly with its C2 suite, allowing units to train within the same interface they use for combat operations. The “train as you fight” integration is a genuinely powerful value proposition. This threat should not be understated.

For many military planners, a built-in training tool native to their operational software may be preferable to integrating a separate third-party evaluation platform. The defensive case for 4C rests on an architectural distinction: Exonaut is vendor-agnostic evaluation, whereas Aspire is system-specific instruction. Exonaut does not teach soldiers how to use SitaWare. It evaluates whether a brigade met NATO’s doctrinal standards during an exercise, regardless of which C2 system the brigade was using. The ability to grade a formation using SitaWare C2 and MASA simulation simultaneously, within a single evaluation framework, is a capability Systematic cannot replicate without abandoning its own product ecosystem. And in multinational NATO exercises where different nations bring different C2 systems, a vendor-agnostic evaluator is structurally necessary.

However, as Systematic adds more evaluation modules, the modularity moat will be increasingly tested. This is the competitive dynamic that bears closest watching: not whether Palantir eats 4C’s lunch, but whether the C2 incumbents grow backward into Force Generation faster than 4C grows forward into deeper NATO standardization.

MASA/SWORD is a French AI simulation engine that has partnered with 4C, using Exonaut as the administrative and evaluation interface on top of SWORD’s scenario generation. Partner, not competitor.

BAE Systems, CAE, MAK are 3D simulation engine providers. Exonaut bolts on top of all of them for NATO-accredited evaluation and grading. Complementary, not competitive.

Generic AI and big tech. Exonaut’s NATO Secret accreditation, combined with its air-gapped deployment capability and operational track record, creates barriers that generic AI cannot bypass. You cannot deploy cloud-based AI in a NATO Secret environment. You cannot prompt-engineer the doctrinal evaluation criteria for a multinational brigade exercise. The security accreditation alone takes years. The domain knowledge takes decades.

The biggest competitor? Excel spreadsheets and whiteboards. The majority of military training management globally is still done manually. This is not a sign of competitive pressure on 4C. It is a sign of how early the market is and how much greenfield opportunity remains.

Cash Flow and Capital Structure

The balance sheet is where the bear case finds its most legitimate ammunition, and it deserves an honest assessment.

Operating cash flow was negative SEK 47 million in FY2025. Cash fell from SEK 24.2 million to SEK 11.5 million. Net debt stands at approximately SEK 120 million. The company raised SEK 55 million in a directed share issue in March 2025 at SEK 17.50 per share, a price that now represents roughly a 50% premium to where the stock trades today. The dilutive nature of that raise, issued to institutional investors at prices that retail holders could not access and that have since been eroded by market weakness, is a legitimate grievance.

The core dynamic driving the cash burn is the contract asset build. Exonaut contracts are typically structured with milestone-based payment schedules aligned to government budget cycles and procurement procedures. 4C delivers the work, the revenue is earned economically, but the invoice cannot be submitted until the government counterpart signs the acceptance certificate. The government counterpart is a procurement officer who may be managing dozens of contracts across multiple fiscal years. Delays are structural, not exceptional.

The market is not wrong to be cautious here. The bank facility provides a bridge, not a fortress. If contract asset conversion delays persist into 2027, the liquidity position will require attention.

The evolving picture is more encouraging. Management has committed explicitly to cash-flow-positive operations in 2026. The SEK 40 million in annualized cost savings from the Q3 2025 Resilience restructuring are fully effective from Q1 2026. Approximately half of the SEK 332 million backlog is expected to convert to invoiced revenue in 2026. If both of those dynamics materialize, the working capital cycle begins to self-fund. The 2026 cash flow trajectory is the single most important monitoring variable for this investment.

The Resilience segment restructuring is worth understanding as a separate chapter. In Q3 2025, the CEO announced the elimination of roughly 30 positions, primarily in Resilience segment sales, marketing, and low-margin municipal consultancy delivery. The stock dropped 27% in a single day. The market read it as a sign of distress. The more accurate reading is that management chose to stop subsidizing a loss-making segment rather than continue reporting misleadingly blended margins. The SEK 8 to 9 million one-time restructuring charge produces SEK 40 million in annualized savings, a roughly 5-to-1 payback in under three months. The Resilience business that remains after the restructuring focuses on higher-margin software deployments for telecom resilience (the SEK 48 to 100 million PTS framework agreement), financial sector business continuity, and power grid operators, a better quality portfolio.

Shareholders and Management

The ownership structure is an underappreciated part of the thesis.

Andreas Hedskog, the founder and chairman, holds approximately 10 to 11% through Hedskog Equity. He has not sold. Martin Gren, co-founder of Axis Communications, the company that created the global IP camera market and sold it to a SEK 50 billion business, holds approximately 8 to 9% through Grenspecialisten. His continued stake, without any reduction during the sell-off, signals a specific hypothesis: that 4C is on the same trajectory from Nordic niche solution to global software standard that Axis followed. Klas Lindström holds approximately 8%.

Institutional shareholders include AP4 (the 4th Swedish National Pension Fund), TIN Fonder (Carl Armfelt and Erik Sprinchorn, a Nordic SaaS-focused fund with a track record of identifying software transitions early), Carnegie Fonder, Chelverton Asset Management (a UK small-cap specialist), Swedbank Robur, and Schroders.

Recent insider buying is notable because of the depressed price context. CEO Jonas Jonsson purchased shares in open market transactions in early March 2026. Board member Anders Fransson bought 50,000 shares at SEK 8.42 on March 10, 2026, bringing his holdings to 272,314 shares. These are not token gestures. When the CEO and a board member are buying in the open market at prices representing a 50% discount to the last institutional round, the directional signal is clear.

The selling pressure has come primarily from passive funds executing mechanical rebalancing, not fundamental selling. The March 2025 directed issue amplified retail frustration over dilution. For a company with SEK 250 million in ARR and 80% software gross margins, the fundamental unit economics remain intact despite the balance sheet noise.

On management, a notable board development: Magnus Hansson was proposed as a new board member in February 2026. Hansson is CFO of Karnov Group and was previously at Lime Technologies, both Nordic SaaS companies that navigated the transition from services-heavy to software-first revenue models. This is a specific, operational skill set, not a figurehead appointment.

The Financials

FY2025 results, which have not yet triggered the re-rating, tell the underlying story more clearly than the headline numbers suggest.

Net sales were SEK 352 million, up 3% nominally and 7% on an FX-adjusted organic basis. Order intake was SEK 501 million, up 32% year-over-year. The order book ended the year at SEK 332 million, up 50%. ARR reached SEK 250 million, up approximately 53% year-over-year. Software ARR specifically was SEK 181 million, and the software mix reached 74% in Q4 2025.

The EBIT story requires a careful read. The full-year blended adjusted EBIT margin was 2%, on SEK 8.6 million of adjusted EBIT. That number reflects a year during which the Resilience restructuring charge hit in Q3, US government shutdowns deferred deal conversions, and cost savings had not yet fully taken effect. The Q4 2025 adjusted EBIT margin was 21%, on a standalone basis. These two figures measure different things and should not be conflated: the 2% is the full-year blended result including the restructuring impact; the 21% is the Q4 run-rate on normalized volumes with software mix at 74%.

MetricFY2023FY2024FY2025Net SalesSEK 332MSEK 343MSEK 352MOrder IntakeSEK 358MSEK 380MSEK 501MOrder Book~SEK 180M~SEK 221MSEK 332MARR~SEK 115M~SEK 163MSEK 250MAdj. EBITNegativeNegativeSEK 8.6MAdj. EBIT MarginNegative-2%2% FY / 21% Q4

The headline story is the divergence between intake and revenue. Order intake grew 32% to SEK 501 million while reported revenue grew just 3%. This gap is entirely explained by IFRS 15 milestone-based recognition and the contract asset buildup described above. Q4 2025 provides a preview of what normalized quarters look like: 21% EBIT margins on SEK 185 million of order intake, with software representing 74% of revenue.

The Valuation

The core valuation question: if order intake is growing 32%, the order book is growing 50%, ARR is growing 53%, churn is below 2%, NATO is expanding the platform’s role, and the US Army is adopting it, why does the stock trade at 1.3x revenue when defense tech peers trade at 28x EBIT? The answer: post-IPO losses, a dilutive share issue at SEK 17.50 (now trading at approximately 8.70), a US government shutdown that froze deal flow, and the Q3 2025 Resilience restructuring that crushed sentiment. Those are solvable problems.

The scenario math is laid out in the earlier section. To restate it succinctly with the full table:

ScenarioFY27-28E RevenueEV/Rev MultipleImplied EVImplied Per ShareMuddle ThroughSEK 375M2xSEK 750M~SEK 14 to 17Base CaseSEK 450-500M3-5xSEK 1.35-2.1B~SEK 30 to 45Bull CaseSEK 550-650M4-6xSEK 2.2-3.9B~SEK 45 to 70+Blue SkySEK 800M+6-8xSEK 4.8B+SEK 100+

The muddle-through scenario is worth dwelling on. If revenue only reaches SEK 375 million on mid-single-digit growth, EBIT margin expands to just 8% as cost savings take hold but revenue disappoints, and the stock is assigned 2x EV/Sales, the implied equity value is roughly SEK 14 to 17 per share. That is 60 to 100% upside from the current price in a scenario that essentially assumes the business barely grows. That asymmetry is what makes this a compelling setup even for skeptics.

The base case does not require heroic US pipeline assumptions. It requires executing on the backlog already on hand. The bull case requires meaningful US Army adoption, even 10 to 15 commands beyond today’s 6. The blue sky scenario requires the US TAM to begin materializing at scale and the market to re-rate 4C as the defense readiness platform it is becoming, rather than the Nordic consultancy it used to be.

At roughly 1.3x EV/Sales, the current valuation prices in none of it.

The Case Against

Intellectual honesty requires a serious red team.

Cash and financing risk. Operating cash flow was negative SEK 47 million in FY2025. If the 2026 cash-flow-positive commitment fails, or if the government shutdown cycle repeats and defers cash collection again, the company may need to raise capital. Given the share price relative to the March 2025 issue price, any new raise would be highly dilutive. This is the bear case’s most powerful argument and should be taken seriously.

IFRS 15 lumpiness is not the whole story. The accounting artifact explanation is genuine and well-supported. But the contract asset balance is also growing, which means cash conversion has been slower than the bull narrative implies. The 2026 conversion thesis is testable, and Q1 and Q2 results will be the first evidence of whether it is materializing.

US political volatility. The largest growth market is hostage to federal budget cycles and government shutdown risk. The 2025 shutdown cost the company a quarter of conversions. This risk is structural, not exceptional.

Systematic/SitaWare. The “train as you fight” value proposition is real and the competitive encroachment from C2 incumbents is a genuine long-term risk. It has not materialized at scale yet, but “not yet” is not “never.”

Recruitment bottleneck. Scaling delivery requires personnel with military experience, software proficiency, and high-level security clearances, a genuinely scarce talent pool. This probably constrains growth rate more than the bull case assumes. 15 to 20% organic growth is more realistic than 25%+, which still works at current valuations but produces a lower terminal value.

Small-cap illiquidity. The stock is thinly traded, amplifying price swings in both directions. For institutional investors, the position-sizing constraints are real.

The genuine upside scenario requires all of the following to work in parallel: cash flow turns positive in 2026, the US pipeline converts at a meaningful rate, the Systematic threat remains contained, and no further dilutive capital raise is needed. Each of those is individually plausible. All four simultaneously is a tighter ask.

Conclusion

4C does not own NATO doctrine. No company does. But it has built the only accredited platform that operationalizes that doctrine into structured, digital evaluation frameworks, and it has twenty years of exercise data, readiness baselines, and assessment templates that no competitor can replicate without starting from scratch.

4C is not building a simulation engine. It is not building an autonomy platform. It is not competing with Palantir. It is building the evaluation layer that sits above all of them, the layer that determines whether the pilot is ready, whether the brigade is certified, whether the division can deploy. It integrates with every simulation engine. It grades performance against every doctrinal standard. It captures every lesson learned. And it has been doing this, quietly, for twenty years, accumulating the institutional memory of NATO’s collective training apparatus inside a single software platform.

2026 is the year the thesis either proves or breaks. The cash flow commitment is testable by Q2. The backlog conversion is visible in the order book. The US pipeline trajectory will be evident in new contract announcements. The restructuring payoff is already flowing through the cost base.

The market has assigned that layer a value of $30 million.

Something is wrong with the market’s math.

DISCLOSURE

Position: At the time of publication, the author owns 4C Group.

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

I am not a biotech specialist. I do not hold a PhD in immunology, nor did I attend medical school. I never covered biotech in my ~10 years at a hedge fund. I look for asymmetric setups where the data, the incentives, and the timing converge in a way that demands attention.

Greenwich LifeSciences (GLSI) is one of those situations. It is a small (~$350mm market cap), clinical-stage company developing a vaccine designed to prevent breast cancer from returning after treatment. The early data has been remarkable. The CEO owns over 40% of the company and has been buying shares on the open market, consistently and at every price level, for years. Insiders have voluntarily extended share lock ups and are now still locked up six years after the IPO. A quarter of the tradable float is shorted. And in five days, on March 17th, the titles of their two research abstracts will be published ahead of a major cancer conference in April. Lastly, Phase III results could appear in second half 2026 onward.

This is a high-risk, high-reward situation, and I want to be direct about that from the outset. GLSI is a micro-cap biotech with a single drug candidate, no revenue, and a Phase III trial that has not yet read out. If the trial fails, the stock goes to zero. That is not hyperbole, it is the fundamental reality of single-asset clinical-stage biotechs. What follows is my attempt to lay out why I believe the setup is compelling despite that risk. This is not a recommendation to buy the stock. Do your own homework. Size accordingly. Do not bet what you cannot afford to lose.

Subscribe now

60-Second Pitch

If you only have a minute, here is the case for why GLSI has attracted growing investor attention ahead of the AACR conference:

The data is extraordinary. In the Phase IIb trial, patients who received the full course of the GP2 vaccine had zero cancer recurrences over five years. The placebo group recurred at an 11% rate. That is a statistically significant result. The GP2 Phase IIb data showed a hazard ratio approaching zero. The FDA has previously approved cancer vaccines on the basis of far more modest effect sizes (Provenge).

The CEO now owns 5.6m shares, or 40% of the company. Snehal Patel, who serves as both CEO and CFO, has been buying on the open market consistently since 2021, including at $27 to $30 per share in January 2026. No insider has sold a single share. The entire insider block is voluntarily locked up through September 2026.

The float is tiny and heavily shorted. After subtracting insider holdings, only about 6.4 million shares actually trade. Of those, approximately 1.6 million are sold short, representing roughly 25% of the float. Furthermore, there are several groups of sticky, long-term investors who likely own another 1 million shares. If meaningful positive data arrives, short sellers face a structural problem – there are not enough shares available to cover without driving the price materially higher, perhaps far above what fundamentals would suggest is reasonable (like the ~3000% move in 2020).

The addressable market is enormous. If the vaccine proves effective beyond just one genetic subtype (and preliminary open-label data, with important caveats discussed later, suggests it may), the potential patient population roughly doubles to 88,000 new patients per year in the US and Europe. At pricing comparable to existing HER2 therapies, that represents an $8 to $10 billion annual market.

The catalyst calendar is concentrated. Abstract titles publish March 17. Full abstracts and poster presentations at AACR in April. Enrollment completion is likely by mid-2026. An interim data readout, potentially the first look at Phase III efficacy, could arrive as early as Q3 2026. And the world’s most prestigious cancer research institutions are co-authoring the upcoming presentations.

Equity value of $1.5 to $3.0 billion is possible with good data. Should Phase III show as strong of results as Phase IIb, then stock could re-rate 4-8x in a short period of time. This excludes potential upside from expansion to non-HLA-A*02 patients, as well as a non-fundamental move much higher from short covering. A takeout is possible anywhere in this range.

The Problem: Breast Cancer Comes Back

One in eight women in the United States will be diagnosed with invasive breast cancer in their lifetime. Thanks to decades of progress in surgery, chemotherapy, and targeted therapies, survival rates have improved dramatically. But there is a part of the story that does not receive enough attention: for many patients, the real fear is not the initial diagnosis. It is what comes after.

Even after successful surgery and treatment, breast cancer can return. The medical term is “recurrence,” and it is the shadow that follows survivors for years. When breast cancer recurs, it often appears in distant organs (the lungs, liver, bones, or brain) as metastatic disease. Metastatic breast cancer, despite all the progress we have made, remains largely incurable. Median survival for metastatic HER2-positive breast cancer is approximately 5 years.

About 15 to 20% of breast cancers are classified as “HER2-positive,” meaning the cancer cells overproduce a protein called HER2 that functions as a growth accelerator. The development of HER2-targeting drugs, beginning with Herceptin (trastuzumab) in 1998 and followed by Perjeta, Kadcyla, and others, was one of the great triumphs of modern oncology. These drugs reduced recurrence rates by 40 to 50%.

Yet even with the best available treatments, 15 to 30% of HER2-positive patients still experience a recurrence. Residual cancer cells, microscopic traces that survive surgery and chemotherapy, can lie dormant for years before reactivating and metastasizing.

This is the gap that Greenwich LifeSciences is trying to fill.

The Idea: Training the Immune System to Hunt What Remains

The concept behind GLSI-100 is elegant in its simplicity, even if the underlying science is complex.

Traditional HER2 therapies like Herceptin function as externally administered agents. They patrol the outside of cancer cells, identify the HER2 protein on the surface, and flag those cells for destruction. They are effective during the course of treatment, but once the regimen ends, the protection fades. Any cancer cells still hiding in the body are left unchecked.

GLSI-100 takes a fundamentally different approach. Rather than providing temporary, external protection, it trains the patient’s own immune system to recognize and destroy HER2-expressing cancer cells on a durable basis.

The vaccine contains a small fragment of the HER2 protein called GP2, a chain of just nine amino acids. When injected under the skin alongside an immune-boosting agent called GM-CSF, the GP2 fragment is picked up by the immune system’s antigen-presentation machinery (molecules called HLA, which display protein fragments on cell surfaces for inspection by passing immune cells). When cytotoxic T-cells, the immune system’s most targeted killers, encounter the GP2 fragment on display, they learn to recognize it as a threat. From that point forward, any cell in the body expressing HER2 becomes a potential target.

The analogy is straightforward: Herceptin is a hired bodyguard who works for a fixed term. GLSI-100 is a permanent self-defense education.

This general approach has precedent in oncology. In 2010, the FDA approved Provenge (sipuleucel-T), a therapeutic cancer vaccine. Provenge also uses GM-CSF as its immune-boosting component and operates on a conceptually similar principle: training the patient’s immune cells to attack cancer.

However, the two products differ in important ways. Provenge is a therapeutic vaccine: it treats men with active, metastatic prostate cancer that is already progressing. GLSI-100, by contrast, is a preventative vaccine: it is administered to breast cancer survivors after treatment to stop recurrence from happening in the first place. These are fundamentally different clinical goals. Preventative trials typically require longer follow-up periods to demonstrate efficacy, because you are measuring whether something doesn’t happen rather than whether an active disease responds to treatment.

The products also differ in practical complexity. Provenge requires extracting a patient’s immune cells via leukapheresis, engineering them outside the body, and reinfusing them, a personalized process that cost $93,000 per course of treatment and created persistent supply constraints. GLSI-100, by contrast, is an off-the-shelf intradermal injection, simple to manufacture at scale and administer in an outpatient setting.

One important detail: the GP2 fragment binds most effectively to a specific type of HLA molecule called HLA-A*02. Think of it as a lock and key: GP2 was originally believed to work primarily in patients who carry this particular genetic marker. Approximately 46% of the population does. This matters for the trial design, as we will see.

The Early Evidence: Phase I and Phase IIb

The story of GP2 begins not in a corporate boardroom but in the laboratories of MD Anderson Cancer Center in Houston, one of the top cancer research hospitals in the world. Researchers there identified the GP2 peptide in the late 1990s and early 2000s as a promising target for immune activation against HER2-positive cancers. Greenwich LifeSciences licensed the technology and, operating on a limited budget, began advancing it through clinical trials.

Phase I (approximately 2010 to 2012): Three small studies enrolled a total of 146 breast cancer survivors. The primary objective was safety, and the results were unambiguous: no serious adverse events were attributed to GP2. The most common reactions were mild redness and swelling at the injection site, indicators that the immune system was responding as intended. Blood tests confirmed that patients were generating GP2-specific killer T-cells.

Phase IIb (2011 to 2020): This was the study that put Greenwich on the map. Conducted in partnership with MD Anderson across 16 US sites, it was a randomized, placebo-controlled trial, the gold standard in clinical research. Among the key analysis group (HLA-A*02 positive patients with high HER2 expression who completed the full six-month vaccination series):

• Vaccinated patients: 0% recurrence rate over five years.

• Placebo patients: 11% recurrence rate over five years.

• Statistical significance: p = 0.0338 (indicating roughly a 3.4% probability that this result occurred by chance).

These are striking numbers, but they deserve honest context. The analysis group was small: 96 patients. Small trials can produce dramatic results that do not replicate at larger scale. The per-protocol analysis (patients who completed the full vaccination series) can also introduce selection bias, as patients who complete a full course of treatment tend to be healthier than the broader enrolled population. These are standard caveats in oncology, not specific criticisms of this trial, but they are important reasons why Phase III confirmation is required.

That said, the magnitude of the result is difficult to dismiss. Provenge earned approval with a 22% relative reduction in the risk of death (HR 0.78). The GP2 Phase IIb data showed a hazard ratio approaching zero. Again, the comparison is imperfect: different cancers, different clinical settings (treatment of active disease versus prevention of recurrence), and different endpoints. But it establishes the regulatory precedent that cancer vaccines can be approved on the basis of modest data, and the GP2 data is not modest.

When these results were presented at the San Antonio Breast Cancer Symposium (SABCS) in December 2020, the market responded. GLSI stock surged from $5 to $158 intraday, a roughly 3,000% move, on 19 million shares of volume.

The critical question became: can this be replicated in a larger, more rigorous study?

FLAMINGO-01: The Phase III Trial

In August 2022, Greenwich launched FLAMINGO-01, its pivotal Phase III trial designed to answer that question. Phase IIb was the proof of concept, and FLAMINGO-01 is the confirmation study.

Here is how the trial is structured:

Eligible patients: HER2-positive breast cancer patients who have completed standard treatment (surgery plus Herceptin-based therapy) but still had residual disease at the time of surgery. These are the patients at highest risk of recurrence.

The three arms:

• Arm 1 (Vaccine): HLA-A*02 positive patients randomized to receive GLSI-100. Neither patients nor investigators know who receives the active treatment.

• Arm 2 (Placebo): HLA-A*02 positive patients randomized to receive a saline injection. Also blinded.

• Arm 3 (Open-Label): Patients who do not carry HLA-A*02; all receive the vaccine, and all parties are aware. This arm was added to explore whether the vaccine might work in a broader genetic population than originally expected.

Arms 1 and 2 together target approximately 500 patients. Arm 3 enrolled 250 patients and is already fully complete.

The treatment regimen: Patients receive six monthly injections (the “Primary Immunization Series”), followed by five booster shots at six-month intervals over the subsequent 2.5 years. That amounts to 11 total injections over three years, followed by one year of monitoring. The simplicity and tolerability of this regimen contrast with Provenge, which requires leukapheresis, ex vivo cell engineering, and reinfusion, all repeated three times over a single month.

The statistical framework: The trial is event-driven, not time-driven. An independent safety board (the DSMB) will conduct an interim analysis once 14 cancer recurrences have occurred across Arms 1 and 2, and a final analysis at 28 recurrences. The trial is powered to detect a hazard ratio of 0.3, meaning a 70% reduction in recurrence risk.

The paradox of high efficacy: If the vaccine performs as well as it did in Phase IIb (near-zero recurrences in the treatment group), virtually all of the required 14 events would need to come from the placebo arm. This means the stronger the vaccine works, the longer it may take to accumulate sufficient events for the interim analysis.

This dynamic is sometimes described as a positive signal, and from a purely scientific standpoint, it is: a low event rate in the treatment arm would be direct evidence of efficacy. But it is important to note that delayed event accrual can also result from factors unrelated to efficacy, including slower-than-projected enrollment, patient dropout, or an unexpectedly low baseline recurrence rate in the placebo arm. A prolonged wait for the 14-event trigger also places additional strain on the company’s limited cash reserves, a point we will return to shortly.

The Institutions: A Roster of Global Oncology Leadership

One of the most underappreciated aspects of FLAMINGO-01 is who is running it. This is not a trial conducted at small clinics by unknown investigators. The Steering Committee, the group of senior physicians who oversee the trial’s scientific integrity, represents some of the most prominent names in breast cancer research:

• Dr. Mothaffar Rimawi – Baylor College of Medicine (Trial Chair; one of the world’s foremost HER2 breast cancer researchers)

• Dr. Laura Spring – Harvard Medical School / Massachusetts General Hospital

• Dr. Cesar Santa-Maria – Johns Hopkins University

• Dr. Hope Rugo – University of California, San Francisco

• Dr. William Gradishar – Northwestern University

• Dr. Joyce O’Shaughnessy – US Oncology Network (one of the most published breast cancer clinicians in the United States)

• Dr. Sibylle Loibl – German Breast Group (GBG), one of Europe’s most influential breast cancer research networks

• Dr. Miguel Martin – GEICAM, Spain’s premier breast cancer cooperative group

• Dr. Francois-Clement Bidard – Unicancer, France’s leading cancer research network

These are physicians and researchers who can choose from dozens of clinical trials competing for their participation. They do not lend their names, or their institutions’ reputations, to studies they do not believe have scientific merit. The involvement of Harvard, Johns Hopkins, UCSF, Baylor, Northwestern, and the leading European oncology networks is a meaningful signal regarding how the medical community views this data.

The trial now encompasses approximately 140 to 159 active sites across the United States and 10 European countries, including Spain, France, Germany, Italy, Poland, Romania, Ireland, Portugal, Belgium, and Austria. The UK and Canada are also under consideration. The screening rate has accelerated to over 800 patients per year, with the CEO noting a shift from investigator-driven enrollment to patient-driven demand, with some sites maintaining waitlists.

One of the two AACR abstracts to be released next week is the first ever co-authored by the full Steering Committee. When an entire committee of this caliber puts their collective name on a publication for the first time, it is a strong indication that the data being presented is deemed clinically significant.

The Open-Label Signal: Arm 3 Results (With Important Caveats)

While the blinded Phase III data remains under wraps, the open-label Arm 3 has provided a preliminary signal.

On December 15, 2025, Greenwich announced preliminary results from the 250-patient Arm 3 (the non-HLA-A*02 patients who all received the vaccine). The headline finding: approximately 80% reduction in breast cancer recurrence rates.

This number requires significant context. Because every patient in this arm received the vaccine (there was no concurrent placebo group), the company employed two methods to estimate efficacy:

• Historical comparison: Recurrence rates were benchmarked against the KATHERINE study, a major trial of T-DM1 (Kadcyla), the current standard of care for high-risk HER2-positive patients. That study documented annual recurrence rates of 3.5 to 4% in a comparable population.

• Longitudinal comparison: Recurrence rates during the first six months of vaccination (when the immune system is still developing its response) were compared against the period after the full immunization series was complete.

Both methodologies converged on the same conclusion: roughly 80% fewer recurrences than expected.

The caveats are real and should not be minimized. Open-label data without a concurrent placebo arm is considered less reliable than blinded, randomized data in the medical community. Historical comparisons are inherently imperfect: standards of care improve over time, patient selection criteria evolve, and older benchmark studies may overstate the expected recurrence rate for a current patient population. The KATHERINE study, used as the benchmark here, enrolled patients in a different era of HER2-targeted therapy. It is entirely possible that the “true” expected recurrence rate for patients entering FLAMINGO-01 today is somewhat lower than the historical figure, which would mean the actual treatment effect of GLSI-100 is less dramatic than the headline 80% suggests.

That said, the consistency of the signal deserves attention. The 80% figure in Arm 3 aligns closely with the 80%-plus reduction observed in the blinded, placebo-controlled Phase IIb trial. Two independent datasets pointing in the same direction does not constitute proof, but it does strengthen the case for the blinded Phase III arms.

Why the potential TAM expansion matters: GP2 was originally understood to bind primarily to the HLA-A*02 genetic marker. Arm 3 enrolled patients without that marker. If the vaccine is generating a meaningful response in this broader population, it could potentially double the addressable patient population from approximately 44,000 to roughly 88,000 new patients per year in the US and Europe. For context, Provenge’s approved indication covered approximately 30,000 men annually in the United States, and that was considered commercially viable enough to command a $93,000 price point and a peak market capitalization of ~$7.0 billion for its parent company, Dendreon (before manufacturing and commercial execution challenges led to Dendreon’s bankruptcy in 2014).

Management: Skin in the Game, With a Governance Footnote

In biotech, management teams routinely express confidence in their pipeline. Snehal Patel expresses his with open-market purchases.

Patel holds an engineering degree from MIT and an MBA from UChicago. He spent time on Wall Street analyzing biopharma companies before transitioning to the operational side. At Greenwich, he serves as both CEO and CFO, a deliberate choice to minimize overhead.

A note on governance: While the dual CEO/CFO arrangement conserves cash in a resource-constrained company, it is worth acknowledging that institutional investors may view the combination of these roles as a governance concern. The person responsible for corporate strategy and spending is also the person overseeing financial reporting and internal controls. For a pre-revenue micro-cap, this may be a pragmatic tradeoff. For larger funds with governance mandates, it may be a reason to stay on the sidelines until the company matures its executive structure. Readers should weigh this according to their own standards.

What distinguishes Patel from the vast majority of biotech CEOs is the scale of his ownership and the consistency of his buying:

• He owns approximately 5.6 million shares, representing over 40% of the company.

• He has purchased shares on the open market consistently for five years, at price points ranging from $7.91 to $29.83, including purchases at $27 to $30 in January 2026.

• His largest single purchase was 174,825 shares at $14.30 in June 2024, a $2.5 million commitment.

• Not a single insider has sold a share. The entire board has extended its lock-up agreement to September 30, 2026, approximately six years after the IPO. This is virtually unprecedented in the biotech sector.

The typical pattern for insider buying is to purchase after a stock declines, signaling confidence at a discount. Patel buys into strength. He was purchasing at $8 and continued purchasing at $29. The signal is consistent: he believes in the data, and he is willing to back that belief with substantial personal capital.

The company’s financing approach reflects a similar discipline. Rather than dilutive secondary offerings, Greenwich employs a conservative at-the-market (ATM) program, selling modest quantities of stock at prevailing prices with minimal fees (1 to 3%, versus 5 to 7% for underwritten deals). As of late January 2026, the company held approximately $12.5 million in cash.

The Financial Reality: Tight Runway, Real Dilution Risk

It would be irresponsible to discuss GLSI without being direct about the financial picture.

The company’s cash position as of January 23, 2026, was approximately $12.5 million. The annual burn rate has been trending upward, from roughly $7 million historically to an estimated $9.5 million as global trial sites mature. That arithmetic produces a runway of approximately 15 months, a thin margin for a company approaching a Phase III readout that may not arrive until Q3 2026 or later.

Management has stated that current reserves could cover the entirety of 2026, supplemented by the ongoing ATM program. But the ATM is not free capital: every dollar raised through it represents dilution to existing shareholders. And if the interim data readout is delayed beyond Q3 2026, or if trial costs escalate unexpectedly, a larger capital raise becomes increasingly likely. A dilutive secondary offering in a stock with a 6.4-million-share float would represent meaningful downward pressure on the share price.

The Float Dynamics

The technical setup merits examination, though with appropriate caution about what it does and does not imply:

• Total shares outstanding: approximately 13.85 million

• Insider/locked shares: approximately 7.4 million (53.5% of total)

• True free float: approximately 6.4 million shares

• Short interest: approximately 1.6 million shares (about 25% of the float)

• Days to cover: 3.7 days based on recent average volume

When a quarter of the available shares are sold short and more than half the company’s equity is locked by insiders, the supply and demand dynamics become acutely sensitive to catalysts. A positive data event could force short sellers to repurchase 1.6 million shares from a float where a meaningful portion is held by long-term holders. This creates the conditions for significant upward price pressure.

The same dynamics amplify downside risk. If the data disappoints, the thin float means exit liquidity may evaporate quickly. This structure rewards conviction but punishes indecision. Position sizing matters enormously in a setup like this.

The Catalyst Calendar

The next several months contain a sequence of potential inflection points. I want to be precise about what each date represents, because there is a meaningful difference between an abstract title and a full data release.

March 17, 2026 (4:30 PM ET): AACR publishes the titles of the two accepted abstracts. To be clear: titles alone do not contain detailed statistics or efficacy data. What they reveal is the scope and focus of the research, whether the presentations will cover mature Arm 3 efficacy data, long-term Phase IIb follow-up, immune response analysis, or other endpoints. The fact that one abstract is the first Steering Committee co-authored paper is notable, but investors should not necessarily expect the 80% recurrence reduction figure to be confirmed or updated on this date.

April 17, 2026 (3:00 PM ET): Full abstracts are published. This is the substantive data event in the AACR cycle, containing detailed statistics, patient counts, efficacy metrics, and safety data.

April 17 to 22, 2026: AACR Annual Meeting in San Diego. Poster presentations and direct engagement between investigators and the research community.

Q2 2026 (April to May): Projected completion of enrollment for the randomized blinded arms (target: 500 patients). The underlying math: with 250 non-HLA-A*02 patients enrolled and approximately 46% of screened patients carrying HLA-A*02, an estimated 205 patients have likely been randomized, leaving approximately 295 remaining at a current pace of roughly 31 per month.

Q3 2026 to Q1 2027: The projected window for the 14-event interim analysis, representing the first potential look at Phase III efficacy. As discussed above, the timing of this readout depends on factors that are difficult to predict from outside the trial.

September 30, 2026: Insider lock-up expiration. The board’s decision to extend this date through the anticipated data readout window is a notable expression of alignment with long-term shareholders.

December 31, 2026: Current primary completion date listed on ClinicalTrials.gov.

The Regulatory and Manufacturing Picture

Two developments reduce, though do not eliminate, regulatory risk:

Fast Track Designation (September 2025): The FDA granted GLSI-100 Fast Track status, providing more frequent agency interaction, eligibility for priority review, and the option for rolling BLA (Biologics License Application) submission. For reference, Provenge’s initial FDA application was rejected in 2007, requiring three additional years of clinical work before approval in 2010. Fast Track designation may help GLSI navigate a smoother path, though it does not guarantee approval.

Commercial Manufacturing Approved (January 2026): The FDA approved the use of the first commercially manufactured lot of GP2 vials in the FLAMINGO-01 trial. Three commercial lots of the active ingredient were manufactured in 2023 (sufficient for approximately 200,000 doses), and stability data supports a three-year shelf life. This is significant for two reasons: it demonstrates that GP2 can be produced at commercial scale, and the FDA has already reviewed and accepted the manufacturing data, reducing one layer of regulatory risk during an eventual BLA review. This off-the-shelf manufacturing profile contrasts with Provenge, whose requirement for individualized production from each patient’s own cells created supply constraints that contributed to Dendreon’s commercial struggles.

What Could Go Wrong

The Phase III trial could fail. Phase IIb was small (96 patients in the key analysis group). Small trials can generate striking results that do not replicate at larger scale. This is the single largest risk, and it is binary. If the trial fails, it could result in permanent capital impairment.

The 14-event trigger may take longer than anticipated. This could reflect high vaccine efficacy, but it could also reflect slow enrollment, higher-than-expected dropout rates, or a lower-than-projected baseline recurrence rate. Any of these would delay the interim analysis and increase cash pressure on the company.

The cash runway is tight. $12.5 million against a burn rate trending toward $9.5 million per year provides roughly 15 months of capital. If the ATM program cannot keep pace with expenses, a dilutive capital raise becomes likely, and in a stock with a 6.4-million-share float, even a modest offering would represent meaningful dilution.

The CEO/CFO dual role is a governance concern. While it conserves cash, the lack of separation between operational leadership and financial oversight may deter institutional investors who require traditional governance structures. This could limit the stock’s investor base until the company hires a dedicated CFO.

Micro-cap liquidity risk is real. With a float this small, the stock can move 10 to 20% on modest volume. This amplifies risk on both sides and makes the stock unsuitable for investors who may need to exit quickly.

No partnership or acquisition is guaranteed. Dendreon’s experience with Provenge is instructive: even an FDA-approved cancer vaccine does not guarantee commercial success or strategic interest. Dendreon peaked at a $7.5 billion market capitalization after Provenge’s approval and filed for bankruptcy five years later.

Regulatory uncertainty persists. Even with Fast Track designation, FDA approval is never assured. Preventative vaccines may face a higher evidentiary bar than therapeutic vaccines because regulators need to be confident that healthy survivors are not being exposed to unnecessary risk.

Conclusion

GLSI sits at the intersection of compelling science, extreme insider conviction, an unusual market structure, and a concentrated catalyst calendar. The Phase IIb data (100% disease-free survival over five years in the vaccinated group) is the kind of result that, if confirmed in Phase III, would represent a genuine shift in the standard of care for HER2-positive breast cancer. The open-label Arm 3 data, while subject to the significant limitations discussed above, adds a preliminary signal that the vaccine’s potential may extend beyond its original target population.

There is regulatory precedent for cancer vaccines earning FDA approval with far less dramatic effect sizes. Provenge was approved with a 4.1-month survival benefit in a different cancer type, a different clinical setting, and with a complex manufacturing process that ultimately undermined its commercial viability. GLSI-100, if successful, would offer what appears to be a substantially larger treatment effect, a simpler administration protocol, and an off-the-shelf manufacturing profile. The comparison is imperfect, but it establishes the floor for what the FDA has been willing to approve in the cancer vaccine category.

The CEO has invested millions of his own capital at every price level. The world’s leading cancer research institutions have signed on to oversee the trial. A quarter of the float is sold short heading into a month that begins with the publication of abstract titles on March 17 and culminates with full data presentations at AACR in late April.

Is it risky? Without question. This is a clinical-stage biotech with no revenue, a tight cash runway, a binary trial outcome, and governance that has not yet matured beyond its founder-led phase. On the other hand, success is far from discounted, and, as is common in this industry, could lead to many multiples of upside.

March 17th is five days away. The abstract titles are published at 4:30 PM Eastern.

DISCLOSURE

Position: At the time of publication, the author owns GLSI.

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

BeWhere Holdings is a 22-person company based in Mississauga, Ontario, founded in 2014, with a market cap of ~C$90M. They design and sell low-power 5G-enabled sensors and software to track the real-time location and condition of non-powered, mobile assets (trailers, containers, equipment). Manufacturing is handled by third parties making the business very asset light. BeWhere’s asset tracking devices are small, rugged, battery-powered devices that stick onto trailers, generators, cable reels, and just about any other unpowered asset a company needs to keep tabs on. The devices report location, temperature, motion, tilt, and light exposure over low-power 5G cellular networks (LTE-M / NB-IoT) for years on a single battery charge. They have deployed ~500,000 from 2018 to 2025, with ~100,000 of those coming in 2025 alone, reaching over 10,000 companies.

BeWhere’s devices are eyes for the millions of “dumb” assets sitting in construction yards, on flatbed trucks, and at rail depots across North America. BeWhere sells through massive distribution partners like AT&T, Bell Canada, T-Mobile, Geotab, Ford Pro, and Tenna – impressive for such a small company facing rigorous security and performance requirements that take years from some of the world’s largest companies. Several large relationships are maintained direct. The customer buys the device (sub-US$100) and pays a recurring monthly software fee (US$1–5/month) for data access. They count CostCo, UPS, Lyft, Lowe’s, Toyota, Boeing, and Ford as customers. Their strategy is straightforward – engineer the lowest cost devices possible with the most advanced forms of connectivity that customers want, don’t price gouge, and slowly mop up market share. They offer modest software capabilities vs. peers yet are still chosen by some of the largest corporations.

These markets are highly fragmented – both those providing service and customers. Growing regulatory and compliance requirements, threats of theft, and general efficiency provide powerful secular tailwinds which have and will continue to persist for years. The low-cost nature of their devices has actually expanded the market overtime beyond large transportation-related assets such trailers, containers and large equipment, to first responder kits, portable toilets, and rideshare bikes.

The management team has done this before. CEO Owen Moore and SVP Brian Boychuk co-founded Grey Island Systems International, a publicly traded telematics company that helped Moore grow from zero to C$24M in revenue before selling it in 2009 for C$40M. They know how to build, scale, and exit an asset-tracking business. Insiders also own 22% of the company, including 10% by CEO and 9% by COO.

The numbers are unusual for a micro-cap. 24 consecutive quarters of positive Adjusted EBITDA, ~30% revenue CAGR since 2018, C$21M in LTM revenue growing 28% YoY, C$9M in ARR growing 21% YoY, and ~$9M in cash with minimal debt. Insider ownership stands at 22% with no warrants outstanding. Recurring revenue now covers just under 100% of all cash operating expenses. This is not a science project burning capital, rather they’ve compounded profitably with new product launches every 2-3 years which have reliably grown their customer count (and into Fortune 500), increased customer penetration, and expanded the market itself.

The stock trades at ~3.0x 2026e sales versus an IoT/SaaS peer average of approximately 8.0x, and ~20x 2026e EBITDA (on 50%+ EBITDA CAGR through 2028).

Subscribe now

Share

Why Care Now? Eight Catalysts Converging

BeWhere has been quietly compounding for years. Most investors never look at a sub-C$100M market cap stock on the TSX Venture Exchange. But we’re approaching the most catalyst-dense 12–18 months in the company’s history. Here’s what’s stacking up.

1. Product Launch Cycle Is Repeating

BeWhere has a remarkably consistent product release pattern… each new generation of hardware, device sales accelerate sharply. This has happened three times now, and a fourth cycle is underway.

The cadence is clear… Each refresh engineers cost out of the BOM while adding functionality — lower price, better margin, new use cases. The result is a 59% six-year M-IoT device CAGR.

BeWhere is rolling out three new products in sequence. BeBatt launched in February 2026 as a fifth-generation tracker with 10+ year battery life at the company’s lowest price point ever (~US$30–35 BOM cost versus ~US$45–50 for the unit it replaces, but with higher absolute dollar margin). There is an opportunity for this device to incrementally expand the market because of its low cost. The B5-BeSol+ (solar-powered) arrives Q2 2026 and B5-BeWired+ (external power) in Q3 2026. All three are built on LTE Cat 1 Bis architecture. This is the same chipset that enables future satellite connectivity via AST SpaceMobile (ASTS).

BeBatt was purpose-built for cable reels, pallets, and other lower-value assets that were previously too cheap to justify tracking. At sub-US$50 device cost and monthly fees approaching US$1, BeWhere is expanding the addressable market into asset classes that legacy US$200+ trackers can’t touch economically.

This cycle could be even bigger than prior ones because the installed base of enterprise customers is substantially larger today than during previous launches.

The “Just Landed” cohort on the left half above represents early-stage relationships with enormous upside. Once a client like UPS or Costco completes their initial RFP process and gets BeWhere approved by IT security, other departments can piggyback on that procurement with minimal friction. Costco went from a small pilot to 10,000+ units. UPS is deploying 20,000+ seasonally. FirstNet deployed 11,000+ over the course of 2025 and have a partnership with AST SpaceMobile for direct-to-device satellite coverage once their constellation is operational (likely late 2026/early 2027), which could lead to much broader adoption across their 7.8m users. Each new product refresh gives their partner sales teams a reason to go back to these accounts with something new. Management estimates they have penetrated just 17% of their land-and-expand opportunity depicted above for just 57,000 devices with material upside over time – moving this to 50% penetration would add another ~125,000 devices or 25% growth on their installed based today.

2. The Device-as-a-Service Shift Changes Everything

For most of its history, BeWhere operated a classic “razor and blade” model – sell the hardware upfront (~US$70), collect a monthly software fee (~US$3/month). This worked but created lumpy quarterly revenue and required customers to find CapEx budget.

Starting in early 2025, BeWhere began offering a rental model. Under the new DaaS (Device-as-a-Service) structure, customers pay zero upfront and instead pay a higher monthly fee (roughly US$5–7/month) that bundles hardware and software. The economics are compelling on both sides (estimated figures):

CEO Owen Moore on the rental economics cites a six month payback on a three-year contract. The model has been capped at 8,000 units per quarter to manage balance sheet impact, but within two to three quarters it generates free cash flow on its own that can be reinvested to increase the cap. This funding has been addressed following their equity issuance in early February 2026 for C$5M at C$0.70 to expand their rental business and expand into Europe (more on this later). The lifetime value nearly doubles over a six-to-eight-year term.

This matters for three reasons. First, the market rewards recurring revenue for its predictability and higher blended margins. Second, it removes the biggest friction point in enterprise sales as customers with no CapEx budget can now sign off on an OpEx line item. Third, and most importantly for the stock, SaaS/recurring revenue businesses trade at dramatically higher multiples than hardware businesses. As the recurring revenue mix climbs from 40% toward 60%+, the stock should re-rate accordingly.

3. Margin Inflection

BeWhere has a series of positive gross margin drivers hitting in 2026…

· Organic growth in mix of Recurring Revenue deployments, from 40% of mix today

· Rollout of new “rental”/DaaS model

· Lapping 2025 tariff impact of 3-4pts

· Lower BOMs for new devices could add 1pt

Assuming that Recurring Fees Revenue GMs are 40% and revenue mix grows to 55% of total, GMs could exceed 40% by 2028 from depressed 33% in 2025. Add to this 50bps of annual Cash OpEx margin declines (which fell from ~30% to ~22% in 2022 to 2025 as revenue doubled, or put another way Cash OpEx grows ~80% in a few years), and EBITDA margins would find themselves growing from 12% to 20% by 2028. To illustrate the power of this prospective improvement in margins, a ~25% revenue CAGR to 2028 would result in an EBITDA CAGR of 50%+.

4. Satellite Connectivity — Zero CapEx, Massive TAM Expansion

This is where the story gets genuinely exciting. Terrestrial cellular networks cover only about 15% of the Earth’s land surface. Historically, tracking an asset in a “dead zone” required a specialized satellite terminal costing US$500–1,500 with monthly satellite data plans running US$50+. The result is roughly 85% of global cargo goes untracked once it leaves a cell-covered area.

In October 2025, BeWhere made history: they successfully connected a standard, off-the-shelf BeWhere LTE tracker directly to AST SpaceMobile’s BlueBird LEO satellite. The signal traveled from the device in New Brunswick, Canada, to space, and routed seamlessly through Bell Canada’s terrestrial network. BeWhere is the first asset-tracking company to achieve this with an unmodified cellular IoT device.

The breakthrough was not needing to build a “satellite tracker.” A simple over-the-air firmware update to their existing devices will enable satellite connectivity. Zero incremental hardware cost. Zero new SKUs. Same sub-US$50 device, but now capable of tracking assets anywhere on the planet.

AST SpaceMobile is targeting deployment of its 45-satellite initial constellation by year-end 2026, which would enable commercial-scale coverage. BeWhere is positioned to be among the first IoT device makers to go live on this network, courtesy of its carrier relationships and the integrated technology already proven in testing.

The new addressable markets this unlocks are enormous: maritime container shipping, remote mining and forestry operations, offshore energy platforms, agricultural equipment tracking, and cross-border logistics through territories with no cellular coverage. These are multi-billion dollar markets that were previously unreachable at BeWhere’s price points. This solution should also come with higher pricing and margins.

5. The European Opportunity and Vodafone Connection

BeWhere today generates zero revenue from Europe. That’s about to change, and the breadcrumb trail is hard to ignore.

Follow the board seats. Luke Ibbetson sits on both BeWhere and AST SpaceMobile (as Vodafone’s designee) boards, and he runs Vodafone’s Group R&D including 5G, 6G, and NB-IoT strategy. Peter Wilcox, a BeWhere director appointed in January 2025, is the Director of Enterprise Solutions at Bell Canada. These aren’t advisory roles, rather they’re strategic positions linking the IoT device maker to two of the world’s largest cellular networks and the satellite company connecting them.

Vodafone operates one of the world’s largest IoT platforms with 215+ million connected devices globally. They’re an anchor investor in AST SpaceMobile (14.5m shares owned), share a JV called SatCo, and will be among the first carriers to launch D2D satellite service in Europe. BeWhere co-authored the GSMA Foundry whitepaper on integrated 5G and satellite asset tracking, literally helping write the industry blueprint that major carriers are building toward.

The company opened European operations in 2025 and completed a C$5M brokered equity offering in February 2026 with stated proceeds earmarked in part for European expansion and the equipment rental business. They also onboarded a second contract manufacturer in Albania during Q4 2025, providing a production base with favorable tariff treatment for European distribution.

This mosaic includes a shared board member running Vodafone’s IoT strategy, co-authorship of the GSMA industry whitepaper, a proven D2D satellite test on an AST network that Vodafone has invested heavily in, the opening of European ops, a new Albanian manufacturing base, and a fresh equity raise to fund expansion. A formal Vodafone distribution agreement hasn’t been announced yet. However, there’s strong reason to believe this could be the case, and if so, Vodafone would bring the lowest cost solution to the European market which could significantly grow their own share, while simultaneously expanding the market as BeWhere did in North America.

6. Potential Move to the TSX Main Board

BeWhere currently trades on the TSX Venture Exchange, Canada’s junior market. History of profitability appears to be the primary gating metric, but with 24 consecutive quarters of positive EBITDA and a trajectory toward full-year GAAP profitability, 2027 looks like a realistic timeline for this move.

An uplisting could expand institutional investor and sell-side research interest (many funds have policies preventing TSX-V purchases), improved trading liquidity, inclusion in additional indices, better access to capital markets, and a general credibility upgrade in commercial negotiations. Historically, junior companies that graduate from TSX-V to TSX experience multiple expansion as liquidity and institutional participation increase.

7. Entering the Seasonally Strongest Period

BeWhere’s Q4 and Q1 quarters are typically their strongest, driven by seasonal logistics demand (holiday shipping, year-end fleet procurement cycles) and the fact that a portion of recurring revenue from one major client (UPS) is seasonal, benefiting Q4 and Q1. Q3 2025 was already a record quarter at C$6.1M in revenue (grew 21% YoY driven by stable mid 50s growth in Product/Hardware Revenue and stable mid 30s growth in Recurring Revenue). Management has flagged it as the second-highest unit volume quarter in company history, offering strong visibility into Q4 and Q1 recurring revenue growth.

8. Potential Takeout

CEO Owen Moore’s first business, Grey Island Systems International, was acquired for ~C$35M in an all-stock deal in October 2009 by competitor WebTech Wireless. He served as CFO and then President, helping the business scale to C$24M of revenue. This early vehicle telematics business was part of the large wave of consolidation at the time. While BeWhere lacks the heavy software layer today that likely contributes greatly to peers’ revenue multiples in high-single digits vs. their ~3.0x LTM, rapidly growing revenue plus margin expansion plus no debt at a below-average multiple is a strategic acquirer’s dream. If management can execute on the DaaS transition and new product launches while continuing the successful enterprise land-and-expand strategy and growing the market itself, it would not be surprising to see them acquired for a healthy multiple in the coming years.

The AI Question: Enabler, Physical AI, Not Disrupted

In every stock pitch today, you inevitably get the question, “but what about AI?” For BeWhere, the answer reveals something important about their competitive positioning.

BeWhere Collects the Data AI Needs

AI models are only as good as their input data. BeWhere’s devices generate a continuous stream of location, motion, temperature, and environmental data from hundreds of thousands of assets globally. This is precisely the real-world physical data that supply chain AI, predictive maintenance algorithms, and logistics optimization engines need to function.

CEO Owen Moore has stated publicly that BeWhere doesn’t position itself as an AI company. It positions itself as an AI enabler. The data they provide to clients like Costco, UPS, and J.B. Hunt feeds directly into those companies’ own machine learning algorithms for asset utilization, predictive maintenance, and route optimization.

API-First Approach

This is where BeWhere’s strategic positioning differs fundamentally from competitors like Samsara. Samsara has built a comprehensive “Connected Operations Cloud” – a full software platform with AI-powered dashcams, routing, compliance, and analytics. It’s a powerful lock-in strategy, but it also means customers are buying into a single vendor’s software vision.

BeWhere took the opposite approach. Their API-first architecture translates raw device data into clean JSON feeds that inject natively into whatever ERP, fleet management, or analytics system the customer already uses. BeWhere becomes an invisible data layer. This means:

• Customers aren’t locked into software and can swap analytics layers without friction

• As individual AI/software layers become easier to replicate (and they will), physical hardware generating the data retains its value

• Large enterprises that build their own AI-powered operations platforms internally still need someone to provide low cost, most reliable hardware (that’s BeWhere)

• Enabling shift from CapEx to OpEx for customers further insulates BeWhere by reducing the customer’s switching friction and increasing contract duration

Competitive Positioning Matrix (see Appendix for more details)

Source: Company filings, product specifications, management commentary, analyst reports, press releases. Iridium 9604 announced Feb 24, 2026. All costs USD unless noted. BeWhere DaaS pricing reflects all-inclusive device + connectivity + software bundle.

BeWhere occupies a “middle ground” that’s difficult to attack from either direction. High-end players like Samsara and ORBCOMM can’t profitably serve sub-US$100 asset tracking. Low-end consumer tags (AirTag, Tile) are passive and useless in industrial environments. BeWhere’s API-first approach means they’re complementary to, not competitive with, emerging AI analytics platforms, positioning them as the go-to data collection layer regardless of which software wins.

BeWhere occupies the low-cost, high-volume segment where the unit economics enable tracking of assets previously too cheap to justify. Iridium and ORBCOMM compete at the opposite end with high-cost, satellite-first solutions for assets in locations where cellular coverage doesn’t exist. The convergence point is the emerging NTN/D2D satellite layer. BeWhere’s AST SpaceMobile approach offers satellite as a free firmware overlay on cheap cellular devices, while Iridium’s approach requires dedicated (and expensive) satellite hardware. If AST’s D2D network reaches commercial scale, BeWhere can deliver equivalent global coverage at a fraction of Iridium’s cost structure.

4. Financials and Valuation

The base case assumes successful launches leading to a step up of just 20,000 annual unit sales in 2026 with additional contribution from the new DaaS model and European expansion. Out years assume no new launches, but nice organic growth from DaaS and Europe (a market likely as large as their own North America core today).

This cadence yields a 25% revenue CAGR to 2028 and significant margin expansion.

Using the Satellite Device upside depicted above, 2029 could see significant upside to EBITDA. This scenario would yield a 55%+ EBITDA CAGR from 2025 to 2029. This would not be possible without an asset light model and scaled distribution partners.

Finally, BeWhere’s current share price of C$.90 represents a compelling entry point as a result of the numerous initiatives set to drive meaningful growth in 2026. The early February offering was met with significant demand, closing the next day at C$0.86 and recently touching C$1.00. It would appear management told a compelling story of expansion.

APPENDIX

Appendix Contents

Competitive Landscape — Extended Analysis

Go-to-Market Strategy — The Channel Model

Manufacturing Model & Supply Chain

Product Portfolio — Detailed Hardware Specifications

Customer Base & Case Studies

AST SpaceMobile Partnership — Technical Deep Dive

Vodafone IoT Ecosystem — Extended Analysis

Risks

GSMA Whitepaper & Industry Framework

Recent News & Press Releases

Management Team & Board of Directors

Competitive Landscape

Source: Company filings, product specifications, management commentary, analyst reports, web research. Iridium 9604 data from Feb 24, 2026 press release. Assessment as of Feb 2026. Ratings are author estimates and reflect competitive positioning in the unpowered/low-power IoT asset tracking segment specifically.

Samsara (IOT-NYSE)

San Francisco-based. The IoT industry bellwether. Revenue ~US$1B+. Offers a full “Connected Operations Cloud” platform including AI dashcams, vehicle telematics, equipment tracking, and connected worker solutions. Commands a 10–20% price premium driven by software value proposition. Employs 3,500+ professionals. Not a direct head-to-head competitor in the mid-tier asset tracking segment but is expanding downmarket into trailers and smaller assets. The key difference: Samsara’s monthly subscription runs US$25–45/device versus BeWhere’s US$1–5. Different markets, different economics.

Digital Matter (Private, Australia/South Africa)

The closest direct competitor. Specialist in low-power, battery-powered GPS/IoT hardware. Strong in Europe, Australia, and New Zealand but limited North American presence. Received PE investment from Five V Capital in January 2025. Founded 2001. Key overlap: similar price points, similar device types, similar target markets. Key difference: Digital Matter lacks BeWhere’s carrier relationships and D2D satellite capability.

Geotab (Private, Oakville ON)

Global fleet management telematics leader with millions of connected vehicles. Acts as both BeWhere’s partner and competitor. As a partner, Geotab sells BeWhere devices through its marketplace to track non-powered assets alongside Geotab-tracked vehicles. As a competitor, Geotab is expanding into higher-value asset tracking (trailers, generators). The relationship is net positive for BeWhere today but worth monitoring.

ORBCOMM (Private, acquired by PE)

The incumbent in trailer tracking with revenues historically exceeding US$1B. Relies on older, higher-cost proprietary satellite hardware. CalAmp/ORBCOMM devices typically cost US$200–500+ and require external power. BeWhere undercuts them by 70%+ on price with 5x battery life. Their counter-strategy is to spread FUD about BeWhere’s small size, but this is mitigated by BeWhere selling through AT&T and Bell rather than as an unknown startup.

Apple AirTag / Tile / RFID

Consumer-grade trackers and passive tags. AirTags cost US$25 but are passive — they rely on iPhones walking past them to relay location. Useless in industrial settings (construction yards, rail depots, remote logging camps). RFID costs pennies per tag but requires a human with a US$1,500 scanner to physically walk the yard. BeWhere devices are autonomous, cell-connected, and report continuously without human intervention.

Go-to-Market Strategy

If there is one thing to understand about BeWhere, it’s their B2B2B channel partner model. They rarely sell direct-to-consumer. Rather than spending tens of millions building an enterprise sales force, BeWhere acts as the “Intel Inside” for massive distributors, giving their 22-person team an army of thousands of proxy salespeople.

Channel 1: Telematics Giants

BeWhere integrates natively with Geotab (world’s largest commercial fleet tracker with millions of connected vehicles) and Ford Pro Telematics. When a logistics firm buys Geotab for their trucks, they inevitably ask about tracking trailers too. Geotab sells them a BeWhere device from the Geotab Marketplace. Ford Pro completed its soft launch of BeWhere device integration in February 2026.

Channel 2: Telecom Carriers (MNOs)

AT&T, Bell Canada, T-Mobile, and others sell white-labeled BeWhere hardware to their enterprise clients. Carriers want to grow IoT data subscriptions and BeWhere provides fully certified hardware they can resell. The FirstNet relationship (8,000 units for public safety applications) is a prime example.

Channel 3: Regional and Specialty Partners

GISCAD (Caribbean/Latin America, 29 territories), Tenna (construction), GPS Insight, Titan GPS, and others provide geographic and vertical-specific reach. These partners handle the sales cycle; BeWhere fulfills orders and collects the recurring revenue.

The beauty of this model: BeWhere’s Sales & Marketing expense stays extremely low relative to revenue because the channel partners bear the majority of customer acquisition cost. It’s how 22 people generate C$20+ million in revenue.

Manufacturing Model & Supply Chain

BeWhere operates a fabless manufacturing model. All PCB design, engineering, R&D, and proprietary firmware development is done in-house in Mississauga, Ontario. Physical assembly is outsourced to contract manufacturers (CMs). While it is not abundantly clear they have an IP moat, their access to market / distribution is impressive for such a small company and is a testament to their build and pricing strategy. This acts as a sort of moat at best, and strategic in-roads to many enterprise conversations at worst.

As of Q4 2025, BeWhere operates a dual-CM strategy. The primary CM is in China and has been the company’s manufacturing partner for years. BeWhere represents approximately 10% of this CM’s business. A second CM was onboarded in Albania in Q4 2025. The Albania facility was chosen specifically for its favorable tariff position — a maximum effective tariff rate of ~10% into the U.S. or EU, providing a hedge against CUSMA renegotiations.

The tariff situation in 2025 was a meaningful test for the business. In Q2 2025, U.S. tariffs cost BeWhere C$425,000 in a single quarter, temporarily wiping out quarterly profit. Management responded aggressively: by Q3 2025, they achieved full CUSMA compliance (0% effective tariff rate), bringing product from China into Canada for firmware loading before shipping to the U.S. They also acquired Moore Installs, a U.S.-based installation and logistics company, for US$600K in January 2025 to improve supply chain capabilities.

Devices undergo “potting” during manufacture — the internal circuitry is injected with epoxy resin, creating a solid waterproof brick. This is what enables the IP67 rating and multi-year outdoor deployment durability.

Product Portfolio

BeMini

A compact, rugged tracker with GPS, cellular (LTE-M/NB-IoT), and BLE connectivity. Features include temperature/humidity sensors, motion detection, and geofencing alerts. Priced around US$50–100 per unit. Ideal for container and cargo tracking. The BeMini was the subject of the 8,000-unit FirstNet order in August 2025.

BeTen+

An industrial-grade beacon with extended battery life (10 years on 2 AA batteries at 1x/day reporting) and future satellite fallback capability. Used in mining, oil & gas, and heavy equipment monitoring. The “10” in the name stands for 10 years of battery life.

BeSol / BeSol+

A solar-powered variant for outdoor applications. The solar panel and energy harvesting system enables an industry-leading 5-minute reporting rate purely from solar charging. Ideal for agricultural machinery, outdoor equipment, and long-haul trailer tracking. The B5-BeSol+ refresh is scheduled for Q2 2026.

BeWired / BeWired+

A rugged, waterproof outdoor-mounted beacon for tracking assets with an external power source. Applications include trailers, dry vans, construction equipment, and chassis. Sensors cover light exposure, temperature, air pressure, humidity, and acceleration. The B5-BeWired+ refresh is scheduled for Q3 2026.

BeBatt (NEW — February 2026)

The first fifth-generation device. Purpose-built for cable reels, pallets, and lower-value assets. Features hybrid power (replaceable lithium battery + supercapacitor) for 10+ year operational life. Universal location intelligence switching between GNSS for outdoor and WiFi/BLE for indoor environments. Real-time alerts for motion, tilt, and light-based tamper detection. Critically, BeBatt was engineered at approximately 30% lower BOM cost than the BeTen+ it partially replaces, while delivering higher absolute dollar margins.

All devices comply with IP67 (water/dust resistance) and selected models carry ATEX certification for hazardous environments. The full product line operates on LTE Cat 1 Bis architecture, which is the same chipset enabling future D2D satellite connectivity through AST SpaceMobile.

Customer Base & Case Studies

UPS

Deployed 20,000+ BeWhere units seasonally (Q4/Q1) to track equipment during peak shipping periods. The recurring revenue from this account is seasonal, benefiting Q4 and Q1 quarters. UPS also has a separate business relationship with Moore Installs (acquired by BeWhere in January 2025).

Costco

Tracking 10,000+ container fleets to manage inventory flow from yard to warehouse. A classic land-and-expand story that grew from a small initial pilot.

Lyft

Tracking over 12,000 e-bikes in their ride-share program. This represents a creative non-traditional use case that demonstrates the versatility of BeWhere’s low-cost tracking platform.

FirstNet / AT&T Public Safety

An 8,000-unit order in August 2025 for BeMini trackers across 100+ first responder agencies including Boston Fire and Florida Emergency Management. FirstNet provides prioritized cellular connectivity for first responders during disasters. BeWhere has already deployed 3,000+ FirstNet units to agencies like Denver Water, Alabama DOT, and North Carolina DOT.

Examinetics (Healthcare Case Study)

BeWhere partnered with Examinetics to transform occupational health with low-power 5G asset tracking, monitoring mobile health screening equipment across hundreds of deployment sites. This demonstrates the expansion beyond traditional logistics into healthcare and compliance verticals.

Ford Pro

Completed commercial soft launch in February 2026. Ford Pro customers can now access BeWhere’s BeTen+, BeSol+, and BeWired+ devices directly through Ford Pro Telematics software, enabling fleet managers to track both their Ford vehicles and their non-powered assets on a single platform.

AST SpaceMobile

AST SpaceMobile (NASDAQ: ASTS) is building the first space-based cellular broadband network accessible directly by standard, unmodified devices. They’re not building satellite phones — they’re building cell towers in space that communicate with standard LTE/5G chipsets using 3GPP telecom standards.

Technology & Deployment Status

AST validated its technology with the BlueWalker 3 prototype in 2022. As of early 2026, they have launched six commercial BlueBird satellites, with BlueBird 6 being the largest commercial phased array ever deployed in LEO (launched December 2025). The company plans to deploy a 45–60 satellite constellation through 2026, which represents the minimum required for commercial-scale coverage.

The BeWhere Integration

BeWhere’s October 2025 test in New Brunswick, Canada demonstrated that a standard, unmodified BeWhere LTE IoT tracker could connect to a BlueBird satellite and route data through Bell Canada’s terrestrial network. This is significant because BeWhere’s existing devices use the same LTE Cat 1 Bis cellular module that AST’s satellites target. No hardware modification is needed — only a firmware update that manages the handover between cellular and satellite connectivity.

Economic Implications

Traditional satellite tracking requires US$500–1,500 devices with US$50+/month data plans. BeWhere’s D2D satellite approach uses the same sub-US$50 device, meaning the incremental hardware cost for satellite capability is zero. The only incremental cost is the satellite data plan, which will be billed through the carrier (AT&T, Bell, Vodafone) at rates that management expects to be dramatically lower than legacy satellite providers. This could unlock tracking for maritime containers, remote mining equipment, offshore energy platforms, and agricultural assets in areas with zero cellular coverage.

MNO Partnership Structure

AST operates on a B2B2C model — they partner with MNOs (AT&T, Verizon, Bell, Vodafone, stc group, and 50+ others globally) who provide spectrum access in exchange for a 50/50 revenue share. Both AT&T and Bell are equity investors in AST. Vodafone is a strategic investor with Luke Ibbetson serving on the AST board. This means BeWhere’s existing carrier distribution partners are the same carriers launching AST’s D2D service — creating a natural channel for satellite-enabled BeWhere devices.

Vodafone Opportunity

Vodafone’s IoT Platform — Scale and the Device Gap

Vodafone connects over 215 million IoT devices across 180+ countries through 760+ network partnerships. In 2024, it signed a 10-year strategic partnership with Microsoft to “hyperscale” the platform, with Microsoft investing in a planned spinoff of the IoT unit as a standalone business. Yet the hardware ecosystem remains fragmented. Its “Integrated Terminals” partners (BEC Technologies, Cradlepoint, Digi, Teltonika) orient toward high-throughput gateways and routers, not low-cost battery-powered trackers. Vodafone’s in-house “Asset Solar” tracker sits near BeWhere’s price points, but with notably less functionality and durability. Its Multi-Asset Tracking solution aggregates devices from various manufacturers spanning 2G, NB-IoT, and Cat-M1.

Vodafone’s Three-Pronged Satellite Strategy

Vodafone pursues three complementary satellite partnerships, each addressing a different layer of the stack:

AST SpaceMobile / SatCo (D2D Broadband) The deepest relationship. In March 2025, Vodafone and AST created SatCo, a jointly-owned European satellite service provider that will exclusively distribute AST’s D2D services to European MNOs — 21 EU member states have expressed interest. Vodafone holds ~5% equity in AST with a commercial agreement through 2034. Commercial service targets 2026.

Iridium NTN Direct (NB-IoT via LEO) Announced November 2025, delivering 3GPP standards-based NB-IoT over Iridium’s 66-satellite constellation for global pole-to-pole coverage in remote industrial applications. Commercial launch targets 2026.

Skylo Technologies (NTN NB-IoT via GEO) Partnered January 2026, trialing hybrid cellular-satellite connectivity where devices switch between terrestrial and NTN via a single Vodafone SIM across 36 countries.

Vodafone is preparing its entire IoT ecosystem for connectivity beyond terrestrial coverage limits.

The Luke Ibbetson Bridge

Luke Ibbetson, Vodafone’s Head of Group R&D since 2013, simultaneously serves on BeWhere’s board and AST SpaceMobile’s board (as Vodafone’s designee). His portfolio spans 6G, non-terrestrial networks, quantum technology, and advanced AI/ML; he chairs the NGMN Alliance’s Strategy Committee. This is not a passive advisory role, rather it creates an information and decision bridge between Vodafone’s R&D strategy, AST’s satellite architecture, and BeWhere’s device engineering. Additional board members Peter Wilcox and Nauby Jacob (both Bell Canada executives) reinforce an intentional carrier-ecosystem integration strategy.

The GSMA Foundry whitepaper, “Smart Logistics: Designing Integrated 5G and Satellite Solutions for Global Asset Tracking” (February 2025), amplifies this connection. BeWhere co-authored what functions as an industry blueprint for carrier deployment of integrated terrestrial-satellite tracking, projecting 2–3 billion devices addressable for satellite integration by 2030 with a $10 billion annual revenue uplift. BeWhere and Telit Cinterion are the only two companies named as rolling out integrated solutions in 2025.

A Toehold, Not a Partnership Announcement

No formal commercial agreement exists between Vodafone and BeWhere. Board-level relationships provide strategic access but do not bypass Vodafone’s procurement processes across 15 operating companies. Vodafone’s satellite IoT buildout, particularly through SatCo, opens an entirely new category of European asset tracking demand, and BeWhere’s cost structure, satellite-readiness, and carrier relationships position it to capture an early toehold. The playbook mirrors North American market entry – secure initial deployments through carrier channels, prove value at modest scale, and let economics drive organic expansion.

Why the Price Point Matters

BeWhere’s BeBatt (launched February 2026) delivers 10+ year battery life at what management describes as the company’s “most competitive price point to date.” The historical pricing model of sub-$100 wholesale hardware and $2–5/month SaaS fees (or $0 upfront under DaaS at $5–7/month) justifies tracking assets valued in the hundreds or low thousands of dollars. The GSMA whitepaper projects satellite integration will unlock entirely new categories: remote agricultural equipment, construction assets, portable generators, rural medical equipment, and renewable energy infrastructure. These are exactly the asset classes where ROI requires sub-$100 hardware. Even a modest deployment through a single Vodafone operating company (10,000–20,000 units) would represent meaningful revenue for a ~C$20M company and a reference customer opening the door to 20+ European markets.

Satellite IoT Market Context

Berg Insight reports the global satellite IoT subscriber base reached 5.8 million in 2024, forecasting a 41.1% CAGR to 32.5 million by 2029 with revenue growing from €334M to ~€1.58B and monthly ARPU declining to ~€4.05, aligning with BeWhere’s recurring revenue model. IoT Analytics estimates combined revenue growing at 26% CAGR to surpass $4.7B by 2030. Incumbent operators (Iridium, ORBCOMM, Globalstar) rely on proprietary terminals costing $200–$1,500+ with $20–50+/month data plans. The value proposition of 3GPP-compliant D2D satellite connectivity is eliminating that proprietary terminal barrier entirely. BeWhere’s October 2025 satellite test connecting a standard off-the-shelf LTE tracker to an AST BlueBird satellite routed through Bell’s terrestrial network provides proof-of-concept.

Risks

Customer Concentration

BeWhere’s top clients (UPS, Costco, Lyft) represent meaningful revenue concentration, likely over 50% based on several charts in their presentations, one of which may be as much as 15-20% of revenue. Mitigation: the company has approximately 10,000 customers across the platform and the land-and-expand model means new enterprise relationships are continuously being added. The DaaS rental model also increases switching costs via longer contract terms.

Tariffs and Trade Policy

The Q2 2025 tariff impact demonstrated real vulnerability. Mitigation: CUSMA compliance achieved in Q3 2025 (0% effective rate). Albania CM onboarded in Q4 2025 as a 10% tariff backstop. Stress test: even if the Q3 2025 C$425K tariff hit occurred every quarter, the company has C$9M in cash and C$7M in working capital to survive 2+ years without external capital.

AST SpaceMobile Execution Risk

The satellite opportunity is highly contingent on ASTS deploying its constellation on schedule. Delays, technical failures, or funding gaps at ASTS would push out BeWhere’s satellite revenue timeline. Mitigation: the satellite opportunity is pure optionality — the base business is compounding nicely without it. Multiple re-pricing of ASTS risk is not BeWhere’s problem.

Key Person Risk

22 employees means every person matters. Owen Moore’s departure would be particularly impactful. Mitigation: the Grey Island team (Moore, Boychuk, Panczuk) has worked together for decades, reducing flight risk. The board is deep with strategic expertise (Ibbetson, Wilcox, Jacob).

Competition from Samsara Down-market

Samsara is publicly expanding into lower-value asset tracking — BeWhere’s core market. Mitigation: Samsara’s cost structure (3,500 employees, US$25–45/month SaaS fees) makes it structurally difficult to compete at BeWhere’s price points and would significantly dilute their P&L to the demise of shareholders. Samsara will capture the higher-value end of asset tracking, and BeWhere owns the cost-sensitive middle and low end.

Liquidity and TSX-V Listing

The stock trades on the TSX Venture Exchange with limited daily volume, making it difficult for larger investors to build positions. This is a real friction point for institutional capital. Mitigation: a TSX main board graduation (possibly 2027) and continued revenue growth toward the C$50M threshold would organically resolve this over time.

Dilution

The February 2026 equity offering grew share count by 8%. Future raises to fund the DaaS rental model, European expansion, or acquisitions would further dilute shareholders. Mitigation: management has historically been disciplined with capital — no warrants outstanding, active NCIB buyback program, and the DaaS model generates free cash flow within 2–3 quarters of deployment.

GSMA Whitepaper & Industry Framework

In February 2025, BeWhere co-published through the GSMA Foundry the whitepaper titled “Smart Logistics: Designing Integrated 5G and Satellite Solutions for Global Asset Tracking.” This was a collaboration between BeWhere, Bell Canada, and GSMA to define the technical and commercial framework for next-generation asset tracking that seamlessly transitions between terrestrial 5G and satellite networks.

The whitepaper lays out the architecture for devices that intelligently switch between cellular and satellite connectivity based on available coverage, representing a paradigm shift in supply chain visibility. BeWhere’s involvement as a co-author of this industry blueprint is significant — it positions them as a thought leader and potential preferred implementation partner for carriers building toward this vision.

Recent Developments

February 12, 2026 — Ford Pro Integration

BeWhere completed the commercial soft launch of its collaboration with Ford Pro, integrating BeWhere’s device suite into Ford Pro Telematics Software. Ford Pro customers can now access BeTen+, BeSol+, and BeWired+ devices directly through the Ford Pro ecosystem.

February 9, 2026 — BeBatt Launch

BeWhere unveiled BeBatt, the first fifth-generation IoT asset tracker delivering 10+ years battery life at the company’s most competitive price point. Available today.

February 5, 2026 — Equity Offering

BeWhere completed a C$4.0M brokered LIFE offering of 8.5M common shares at C$0.70 per share. Proceeds earmarked for equipment rental business expansion, European expansion, and general working capital.

October 28, 2025 — AST SpaceMobile D2D Test

Successfully connected an unmodified BeWhere IoT tracker to AST SpaceMobile’s BlueBird satellite via Bell Canada’s network. First asset-tracking company to achieve D2D satellite transmission with an off-the-shelf cellular device.

August 28, 2025 — FirstNet Order

Received order for 8,000 FirstNet-connected BeMini trackers operating on AT&T’s network for 100+ first responder agencies.

March 10, 2025 — GISCAD Partnership

Announced partnership with GISCAD Group (Trinidad & Tobago) covering 29 territories in the Caribbean and Latin America for BeWhere’s LTE Cat 1 Bis devices.

Management Team & Board of Directors

Executive Leadership

Owen Moore — CEO & Co-Founder

Moore was President and Co-Founder of Grey Island Systems International, a publicly traded Canadian/U.S. manufacturer of real-time internet-based vehicle monitoring and predictive arrival systems. He grew Grey Island from startup to C$24M in revenue in less than ten years before selling in October 2009. Grey Island was a multi-year recipient of the Deloitte Technology Fast 50 and Profit 100 honors. Moore holds ~10% of BeWhere’s outstanding shares.

Chris Panczuk — COO & Co-Founder

Panczuk spent 15+ years in GPS and telematics, most recently as VP of Enterprise Sales at BSM Wireless. He has been in the industry since 1998.

Rajiv Khanna — CFO

Khanna has 33+ years of senior finance experience across telematics, manufacturing, and consumer packaged goods.

Brian Boychuk — SVP, Sales & Marketing

Boychuk was co-founder of Grey Island Systems, serving as VP Sales & Marketing and then EVP Business Development at Grey Island.

Alban Hoxha — CTO

Hoxha has two decades of experience spanning data center management, firmware development, hardware manufacturing, M-IoT, telematics, and M2M compliance.

Board of Directors

Paul Christie — Chairman

Former Toronto city councilor and TTC chair. Director at Grey Island Systems. Has been BeWhere Chairman since 2016.

Joanne De Laurentiis — Director

Former CEO of IFIC, Credit Union Central of Canada, Interac, and Mondex Canada. Currently chairs the Financial Services Regulatory Authority of Ontario (FSRA).

Nauby Jacob — Director

SVP of Consumer Products and Platforms at Bell Media. Former Director at EnStream and TELUS. Expertise in telecommunications product strategy and mobile network operations.

Luke Ibbetson — Director

Head of Group R&D at Vodafone since 2013, responsible for 5G, 6G, and NB-IoT strategy. Serves simultaneously on the board of AST SpaceMobile as Vodafone’s designee. Chairs the Strategy Committee for the NGMN Alliance. This is arguably the single most strategically significant board appointment at BeWhere.

Peter Wilcox — Director

Director of Enterprise Solutions at Bell Canada with two decades of experience leading product teams in 5G, Private Mobile Networks, and IoT solutions. Ivey Business School, Western University.

DISCLOSURE

Position: At the time of publication, the author owns BeWhere.

Trading Policy: The author will not materially alter this position within 48 hours of publication. After this period, the author may buy, sell, or otherwise adjust the position without further notice. Changes to the author’s view or position will be reflected in subsequent publications when material.

Conflicts: The author has received no compensation from the issuer or any party with a financial interest in this security.

Forward-Looking Statements: This report contains the author’s opinions, estimates, and projections, including price targets derived from financial models. These are forward-looking statements subject to substantial uncertainty. If these assumptions prove incorrect, the actual value may differ materially, including scenarios of significant loss or total impairment. The price target represents the author’s estimate of fair value under the stated assumptions, not a prediction of where the stock will trade.

This report is provided for informational purposes only and does not constitute investment advice. See the full Terms & Disclosures for additional important information.

Vodafone has agreed to sell its 50% stake in VodafoneZiggo, its Dutch joint venture with Liberty Global, for €1.0 billion in cash plus a 10% equity stake in a newly formed holding company called Ziggo Group. The new entity will combine VodafoneZiggo with Liberty Global’s Belgian operator, Telenet, creating a consolidated regional platform. Vodafone will also earn €625 million in brand licensing and service fees over the next 10 years, bringing all-in consideration closer to €1.6 billion in aggregate value. The deal values VodafoneZiggo at 7.1x 2025 adjusted EBITDAaL. Liberty Global plans to list Ziggo Group on Euronext Amsterdam in 2027, at which point Vodafone’s 10% minority converts from a static JV position into a liquid, publicly traded asset. If the listing does not occur within 18 months of closing, Vodafone retains the right to sell its stake to a third party. The transaction is expected to close in H2 2026, pending regulatory approval.

Strategic Rationale

This deal continues CEO Margherita Della Valle’s multi-year portfolio rationalization. The Netherlands exit continues the cleanup of Vodafone’s European assets, leaving the group with a far simpler, more investable structure.

Portfolio focus. The 50/50 JV structure in the Netherlands gave Vodafone co-control but not operational authority. Every strategic decision required Liberty Global’s alignment, creating governance drag at exactly the moment when the Dutch market needed decisive responses to intensifying competition from Odido (formerly T-Mobile Netherlands). Exiting removes a structurally complex, management-bandwidth-consuming asset in favor of markets where Vodafone holds full operational control.

Retained upside. Rather than a clean exit, Vodafone exchanges a co-control position in a single-country operator for a minority stake in a larger, more efficient Benelux platform expected to generate meaningful operational synergies between the Dutch and Belgian assets. The 2027 Euronext listing should produce a valuation re-rating as the market prices a standalone converged Benelux champion rather than a buried JV on a complex balance sheet.

EU Telcos Continue to Consolidate Subscale and Underutilized Assets

VodafoneZiggo was created in 2016 by merging Vodafone Netherlands’ mobile network with Liberty Global’s Ziggo broadband and cable infrastructure. It was a textbook converged operator with nationwide 4G mobile coverage combined with Ziggo’s fiber-rich fixed network. In practice, the asset never fully closed the gap between its structural promise and its financial performance.

The core problem was competitive intensity in a market that became increasingly irrational on pricing. Odido’s repositioning after Deutsche Telekom’s spin-off injected real aggression into Dutch mobile, pressuring ARPU across the board. VodafoneZiggo held leadership positions but struggled to convert network quality into pricing power, a dynamic that compressed margins and limited the free cash flow generation the JV was theoretically capable of producing. VodafoneZiggo’s ability to respond to Odido’s competitive push or to accelerate its own fiber densification was structurally hampered by needing two parents to agree. This is a recurring pathology in European telco JVs.

The subscale dimension is equally important. The Netherlands is a mid-sized market. VodafoneZiggo, as a standalone Dutch operator, lacked the procurement scale, technology platform leverage, and cost structure of a pan-regional player. Telenet in Belgium faced analogous dynamics with a strong incumbent position, converged infrastructure, but insufficient scale to absorb fixed costs at the efficiency frontier. Combining them creates something closer to a true Benelux platform with shared infrastructure economics, potential roaming and spectrum coordination, and a fixed cost base spread across a larger subscriber pool. The expected synergy NPV of €1 billion cited in the deal press release is a function of exactly this rationale.

This is a central thesis in European telco M&A right now. Regulators across the EU have gradually accepted that consolidation within and across national markets is necessary. The EC’s approval of the Vodafone/Three merger in the UK was a signal moment. The Ziggo Group formation follows the same logic at a cross-border level. Expect this pattern to continue. The real kicker, and a newfound focus, should be whether combining years of disparate CapEx spend results in lower combined-co spend going forward. This could drive major re-rating for the sector in the coming years. Imagine CapEx budgets falling, balance sheets deleveraging, and a sleepy largely forgotten sector being flush with cash to return to shareholders trading at mid-single digits EBITDA.

The SpaceX Profit Secret Is Out

The veil on SpaceX’s financials has been partially lifted, and the uncomfortable truth for the “rockets are the business” crowd is that Starlink is the engine. High recurring subscription revenue, falling marginal cost per subscriber as the constellation matures, and a captive global customer base with few alternatives. Starlink is one of the most quietly compelling infrastructure businesses on the planet.

Share

Subscribe now

xAI Needs a Cash Cow

xAI is subscale relative to its peers on a number of fronts. OpenAI has Microsoft. DeepMind has Google. Anthropic has Amazon. xAI has Grok on X which is real but a narrow distribution footprint by comparison. More importantly, xAI’s vision is genuinely expensive and simply different. The goal of bringing physical AI to life across Teslas, Optimus robots, and Musk’s full industrial stack is a multi-decade bet, not a near-term revenue optimization. The Colossus cluster in Memphis is just the beginning and more mega-clusters are coming which will require billions annually in capital commitments. That number will surely continue to grow annually to maintain pace in the compute race. Reports suggest the combined entity is targeting a raise of up to $50 billion against a burn rate of roughly $1 billion per month for xAI, a figure likely to increase from here.

SpaceX is the cash cow. xAI needs the cash in the coming years to achieve its goals. The merger logic is almost obvious in hindsight.

Why This Makes D2D Pricing More Rational, Not Less

One prevailing bear case on ASTS and partners is that Starlink will eventually weaponize its balance sheet to nuke D2D pricing. Musk has used this tactic before, and a larger combined entity could plausibly be more aggressive, not less.

This may well get the dynamic precisely backwards as the market for the actual D2D service providers is quickly shaping up to be an duopoly.

Within the merged entity, Starlink’s D2D revenue is no longer optimized in isolation. It is a direct funding agent for xAI clusters, orbital data centers, and lunar programs. Every dollar of D2D margin sacrificed to undercut ASTS is a dollar that doesn’t reach those projects. That is a real cost.

The distribution picture reinforces this. AT&T and Verizon are anchored to ASTS and T-Mobile to Starlink. ASTS has signed dozens of operators globally. Neither party needs to win a price war to build its subscriber base. The incremental competition is at the margin of new operator signings and service tier pricing, not existential market share warfare. That is the anatomy of a disciplined duopoly.

AST’s Neutrality as a Structural Asset

AST’s commitment to being a genuinely neutral wholesale partner is underappreciated. Unlike Starlink, which runs a parallel direct-to-consumer broadband service and therefore carries inherent channel conflict with MNOs, ASTS has consistently positioned itself as the silent partner that improves MNO services without threatening their customer relationships or retail economics.

This is not just good marketing. It is a structural feature that lets MNOs commit volume and price above the floor with greater confidence. An operator signing a long-term wholesale deal with ASTS isn’t worried about being disintermediated. That asymmetry, ASTS as the safe choice, Starlink as the capable but strategically ambiguous partner, is durable and valuable and helps stabilize duopolistic dynamics.

Service Parity Is Likely — and That’s Fine

Three or more years from now, D2D service quality from both providers should reach meaningful maturity. Coverage will be broadly comparable, latency profiles similar for the core use cases, and consumers will struggle to articulate a meaningful difference between the two services embedded in their carrier plan. Pricing will naturally converge toward a rational band.

But convergence toward a rational band does not mean commoditization to zero. The better analogy is broadband backbone or cloud infrastructure at certain tiers – there is price competition, but the market clears at prices that acknowledge nuclear price wars hurt everyone and structural rationality reasserts itself. MNOs retain enormous leverage throughout as long as D2D is an enhancement to terrestrial service rather than a replacement. MNOs control the customer relationship and capture enough of the retail value. They have every incentive to keep their D2D supply chain viable.

The One Risk That Blows This Up

Starlink launches its own smartphone.

If Musk decides to own the device and bypass MNOs entirely, the calculus changes dramatically. MNOs would treat Starlink as a hostile actor and should accelerate their commitment to ASTS, which would actually be constructive for ASTS in isolation. But it would mean Starlink walking away from billions in MNO wholesale economics at precisely the moment the merged entity needs every EBITDA dollar it can generate to fund xAI. That seems like a significant strategic own-goal. The probability is low but non-trivial and deserves monitoring.

Three secondary risks are worth tracking alongside the phone scenario. First, Starlink’s existing consumer broadband service already carries the seeds of channel conflict — if D2D evolves toward more robust data tiers rather than emergency-only coverage, that tension intensifies and Starlink may be tempted to use D2D as a loss leader for direct subscriber acquisition. Second, xAI’s actual burn rate could be materially higher than reported, which cuts both ways: more pressure on Starlink EBITDA reinforces pricing discipline, but could also produce a “growth at all costs” mentality that overrides economic rationality. Third, MNO consolidation or defection could destabilize the bilateral duopoly picture. ASTS has particularly deep operator penetration and ties across emerging markets, and those geographies could become battlegrounds if Starlink opts to be aggressive internationally where MNO relationships are less entrenched and switching costs are lower. Any meaningful operator defection in these markets would complicate the pricing stability thesis and is worth monitoring closely.

What We’ll Learn From the S-1

Much of the above rests on figures that are either reported secondhand or inferred from public statements. That changes in the coming months when the S-1 is filed. For the first time, we should get audited Starlink unit economics, actual xAI burn figures, the capital allocation priorities of the merged entity, and how management frames the D2D business in the context of the broader strategic plan. Whether Starlink D2D is presented as a profit center, a strategic asset, or a distribution tool will tell us a great deal about the pricing intentions that no public statement currently can.

The Bottom Line

The xAI-SpaceX merger reframes Starlink’s strategic incentives in a way that is quietly very positive for the D2D pricing environment. A cash-generative Starlink that needs to fund a multi-billion-dollar AI and space infrastructure program has every reason to be a disciplined pricing actor. AST’s structural neutrality reinforces this dynamic from the other side. The two-player duopoly taking shape with locked-in MNO distribution, converging service quality, and strong cross-subsidization incentives against irrational pricing has the hallmarks of a market that can sustain rational (and wildly profitable) economics for years.

Disclosure: This analysis is for informational purposes only and does not constitute investment advice. Positions may be held in securities mentioned. Please see prior disclaimers and disclosures.

Vodafone reported Q3 results last Thursday that were largely in line with expectations but highlighted stable but continued operational challenges in core markets. Germany revenues were in-line despite softness in mobile due to competitive pressures. The most significant surprise came from Turkey, where currency translation turned reported revenue growth sharply negative (-14% YoY in € terms) despite robust local currency performance (+39%). UK revenues turned down to -0.5% as expected, with Q4 anticipated to return to growth. Group EBITDAaL declined -3.8% in Q3 on a pro forma basis.

Vodafone reaffirmed full-year guidance for Adjusted EBITDAaL and Adjusted FCF, while still expecting FY results at the high end of the range. The company has completed €3.5 billion in share buybacks since May 2024 tied to Spain and Italy asset sales, with the next €500 million tranche commencing immediately. Strategic priorities remain customer experience improvements, UK merger integration, B2B growth, and selective price actions to drive value over volume.

Management provided constructive commentary on FY’27, noting this will be the first year showing full cost synergy benefits from simplification efforts, meaningful UK integration synergies beginning to flow through, and continued progress on the multi-year FCF improvement trajectory. German ARPU increased 21% YoY – the strongest performance in three years – driven by disciplined pricing actions and reduced promotional activity.

The stock initially sold off nearly 10% driven primarily by momentum shareholders responding to headline results, but has since recovered almost all losses since Wednesday’s close – a testament to the trust in management and step-by-step progress recognized by investors.

Share

Subscribe now

Germany: Value Strategy Working Despite Competitive Headwinds

Germany delivered Q3 service revenues essentially matched consensus. Fixed-line revenue trends improved significantly to -1.1% versus -2.3% in Q2, exceeding expectations despite weaker broadband net additions (-63K versus -26K in Q2). This outperformance highlights management’s successful pivot toward value over volume.

Mobile revenue growth softened to +2.8% from +3.8% in Q2, missing expectations by approximately 150bps. The primary driver was intense competitive activity creating ARPU pressure that more than offset incremental wholesale revenues from the 1&1 MVNO relationship. Service provider payment phasing created an additional 1pt drag that will unwind in Q4.

The strategic focus on ARPU over subscriber volume is delivering tangible results. German broadband ARPU increased 21% year-over-year in Q3. This is the strongest performance in three years, driven by disciplined pricing and significantly reduced promotional intensity. Management implemented “More for More” pricing across the entire cable portfolio in January, pairing price increases with improved speeds. An additional price increase was implemented in the final week of Q3, demonstrating confidence in the pricing strategy.

Management’s commentary emphasized that German broadband market penetration has effectively plateaued, reinforcing the strategic rationale for prioritizing value extraction over market share gains. Churn performance is outperforming other markets with Net Promoter Scores improving, providing confidence that the pricing strategy is sustainable.

Looking forward to FY’27, management expressed confidence in German EBITDAaL improvement despite acknowledging the business won’t return to positive year-over-year growth in the current fiscal year. Support will come from fully visible TV revenue headwinds (removing uncertainty), continued mobile wholesale tailwinds from 1&1 MVNO, building B2B pipeline with significant improvement expected, and cost simplification actions beginning to show material P&L impact.

Turkey: Currency Translation Masks Operational Strength

Turkey emerged as the primary negative surprise, with reported service revenue growth turning sharply negative at -14% year-over-year in euro terms versus +22% in Q1 and +19% in Q2. However, this headline figure is entirely driven by currency translation effects rather than operational deterioration. Local currency service revenue growth remained very strong at +39% in Q3, following +64% in Q1 and +48% in Q2. When adjusting for hyperinflation accounting impacts, euro-denominated revenue growth showed: Q1 at +27%, Q2 at +15%, and Q3 at +4%. This sequential pattern demonstrates the severity of the currency headwind overwhelming a fundamentally healthy business.

The Turkish situation matters significantly because Turkey has been the single largest contributor to Group EBITDAaL growth over the past 18 months. For investors focused on Vodafone’s asset portfolio value and long-term FCF generation, Turkish currency fluctuations represent noise rather than a reason to fundamentally reassess the investment case.

United Kingdom: Integration Execution on Track

UK service revenue growth turned negative in Q3 at -0.5% following +0.9% in Q1 and +1.2% in Q2, as management had telegraphed. The decline was anticipated due to tough YoY comps. Excluding this one-time project revenue, underlying organic service revenue growth remained approximately +1%, consistent with prior quarters.

Mobile service revenue declined -1.8% versus +0.4% in both Q1 and Q2, attributed to difficult comps in B2B and Wholesale segments. The mobile contract subscriber base declined 73K, with 53K from disconnection of very low-value Business SIM cards and continued legacy Three UK customer churn as expected.

Fixed service revenue growth accelerated to +4.8% from +4.3% in Q2 and +2.7% in Q1, demonstrating continued strong momentum in Consumer broadband. This validates management’s UK strategy of leveraging the merged entity’s expanded infrastructure footprint to drive fixed-mobile convergence and reduce customer churn.

Management explicitly stated expectations for UK revenue growth to return to positive territory in Q4. More importantly, FY’27 will mark the beginning of meaningful cost synergies from the Three UK integration, representing a critical inflection point. UK energy cost pressures will moderate YoY in FY’27, providing another earnings tailwind. Capital expenditure will reach peak levels in FY’27 as network integration accelerates, consistent with the previously communicated multi-year investment plan.

The UK competitive landscape presents additional consolidation opportunities, with management noting that further industry rationalization “makes sense” but awaiting competitors’ moves.

Africa: Strategic Expansion Through Safaricom

Vodafone has significantly expanded its African presence through acquiring a majority stake in Safaricom, extending the Group’s continental footprint to include Kenya and Ethiopia beyond existing markets of South Africa, Egypt, Tanzania, DRC, Mozambique, and Lesotho. This transaction adds €1.4 billion of consolidated annual EBITDAaL and the blue-chip M-PESA money transfer technology platform. Management positioned Vodafone and Orange as the two leading pan-African telco groups, with Vodacom serving as Vodafone’s “resident technology company” for the continent.

Capital Allocation: Disciplined Returns Alongside Strategic Investment

Vodafone has completed €3.5 billion in share buybacks since May 2024, funded by Spain and Italy asset sale proceeds. This demonstrates management’s commitment to sharing asset monetization proceeds directly with shareholders rather than retaining cash for empire building. The next €500 million tranche commenced immediately following Q3 results, signaling continued confidence despite quarterly operational volatility.

Management emphasized that FY’27 represents a critical year marking the first period where full-year cost synergy benefits materialize across the portfolio. UK integration synergies become meaningful contributors, German simplification actions show material P&L impact, and spectrum payment obligations decline. These factors support management’s “constructive multi-year FCF outlook” despite near-term operational pressures.

Value Over Volume: Strategic Repositioning Continues

A consistent theme across Vodafone’s portfolio is the deliberate shift from prioritizing subs growth and market share to optimizing for ARPU and service revenue quality. This strategic repositioning reflects management’s recognition that mature European telecom markets have reached penetration saturation, making volume growth increasingly expensive and value-destructive.

Germany provides the clearest example of successful execution, with broadband ARPU increasing 21% YoY. Management implemented comprehensive “More for More” pricing across the entire cable portfolio, pairing price increases with speed upgrades. Gross additions declined following pricing actions, but churn remained well-controlled and Net Promoter Scores improved, validating that customers accept the value equation.

UK fixed broadband growth of +4.8% despite minimal net additions demonstrates similar success. Management leveraged the expanded infrastructure footprint from the Three UK merger to reduce churn among existing customers and drive ARPU through fixed-mobile convergence bundles.

Conclusion

The Q3 results demonstrate continued operational progress on Vodafone’s multi-year transformation despite quarterly noise that distracted momentum investors. The core thesis remains intact – transition from a volume-focused, market share-obsessed operator to a returns-focused, capital-disciplined infrastructure company.

Germany’s ARPU growth of +21% YoY validates that value-over-volume strategies work even in highly competitive markets when executed with discipline. The €3.5 billion in completed buybacks demonstrates management’s commitment to shareholder-friendly capital allocation. UK integration remains on track with meaningful synergies beginning in FY’27. The African portfolio expansion through Safaricom adds a high-quality technology asset with genuine growth exposure.

What markets continue missing entirely is the strategic optionality created by initiatives that received zero attention in Q3 results commentary. The SatCo JV received no attention, as usual. While analysts focus on whether German mobile revenues declined 1.8% or 3.0%, they’re completely overlooking an asset with potential sovereignty value to European regulators seeking digital infrastructure independence.

The path forward combines operational execution on known value drivers with strategic optionality from underappreciated assets. FY’27 will show the first full year of UK synergies, German cost benefits, and improved cash conversion – all quantifiable and increasingly visible to markets. Meanwhile, the SatCo venture progresses toward commercial service launch with implications for Vodafone’s strategic positioning that markets haven’t begun contemplating. This combination of visible operational improvement and hidden strategic value creates an asymmetric risk-reward profile for investors willing to look beyond quarterly subscriber counts and ARPU trends.

Last week, Vodafone and AST SpaceMobile submitted a joint response to Ofcom’s “Call for Input: Future use of the 2 GHz MSS band.” While regulatory filings rarely make for exciting reading, this one is an exception. It provides the clearest public window yet into how Vodafone and AST SpaceMobile are positioning SatCo to win the upcoming pan-European spectrum allocation and, by extension, to challenge SpaceX’s Starlink Direct-to-Cell ambitions on the continent.

The filing confirms parallel regulatory engagement at both UK (Ofcom) and EU (European Commission) levels, discloses new commercial traction with European MNOs, and lays out concrete technical specifications for the service. Here’s what investors and industry observers should take away.

Subscribe now

The Regulatory Chess Board: UK and EU in Tandem

Perhaps the most significant disclosure is that Vodafone and AST SpaceMobile are actively engaged in parallel regulatory processes across the UK and EU. The filing explicitly states:

“Vodafone Group and AST SpaceMobile have been engaging closely with the European Commission and the RSPG to understand and comment on the arrangements for the award of the 2GHz MSS spectrum ahead of 2027. We responded to the Commission’s recent Targeted Consultation on the matter.”

That confidential submission to the European Commission was not made public, but the companies offered to share it with Ofcom. This suggests a coordinated strategy: build regulatory momentum across both jurisdictions simultaneously, with aligned arguments, timelines, and commitments.

The timing is notable as the current 2GHz MSS licenses expire in 2027, creating a once-in-a-generation opportunity to reallocate this spectrum. The incumbent licensees, Inmarsat and EchoStar (formerly Solaris Mobile/S-band), have been roundly criticized for underutilizing the band. The European Commission’s 2024 review acknowledged as much. Vodafone and AST SpaceMobile are clearly positioning SatCo as the solution to that failure.

SatCo: The European Super-Wholesale Model

The structural choice of a Luxembourg-headquartered joint venture operating as a wholesale provider is deliberate. Rather than competing directly with Europe’s mobile operators, SatCo will supply satellite backhaul capacity to all European MNOs who want it. This “super-wholesale” approach serves multiple strategic purposes:

First, it maximizes addressable market. By offering wholesale access, SatCo can theoretically serve the entire European mobile subscriber base, approximately 500 million users, rather than just Vodafone’s customers. The filing notes the UK alone has 88.4 million mobile devices that could benefit.

Second, it builds a coalition. The filing discloses that SatCo has signed Memoranda of Intent with six additional MNO groups beyond Vodafone’s operating companies, representing over 220 million subscribers across 21 European states. While MOIs are non-binding, they represent meaningful commercial interest and political backers. When the European Commission evaluates competing applications, an applicant backed by the continent’s major carriers will carry substantial weight.

Third, it addresses the sovereignty question. The filing repeatedly invokes European digital sovereignty, describing SatCo as “a solution that directly meets Europe’s critical needs and sovereign priorities, securely and cost-effectively in the current global geopolitical climate.” This is pointed language. SpaceX is American. AST SpaceMobile is also American, but the joint venture structure has European headquarters, European carrier partners, and European regulatory engagement. This creates a defensible narrative of local ownership and control. And, no 100%-owned constellation is anywhere in the works in the next few years with the technical capabilities to compete with Satco or Starlink. The EU will need to choose between a party with aligned interests and some American ownership or purely foreign/American ownership, or fall years behind technologically.

The implicit contrast with Starlink runs throughout the document. While SpaceX is never named, phrases like “home-grown European D2D offering” and “sovereign, secure and resilient communications” are unmistakably designed to differentiate SatCo from a vertically-integrated American competitor.

Technical Specifications: What the Network Will Actually Deliver

The filing provides unusually concrete technical specifications, likely because Ofcom requested evidence of deployment capability. Key figures:

Spectral efficiency: 3 bits per second per Hertz (bps/Hz) on the downlink using SISO (Single Input Single Output) configuration. This rises to 6 bps/Hz with the planned introduction of MIMO (Multiple Input Multiple Output) as more satellites are launched.

Throughput per beam: With the requested 2x15 MHz allocation and SISO configuration, each beam can deliver 45 Mbps downlink and 22 Mbps uplink peak throughput. This is mobile broadband, not just messaging.

Frequency reuse: AST SpaceMobile’s phased array antenna system and beam forming technology enable “full (1:1) frequency reuse” meaning the same frequencies can be used simultaneously across thousands of beams per satellite without interference. This is the core technological differentiation versus competitors using older satellite architectures.

Coverage: 100% geographic coverage of Europe, including Nordic regions.

Compatibility: Works with standard, unmodified 4G and 5G smartphones. No special hardware required on the consumer side.

The MIMO upgrade path is important. While 3 bps/Hz is respectable, 6 bps/Hz with MIMO would represent substantial capacity improvement, effectively doubling throughput per Hz of spectrum. The filing notes this capability will be enabled as more satellites are launched, suggesting ongoing constellation expansion beyond the initial commercial deployment.

The Border Problem: Why 2GHz MSS Matters

A key argument in the filing concerns the limitations of using terrestrial mobile (IMT) spectrum for satellite services. While AST SpaceMobile satellites can operate on MNO partners’ existing IMT frequencies, and will do so for the initial UK launch in 2026, these frequencies have significant constraints:

Border restrictions: IMT spectrum is nationally licensed. At borders, operators must coordinate to avoid cross-border interference. The filing notes that IMT-based D2D services “operate under ITU Radio Regulations article 4.4 and will therefore be especially restricted in border areas.”

Inconsistent allocations: Different MNOs in different countries hold different spectrum portfolios. The user experience would vary depending on what spectrum the local partner can contribute.

Feature deployment complexity: Rolling out new capabilities (6G, specialized encryption, broadcast mode for emergencies, IoT features) would require coordination across fragmented national spectrum holdings.

The 2GHz MSS band solves these problems. It’s harmonized across Europe, enabling seamless cross-border signals. For use cases like pan-European logistics, transport, emergency services, and roaming consumers, this harmonization is genuinely valuable. The filing makes this case explicitly:

“Only the 2GHz MSS frequencies are harmonised and able to provide seamless cross-border signals across UK and its neighbours - assuming the UK and the EU take an aligned approach on licence award.”

This framing positions 2GHz MSS as a complement to, not a replacement for, MNO spectrum. The combination of national IMT spectrum (for in-country capacity) plus harmonized MSS spectrum (for cross-border seamlessness and consistent service quality) is the technical architecture SatCo is proposing.

Consumer Research: Quantifying Demand

The filing cites primary research conducted across 5,000 consumers in nine Vodafone markets. Key findings:

· 67% of users reported connectivity issues with their current mobile service

· 73% expressed willingness to pay for the proposed satellite-based service

· 42% said the service would make them feel safer

· 38% said it would make a big difference to their lives

These numbers are striking, though the methodology isn’t disclosed. What price point was tested? How was the service described? Were respondents shown competitive alternatives? The filing doesn’t say.

Still, the directional signal is useful. Nearly three-quarters of surveyed consumers expressed interest in paying for satellite backup connectivity. That’s a larger addressable market than many skeptics have assumed. It suggests the service won’t be limited to niche use cases (rural coverage, emergency calling) but could see meaningful uptake among mainstream urban and suburban users who simply want more reliable connectivity.

Timeline and Spectrum Request

The deployment timeline is aggressive but credible:

· 2026: UK service launch using terrestrial mobile spectrum

· 2027/28: 2GHz MSS band services operational (assuming successful spectrum award)

The spectrum request is for a minimum of 2x15 MHz, or the amount necessary to achieve the economies of scale, trunking efficiencies, and unit economics that would enable mass-market affordability.

On license duration, the filing suggests 18 years as a baseline (matching the previous MSS license term) but expresses interest in longer tenure, noting that “Ofcom has solved the licensing certainty question for MNOs in the UK by offering perpetual licences, and this might be a suitable long-term ambition also for MSS licences.”

The argument for long license terms is straightforward: LEO satellites have 7-10 year useful lives, so any viable business case requires confidence in replenishment. Security of tenure enables the capital investment needed to maintain and upgrade the constellation over decades.

What This Means for the Investment Case

For AST SpaceMobile investors, this filing is incrementally positive. It demonstrates:

1. Active commercial traction. Six MNO MOIs representing 220 million subscribers is real momentum. These aren’t theoretical discussions – they’re documented commercial interest from named parties.

2. Coordinated regulatory strategy. Parallel engagement with UK and EU regulators, with aligned submissions and arguments, suggests sophisticated execution.

3. Technical credibility. The willingness to put specific spectral efficiency numbers and throughput figures in a public regulatory filing indicates confidence in the technology.

4. Strategic positioning against Starlink. The sovereignty narrative, wholesale structure, and coalition-building approach create defensible differentiation in a European regulatory context.

The key risks remain execution (can AST SpaceMobile actually launch enough satellites, on time?) and competition (will regulators award spectrum to SatCo, or to other applicants?). But this filing suggests the strategic architecture is sound and the commercial interest is real.

For Vodafone investors, the calculus is different. The SatCo joint venture represents optionality on a potentially transformative technology, but it’s not yet material to the overall business. The more interesting question is whether satellite backhaul capability could eventually become a competitive necessity rather than a differentiator. If so, Vodafone’s early positioning would be valuable insurance.

The Bigger Picture

The 2GHz MSS allocation decision, expected in 2027, will be one of the most consequential spectrum awards in recent European telecom history. The outcome will shape whether Europe develops indigenous satellite broadband capability or becomes dependent on American infrastructure.

Vodafone and AST SpaceMobile are making a clear bet: that European regulators, given a credible homegrown alternative, will prefer it to further entrenching US tech dominance. The filing is their opening argument. The next 18 months will determine whether that argument prevails.

Disclosure: This analysis is for informational purposes only and does not constitute investment advice. Positions may be held in securities mentioned. Please see prior disclaimers and disclosures.

Betting against Elon Musk has generally been a bad idea. But the EU satcom market presents a unique structural challenge where regulatory architecture may matter more than sheer execution (where Elon has notably crushed peers).

· The Setup: Critical 2 GHz spectrum licenses expire in May 2027. The EU must decide whether to renew them for Musk-controlled entities or reallocate to sovereignty-aligned alternatives.

· The Problem for Starlink: EU regulators have codified requirements for “technological sovereignty,” dual-sourcing of critical infrastructure, and avoiding “excessive reliance on non-EU solutions.” Starlink’s architecture is US-controlled with data routing through global inter-satellite links, and no oversight mechanism for EU authorities. This presents conflict with all three principles.

· The Opportunity for SatCo: Vodafone’s 50/50 JV with AST SpaceMobile appears designed specifically to satisfy EU requirements: German-flagged satellites, EU operations center, local data routing through carrier gateways, and a “command switch” for European oversight. It empowers carriers rather than threatening them.

· The Thesis: I’m not arguing Starlink won’t win consumer share in Europe. I’m arguing the regulated D2D opportunity of emergency services, government communications, and carrier partnerships has structural barriers that favor the SatCo model. The 2027 spectrum decision is the concrete catalyst and test of this. We should expect this to become an increasingly discussed topic as the year progresses with a potential entry to the public markets for SpaceX, conflict between Musk and the EU continues, and regulators are forced to being laying the framework that will have profound implications for the future.

Subscribe now

Share

The Musk Track Record (And Why It Usually Applies)

Let me start with an fact: betting against Elon Musk has been a reliably terrible investment strategy. That’s not what this note is trying to argue for.

SpaceX transformed launch economics from government-contractor bloat into reusable rocketry that undercuts competitors by orders of magnitude. Tesla proved electric vehicles could be desirable, not just dutiful. Starlink itself went from PowerPoint to 7,000+ operational satellites serving millions of subscribers in under a decade. The pattern is consistent – Musk enters a market dominated by incumbents, absorbs years of skepticism, then executes at a pace that makes the skeptics look foolish.

So when Starlink turns its attention to D2D connectivity, beaming service directly to standard smartphones without specialized hardware, the instinct to assume dominance is understandable. The company has the constellation, the launch capability, the capital, and a track record of converting skeptics into believers. Why would Europe be any different?

The short answer: because Europe has spent two decades proving it plays by different rules and being burned badly when they partner with the wrong side (e.g. Russian gas pipelines).

Europe Is Different

There’s an old saw in tech policy circles: America innovates first and regulates later; Europe regulates first and innovates later. The satellite communications market is following the script. The European Union has a demonstrated track record of constraining US technology giants through regulatory architecture rather than market competition.

GDPR forced every American tech company to fundamentally restructure data handling practices or face existential fines. The Digital Markets Act is actively compelling Apple to open its ecosystem, Google to modify search behavior, and Meta to enable interoperability. The Digital Services Act has X/Twitter under formal investigation with Musk personally in the regulatory crosshairs over content moderation failures. The pattern isn’t that EU regulations prevent US companies from operating. The pattern is that EU regulations impose compliance costs and structural requirements that American companies cannot simply bulldoze with superior products and capital.

Satellite communications add a national security overlay that makes regulators less flexible, not more. When the infrastructure in question supports emergency services, defense communications, and critical government functions, the tolerance for foreign dependency drops to near zero. The bureaucrats writing these rules aren’t concerned with market efficiency. They’re concerned with what happens when a foreign billionaire controls communications infrastructure during a crisis.

The political timing makes this worse for Musk specifically. He’s currently under active DSA investigation for X’s content moderation practices. The Grok AI controversy is generating problematic imagery that Brussels demanded be fixed, further escalating tensions. His public feuds with EU officials, perceived interference in national politics across Germany, the UK, and Italy, and his role in the Trump administration’s DOGE initiative have made him a uniquely polarizing figure in European capitals. Even if regulators wanted to extend favorable treatment, the political optics of approving spectrum licenses for someone under active EU investigation while he publicly attacks European institutions would be extraordinarily difficult to justify internally.

The 2027 Spectrum Cliff

Here’s where the abstract becomes concrete: critical spectrum licenses expire in May 2027, and the EU must decide what comes next.

The 2 GHz Mobile Satellite Services band (1980-2010 MHz paired with 2170-2200 MHz) is the prime real estate for direct-to-device connectivity. It’s the “Goldilocks” spectrum – frequencies that work well for satellite-to-phone communications without requiring antenna modifications. In 2009, the European Commission selected two operators, Inmarsat (now owned by Viasat) and Solaris Mobile (now owned by EchoStar), to provide mobile satellite services across the EU using this band. Those 18-year authorizations expire in May 2027.

Musk’s path to this spectrum runs through EchoStar. SpaceX agreed to acquire EchoStar’s spectrum assets, which would include access to the European 2 GHz licenses. But here’s the critical point: the commercial acquisition doesn’t guarantee regulatory renewal. The licenses belong to EU member states, granted under conditions established by Brussels. The Commission has explicit authority to impose new terms, segment the band among multiple operators, or decline renewal entirely.

EU officials have been unusually direct about their intentions. Andrius Kubilius, the Commissioner for Defense and Space, told the Financial Times that after current licenses expire, the EU “should not miss an opportunity to manage 2GHz allocations wisely.” He called the band “a strategic enabler for space governmental communications, in particular for direct-to-device services.” This isn’t bureaucratic throat-clearing. “Not miss an opportunity” signals the Commission views 2027 as a corrective action window, a chance to restructure the market, and not a routine administrative renewal.

The most likely outcome is band segmentation: splitting the spectrum among multiple licensees rather than allowing any single operator to hold a dominant position. This would directly implement the dual-sourcing principles the EU has codified elsewhere. Musk might retain some European spectrum access. But “some” is very different from “all,” and sharing the sandbox with mandated competitors fundamentally changes the economics.

What Spectrum Segmentation Actually Means

The practical implications of spectrum segmentation deserve attention because they reveal why “partial access” isn’t merely a smaller version of “full access”—it’s a qualitatively different competitive position.

When you split spectrum between operators, you need frequency separation (guard bands) to prevent interference. These guard bands are effectively dead spectrum—unusable capacity. Splitting EchoStar’s 2x15 MHz into two 2x7.5 MHz blocks would require guard bands that reduce total usable spectrum. Think of it as a transaction cost on fragmentation. Multiple operators in adjacent frequencies must also coordinate to prevent harmful interference, creating ongoing technical and legal complexity.

For direct-to-device services, bandwidth directly determines how many simultaneous users you can serve and what throughput each receives. Starlink has already upgraded from 5 MHz to 15 MHz in New Zealand after just six months of operations—they’re bandwidth-constrained for D2D. If Musk receives only 2x7.5 MHz in Europe instead of 2x15 MHz, his European D2D service is fundamentally capacity-limited compared to competitors with fuller spectrum allocations.

The more likely outcome, however, may be clean reassignment rather than fragmentation. Industry analyst Tim Farrar suggests regulators might let Viasat keep its 2x15 MHz (they’ve actually deployed services) while reallocating EchoStar’s entire block to an EU-aligned operator. This would give SatCo a meaningful, usable block rather than fragmented slivers—better for service quality than true segmentation, and worse for Musk’s European ambitions.

Musk’s Limited Recourse

Here’s an underappreciated aspect of the situation: the SpaceX-EchoStar deal is primarily a US-focused transaction. The $17 billion covers US AWS-4 and H-block licenses. EchoStar’s European 2 GHz rights (via Solaris Mobile) are legally separate—and critically, non-transferable. The EU licenses were granted for 18 years with effect from May 2009 and cannot be assigned to a new party. SpaceX cannot simply buy its way into European spectrum the way it can in the US.

What legal recourse exists if renewal is denied? Limited options. There’s no automatic renewal right—the Commission can run a fresh selection procedure. EchoStar could argue investment-backed expectations, but EU spectrum allocation has historically been treated as a sovereign national security matter with substantial regulatory discretion. WTO or trade agreement challenges face similar obstacles. The UK’s Ofcom and the EU Commission are both independently reconsidering the band’s future use, with no automatic path forward for incumbents.

Why 2 GHz Matters More Than Alternatives

Could Starlink simply use alternative spectrum in Europe? The options are constrained. L-band (1-2 GHz) is locked up for safety-of-life services including maritime and aviation communications—sharing would jeopardize mission-critical applications. Terrestrial MNO spectrum (700 MHz, 800 MHz) requires carrier partnerships and faces exclusion zone requirements around terrestrial networks that limit its usefulness in densely-populated Europe. The 700 MHz PPDR (public protection and disaster relief) band offers limited bandwidth with emergency services priority.

Industry analysis consistently identifies the 2 GHz band as the most promising frontier for D2D networks due to significant challenges in other MSS spectrum. The 2 GHz band offers flexibility and capacity with fewer regulatory and technical hurdles and minimal incumbent use. There isn’t a good alternative—the 2 GHz band is the only practical option for large-scale D2D broadband in Europe. For SatCo, winning this spectrum allocation is existential to their European strategy. For Starlink, losing it means relying on a patchwork of MNO partnerships with structural limitations.

The Three Pillars of Regulatory Resistance

EU regulators are assessing Starlink through three specific policy frameworks, each presenting distinct challenges for a US-controlled satellite operator.

Sovereignty: Who Controls the Kill Switch?

The foundational question for EU security planners isn’t whether Starlink technology works. It’s who makes decisions when it matters.

In 2022, Elon Musk declined to extend Starlink coverage to Crimea during a Ukrainian military operation. He later acknowledged restricting service based on his personal assessment of escalation risk, fearing a “mini-Pearl Harbor” scenario if Ukraine used the connectivity to attack Russian naval assets. You can debate whether his reasoning was sound. What you cannot debate is that the decision was his to make, not Kyiv’s, not NATO’s, and not the EU’s. For European defense planners, this wasn’t a bug report. It was a threat assessment.

The EU’s regulatory response has been explicit. The IRIS² regulation establishing Europe’s own €10.6 billion satellite constellation includes language at Article 3 integrating “technological sovereignty” as a core objective, “together with the obligation to avoid excessive reliance on non-EU based solutions.” This isn’t aspirational. It’s binding law that procurement officials and spectrum regulators must consider when making allocation decisions.

Starlink’s architecture offers no mechanism for European oversight, as of today. Decisions about service availability, coverage areas, and operational priorities flow from Boca Chica. SatCo, by contrast, has built in what it calls a “command switch.” This is a technical control over telemetry, tracking, and encryption keys that can be exercised by European authorities – sovereignty by design, not sovereignty by request.

Resilience: The Dual-Sourcing Mandate

European regulations increasingly require critical infrastructure operators to maintain supplier diversity and avoid single points of failure.

The NIS2 Directive and Critical Entities Resilience (CER) Directive mandate that operators of essential services, including emergency telecommunications, assess and mitigate supply chain risks. Relying on a single provider for satellite connectivity, particularly one controlled by a foreign entity with no EU oversight mechanism, creates precisely the concentrated risk these directives target. IRIS² goes further: Article 17 establishes procurement requirements specifying “a minimum of economic operators established in different Member States.” This is codified dual-sourcing, a legal requirement to maintain multiple suppliers, not merely a preference.

The implication for spectrum allocation is straightforward. Granting monopoly access to the 2 GHz band would contradict the resilience principles EU regulators are simultaneously enforcing across critical infrastructure. Band segmentation ensures multiple operators can provide direct-to-device services and aligns regulatory practice with stated policy. Awarding everything to a single US-controlled operator does not.

Data Routing: Where Does the Traffic Actually Go?

This one is technical but important: today Starlink’s architecture fundamentally differs from traditional satellite communications in ways that create regulatory friction.

Starlink satellites communicate with each other via inter-satellite links (ISLs), allowing traffic to hop across the constellation before landing at any ground station globally. This is elegant engineering as it provides resilience, reduces latency for long-distance communications, and allows flexible routing around network congestion. But it also means data originating in Berlin might transit through satellites over the Atlantic, land at a gateway in Texas, then route back to its European destination. From Starlink’s perspective, this is a feature. From an EU regulator’s perspective, it’s a compliance problem.

GDPR establishes data localization requirements. National security services require lawful intercept capabilities. Defense applications demand assured routing that doesn’t traverse foreign infrastructure. Starlink’s ISL architecture makes these requirements difficult to satisfy, not because SpaceX is unwilling, but because the system wasn’t designed with EU data sovereignty as a constraint.

The SatCo model uses traditional “bent-pipe” architecture: traffic goes up to the satellite and immediately back down to a local gateway owned by the national mobile operator. Data from Berlin lands in Germany. The carriers (Vodafone, Orange, or whoever) maintain legal and technical control throughout. No routing through US infrastructure. No ambiguity about jurisdiction. No GDPR gymnastics required.

SatCo: Built for Brussels

Every structural detail of the Vodafone-AST SpaceMobile joint venture reads like a checklist of EU regulatory requirements.

The ownership is split 50/50 between Vodafone and AST SpaceMobile, with the JV incorporated in Luxembourg for EU jurisdiction from day one. AST has registered its satellites with the International Telecommunication Union through Germany, meaning the constellation will be “flagged” as German for regulatory purposes. The satellite operations center will be located near Hannover or Munich, keeping command and control within EU borders. These aren’t incidental details. They’re deliberate architectural choices that anchor the enterprise within European legal and political frameworks.

The business model reinforces regulatory positioning. SatCo operates as a wholesale provider, selling capacity to mobile network operators who then offer services under their own brands to end customers. Vodafone is the anchor customer, but operators in 21 EU member states have already expressed interest in the service. This means SatCo empowers existing carriers rather than threatening to disintermediate them. The distinction matters enormously for regulatory reception.

Consider who influences EU telecommunications policy: national carriers with decades-long relationships with regulators, substantial lobbying presence in Brussels, and direct stakes in spectrum allocation decisions. Vodafone, Orange, and Deutsche Telekom are all members of the SpaceRISE consortium building IRIS². When these carriers tell the Commission “we prefer the partnership model,” that carries weight. Starlink, which may seek to bypass carriers entirely in its commercial model, has no natural allies in the European telecom ecosystem. Its potential success comes at their expense.

The “command switch” feature deserves specific attention. SatCo has explicitly designed technical controls allowing European authorities to manage telemetry, tracking, and encryption keys for both S-band and Q/V-band spectrum. This directly addresses the sovereignty concern that Starlink’s architecture leaves unresolved. When EU defense officials ask “who controls this infrastructure during a crisis?”, SatCo can provide a concrete answer. Starlink cannot.

What I’m NOT Saying

Let me be clear about the limits of this analysis.

Starlink will almost certainly win consumer market share in Europe. The technology works, the user experience is likely to be strong, and pricing will be competitive. For rural broadband, maritime connectivity, and aviation applications, Starlink has demonstrated product-market fit that European alternatives struggle to match. The company’s 7,000+ satellite constellation provides capacity and coverage that IRIS² (290 satellites, operational 2030) cannot replicate for years.

I’m not arguing Starlink faces existential regulatory risk in Europe. The company will operate, will serve customers, and will generate revenue from the European market. Brussels isn’t going to ban Starlink.

I’m also not arguing that Musk’s political difficulties guarantee regulatory defeat. European regulators are bureaucrats, not partisans. They’ll cite policy frameworks and legal requirements, not personal grievances. The analysis here focuses on structural factors such as architecture, data routing, ownership, and oversight mechanisms because those are the considerations that will actually drive decisions.

What I AM Saying

The regulated D2D opportunity involving government communications, emergency services, defense applications, and carrier partnerships has structural characteristics that favor the SatCo model over Starlink.

Spectrum allocation decisions in May 2027 provide a concrete catalyst. The Commission has both the authority and the stated intent to restructure access in ways that promote sovereignty and resilience objectives. Band segmentation is the likely outcome, creating protected market space for EU-aligned operators regardless of Starlink’s technical capabilities.

The regulatory architecture is multi-layered and mutually reinforcing. Sovereignty requirements in IRIS² and the proposed EU Space Act. Dual-sourcing mandates in NIS2 and CER. Data localization obligations under GDPR. Compliance Board review processes that apply different standards to EU and non-EU operators. Cybersecurity certification requirements that could force fundamental hardware redesigns for existing Starlink satellites. Any one layer might be navigated. The combination creates a regulatory environment structurally hostile to concentrated foreign dependency.

SatCo was designed to thread every needle. EU ownership, German flagging, local operations, carrier partnerships, technical oversight mechanisms, bent-pipe architecture keeping data within national borders. This isn’t a company that happens to be EU-compliant. It’s a company designed to be EU-compliant.

The Carrier Economics Kicker

Here’s the dynamic that ties everything together: follow the incentives.

Starlink’s commercial model, at its most ambitious, envisions direct relationships with end users and connectivity sold as a SpaceX product, thus carriers reduced to legacy infrastructure competing for a shrinking terrestrial pie. This may or may not be the company’s actual strategy, but it represents the logical endpoint of vertical integration: own the satellites, own the spectrum, own the customer relationship. The carriers, in this vision, get disintermediated. Musk as spoken to this on multiple occasions.

SatCo’s model points the opposite direction. Wholesale capacity sold to carriers who brand and sell the services themselves. Vodafone retains the customer relationship, the billing relationship, the regulatory license. AST SpaceMobile provides infrastructure; the carriers provide everything else. In this model, direct-to-device satellite connectivity extends carrier relevance rather than threatening it.

Now ask yourself: who has influence over European telecommunications regulation? Who sits on advisory bodies, maintains decades of relationships with national ministries, and employs substantial lobbying resources in Brussels? The carriers. And when the carriers have a choice between a model that empowers them and a model that threatens to make them obsolete, their preference isn’t subtle.

This creates a structural dynamic independent of any technical or regulatory consideration. The incumbents whose influence shapes policy outcomes are natural allies of the SatCo model and natural adversaries of Starlink’s potential vision. Even if every regulatory concern could be addressed, the political economy of European telecommunications tilts the playing field.

Paths Forward: Balancing EU Interests Without a Global Rift

The preceding analysis might suggest an inevitable collision course between European sovereignty objectives and American commercial interests. But regulators face genuine trade-offs, and the path forward likely involves accommodation rather than exclusion. Understanding the realistic options matters for assessing how this plays out.

For Regulators: The Segmentation Compromise

European regulators aren’t operating in a vacuum. The transatlantic relationship matters, and being seen to discriminate against American companies carries diplomatic costs. The proposed EU Space Act has already drawn formal objections from the US State Department calling certain provisions “discriminatory.” FCC Chairman Brendan Carr has delivered ultimatums about European tech policy. Regulators must balance sovereignty objectives against maintaining functional transatlantic cooperation.

The likely regulatory path involves segmentation that preserves some access for all parties. Viasat (the other current licensee) might retain its 2x15 MHz allocation given actual service deployment. The EchoStar/SpaceX block could be divided: perhaps 2x10 MHz for a sovereignty-compliant EU operator like SatCo, with a smaller allocation or conditional access for Starlink tied to specific compliance requirements. This threads the needle—demonstrating commitment to sovereignty principles while avoiding outright exclusion that could trigger trade disputes.

For SpaceX: The European Subsidiary Option

SpaceX could, in theory, restructure its European operations to address sovereignty concerns. Establishing a European subsidiary with meaningful local governance, EU-based ground stations with guaranteed data localization, and technical mechanisms for European oversight would address the architectural objections. Other American tech companies have made similar accommodations—running European data through European infrastructure with European legal controls.

The question is whether SpaceX would accept these constraints. The company’s architecture wasn’t designed with EU sovereignty as a constraint, and retrofitting control mechanisms into an existing constellation presents genuine technical challenges. More fundamentally, accepting European regulatory oversight conflicts with Musk’s public posture toward EU institutions. The GDPR playbook—compliance through adaptation—remains available, but it requires a willingness to accommodate that hasn’t been evident in the relationship to date.

For SatCo: Execution Risk Remains

Regulatory positioning doesn’t guarantee commercial success. SatCo must still execute: launch satellites, achieve reliable service, price competitively, and convince carriers beyond Vodafone to adopt the platform. AST SpaceMobile has demonstrated technology with its existing constellation, but scaling from demonstration to commercial service involves execution risk that regulatory favor cannot eliminate. The structural advantages matter only if the underlying service works.

The Asymmetric Segmentation Thesis

Here’s the crucial point for the investment thesis: validating the Vodafone/SatCo opportunity doesn’t require a “Starlink ban.” It requires asymmetric market segmentation, and that’s exactly what European regulatory architecture is designed to produce.

Picture a two-tier market structure emerging from the 2027 spectrum decision:

The Sovereign Tier (SatCo): The EU allocates the prime 2 GHz blocks to the SatCo joint venture for critical infrastructure, emergency services, and government communications. This is the high-margin B2B and B2G segment for wholesale carrier fees, defense contracts, and IRIS² integration. The sovereignty-by-design architecture makes SatCo the only compliant option for these applications. Carriers who want to offer “coverage everywhere” to enterprise and government customers must route through SatCo’s infrastructure.

The Consumer Tier (Starlink/Viasat): Starlink operates in a segmented spectrum block or through MNO partnerships, serving the commercial consumer market—rural broadband, maritime connectivity, aviation WiFi, recreational users. This is the high-volume, lower-margin segment where Starlink’s technical advantages and scale economics dominate. But critically, regulators mandate that all “critical” traffic (112 emergency calls, police communications, government data) must roam onto sovereignty-compliant networks.

SatCo doesn’t need to beat Starlink on speed, consumer subscriptions, or technical innovation. It just needs to be the mandated wholesale layer for critical services.

If the EU makes “sovereign backup” a requirement for mobile carriers operating critical infrastructure, and the regulatory architecture we’ve examined suggests exactly that direction, then SatCo wins the high-margin B2B and B2G contracts regardless of whether Musk dominates the campers-and-yachts segment. The wholesale carrier fees from Orange, Deutsche Telekom, and others who need sovereignty-compliant D2D to serve enterprise and government customers flow to SatCo by regulatory design.

The SatCo strategy doesn’t require Starlink’s total European failure. It depends on the EU doing exactly what it has done in every other critical technology sector: creating a protected space for sovereignty-compliant providers in the segments that matter for security and resilience, while allowing commercial competition in consumer markets. Vodafone’s SatCo optionality captures the former. The market has priced Vodafone as if the latter is all that matters.

Conclusion: Betting on the Pattern

The default assumption that Musk wins because Musk always wins isn’t wrong. It’s incomplete.

In most markets, superior execution beats regulatory friction. Build a better product, drive costs down, let customers choose. But the EU has spent two decades demonstrating that regulatory architecture can constrain US technology giants in ways that pure market competition cannot. GDPR changed how every American tech company handles data. The DMA is changing how Apple builds products. The DSA has Musk’s own platform under investigation. The pattern is consistent: Europe doesn’t win by out-innovating. Europe wins by writing rules that superior innovation cannot circumvent.

Satellite communications follows the same pattern, with national security concerns amplifying regulatory willingness to act. The 2027 spectrum decision will reveal whether D2D connectivity is subject to the GDPR playbook – structural requirements that reshape market access regardless of technical merit – or whether this market proves different.

My bet is on the pattern.

For Vodafone shareholders, this matters because SatCo isn’t a speculative technology moonshot. It’s a strategically positioned asset designed to capture regulated demand that Starlink may structurally struggle to serve. The 2 GHz spectrum decision provides a concrete catalyst. The carrier alignment provides political support. The sovereignty-by-design architecture provides regulatory cover.

The market has priced Vodafone as a legacy telecom operator without satellite optionality. The regulatory deep dive suggests that optionality may be more valuable than the market appreciates not because Starlink will fail, but because the EU has constructed a framework where certain categories of demand are effectively reserved for sovereignty-compliant providers.

SatCo was built to be exactly that.